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Abstract 
Obstructive sleep apnoea (OSA) is a sleep disorder that involves frequent episodes of 
breathing cessation or significant decreases in airflow during sleep, leading to periods of 
blood oxygen desaturation. These episodes of intermittent hypoxia (IH) followed by 
reoxygenation are thought to induce oxidative stress and neuroinflammation. Patients with 
severe OSA exhibit neuropsychological deficits and impaired memory. Continuous positive 
airway pressure (CPAP) is the standard treatment for OSA patients, but not all cognitive 
symptoms can be reversed by this procedure, suggesting that severe OSA may permanently 
injure the brain. The CA1 region of the hippocampus is one of the first regions of the brain to 
suffer hypoxic injury. This vulnerability is supported by imaging studies showing that the 
volume of the hippocampus is reduced in people with severe OSA. Since it is not known why 
some parts of the hippocampus are selectively vulnerable to hypoxia, an investigation of the 
microvessels in these regions could provide new insights. 
The first aim of the present study was to investigate the effects of OSA severity, regular 
CPAP use and advanced age on angiogenesis and microvascular remodelling in different 
regions of the hippocampus (Chapter 3). It was hypothesised that there would be significantly 
increased microvascular alterations in the high OSA group (oxygen desaturation index: ODI 
≥ 20 events/h sleep) compared to the low OSA group (ODI < 20 events/h sleep). The 
hypothesis was tested by measuring capillaries that had been immunostained by either CD34, 
VWF, Claudin 5, GluT-1 or Collagen IV, in the fimbria, CA4, CA1, subiculum and collateral 
sulcus regions. Analyses were conducted on formalin-fixed, paraffin-embedded hippocampal 
tissues obtained at autopsy from 30 OSA patients. The results showed that angiogenesis did 
not occur in OSA; instead moderate-severe OSA was associated with a 10 − 25% increase in 
the mean diameters of capillaries in the fimbria and CA4 regions, suggesting that 
microvascular remodelling occurred in response to IH in OSA. These changes were not 
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reversed by CPAP treatment. The lack of adaptive microvascular changes in the CA1 region 
might be a factor in the selective vulnerability of this region to hypoxia.  
The second aim was to systematically investigate the presence of morphological 
abnormalities in the microvessels of the hippocampus of OSA patients (Chapter 4). It was 
hypothesised that if microvascular abnormalities are caused by oxidative stress, they would 
be more prevalent in the high OSA group and advanced age group, while regular CPAP users 
would display fewer abnormalities. The results showed there were increased numbers of 
abnormal microvessels in the high OSA group in the CA1 region, but not in other parts of the 
hippocampus. It is speculated that increased numbers of abnormal microvessels in the CA1 
region enhances its vulnerability to hypoxic injury and causes permanent degenerative 
changes that limit the ability of CPAP to reverse memory impairments. 
Corpora amylacea (CoA) are often regarded as correlates of the ageing process, and their 
numbers have been reported to increase steadily after the age of 50. Despite the fact that CoA 
were first identified in the central nervous system (CNS) over a century ago, little is known 
about their spatial distribution in the hippocampus of aged OSA patients. The third aim was 
to determine the distribution and progression pattern of CoA in the hippocampus, and to 
assess how the density and size of CoA change with advancing age (Chapter 5). It was 
hypothesised that CoA would be concentrated in periventricular and subpial regions, and that 
their density and size would increase with age. The results revealed that while the size of 
CoA increases with age, the packing density does not. A distinct distribution pattern of CoA 
was observed by low-magnification scanning photomicrographs that began at the fimbria and 
then progressively spread along the pial surface of the hippocampal formation to more distant 
regions. This progression pattern did not correlate with age. This spatiotemporal sequence has 
not been reported previously, and the reasons for this pattern of spread are unknown. 
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The fourth aim of the present study was to investigate factors that may be associated with 
CoA formation (Chapter 6). Since CoA contain oxidised lipids and proteins, it has been 
speculated that they are markers of oxidative stress or the consequence of neurodegenerative 
processes. It was hypothesised that increased OSA severity would be associated with larger 
and more numerous CoA. The results confirmed that OSA severity was significantly 
correlated with the spatiotemporal distribution of CoA, as well as increased CoA density. 
However, as these correlations did not diminish with regular CPAP use, a role for hypoxia or 
oxidative stress was not supported. Furthermore, CoA were rarely observed in the CA1 
region, despite this region being thought to experience the highest levels of hypoxia and 
oxidative stress. The data also failed to support neurodegeneration as a cause of CoA, as no 
correlations were found between CoA burden (distribution, density or size), and the burden of 
Amyloid β (Aβ) plaques, Tau+ neurofibrillary tangles, neuropil loss or demyelination.  
This study advances our understanding of regional differences in the capacity of the 
hippocampal microvasculature to remodel in response to increasing severity of OSA and to 
ageing, and offers a new explanation for the selective vulnerability of the CA1 to hypoxia. 
This study also advances our understanding of the factors that contribute to the formation of 
CoA, showing that OSA severity is correlated with the spatial extent and numbers of CoA in 
the hippocampus, while patient age is correlated with their size. In contrast, oxidative stress 
and neurodegeneration now appear unlikely to contribute to the formation of CoA in the 
human hippocampus. It is recommended that larger studies be conducted, that include 
patients without OSA, so that the present findings can be confirmed and extended.  
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Chapter 1 Literature Review 
1.0 Overall introduction 
Obstructive sleep apnoea involves frequent cessations of breathing during sleep, leading to 
intermittent hypoxia and oxidative stress in the brain. Animal models of intermittent hypoxia 
have shown that the oxidative stress is associated with neuronal injury and cell death in the 
hippocampus. Hypoxia is a well-known stimulus for angiogenesis and vascular remodelling, 
whereas perturbations in cerebral blood flow and oxidative stress can be injurious to 
capillaries. Since all of these factors are thought to be present in OSA, it seems likely that 
severe OSA will be characterised by remodelling of the capillary network and pathological 
changes in the ultrastructure of the capillaries, particularly in sectors of the hippocampus that 
are known to be sensitive to hypoxia.  
Although it is widely assumed that OSA injures the hippocampus via oxidative stress, direct 
evidence is lacking. In other conditions, such as brain ageing and Alzheimer's disease, 
oxidative stress has been associated with an increased burden of corpora amylacea in the 
hippocampus. These extracellular globules are composed of oxidised lipids and proteins, and 
are regarded as indicators of neuronal damage, particularly from oxidative stress.  
This literature review focuses on relevant research to provide: i) a general introduction to 
OSA, including its diagnosis with polysomnography, and treatment with continuous positive 
airway pressure; ii) an overview of cerebral microvasculature adaptations (angiogenesis and 
vascular remodelling) that typically occur in response to hypoxia; iii) a summary of what is 
known about injury to the cerebral microvasculature in response to oxidative stress; and iv) a 
discussion of current views on the distribution and formation of corpora amylacea in the 
brain. Gaps in the current literature are identified and hypotheses are developed to guide the 
research presented in this thesis. 
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1.1 Obstructive sleep apnoea  
Obstructive sleep apnoea is the most common type of sleep-disordered breathing. It is due to 
upper airway collapse, where the lumen of the pharyngeal airway is obstructed by the 
relaxation of the tongue and soft tissue during sleep (Dempsey, Veasey et al. 2010, Gislason 
and Sunnergren 2014). OSA patients are capable of controlling their upper airway dilators 
properly in wakefulness, yet lose control of these muscles during sleep, resulting in the 
collapse of the upper airway (Schwab, Pasirstein et al. 2003, Dempsey, Veasey et al. 2010). 
The lumen of the pharyngeal airway can also be narrowed by the craniofacial structure or by 
fat deposition in the walls of the throat (Jordan, McSharry et al. 2014). The reduced airflow 
can lead to blood oxygen desaturation, hypercapnia, recurrent snoring, choking or gasping, 
arousals from sleep, sleep fragmentation and sleep deprivation (Malhotra and White 2002, 
Azagra-Calero, Espinar-Escalona et al. 2012, Kielb, Ancoli-Israel et al. 2012). OSA sufferers 
often experience daytime sleepiness, morning headache, fatigue or tiredness, depression and 
anxiety (Kasai, Floras et al. 2012, Phillips and O’Driscoll 2013, Morsy Nesreen, Farrag 
Nesrine et al. 2019), which in turn reduce the quality-of-life (Punjabi 2008). 
As is well known, a sufficient quantity and quality of sleep is critical for our physical, mental 
and emotional wellbeing. The frequent arousals and sleep fragmentation in OSA alter the 
sleep patterns, resulting in less deep sleep and more light sleep (Yaouhi, Bertran et al. 2009, 
Kim, Joo et al. 2016). OSA is recognised as a major public health problem, and individuals 
with OSA are more likely to have motor vehicle accidents (Leger, Bayon et al. 2012, Morsy 
Nesreen, Farrag Nesrine et al. 2019), reduced work productivity and work-related injuries 
(Hillman, Murphy et al. 2006, Morsy Nesreen, Farrag Nesrine et al. 2019). A meta-analysis 
reported a 2.43-fold increased risk of a car accident in OSA patients compared to controls 
(Tregear, Reston et al. 2009). Medical costs plus physical impairment not only place a 
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significant financial burden upon victims, but also on the entire national economy and 
healthcare system (Skaer and Sclar 2010, Tarasiuk and Reuveni 2013, Morsy Nesreen, Farrag 
Nesrine et al. 2019). The burden that OSA places on economic and healthcare system costs in 
Australia was estimated in a report commissioned by the Sleep Health Foundation in 2011 
(Table 1.1); the direct total health system cost for OSA and associated conditions was 
estimated to be $408.5 million per year, while indirect financial costs associated with lost 
productivity, informal care and other costs of motor vehicle accidents amounted to $2.6 
billion annually (Economics 2011).  
Table 1.1 Medical conditions and health costs attributed to OSA. 
Attributed injury/                  
illness 
Proportion (%) of OSA 
prevalence 
Proportion (%) of OSA 
health system cost 
Stroke 5.3% 6% 
Congestive heart failure 1.1% − 
Coronary artery disease 3.6% 14% 
Other cardiovascular 
diseases 
− 24% 
Depression 6.2% 31% 
Motor vehicle accidents 4.3% 10% 
Work-related injuries 0.6% 15% 
Based on (Economics 2011). 
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OSA is often comorbidly associated with metabolic syndrome, which is characterised by 
hypertension, hyperglycaemia, dyslipidaemia, impaired glucose tolerance and increased 
insulin resistance (Punjabi 2008, Kasai, Floras et al. 2012, Phillips and O’Driscoll 2013, 
Cantiello, Cicione et al. 2015, Keenan, Kim et al. 2018), as well as a predisposition to obesity 
and cardiovascular disease (Coughlin, Mawdsley et al. 2004, Arnardottir, Bjornsdottir et al. 
2016, Sutherland, Keenan et al. 2019). Various studies have suggested that OSA may 
contribute to and exacerbate cardiovascular disease (Marin, Carrizo et al. 2005, Peker, 
Carlson et al. 2006, Morsy Nesreen, Farrag Nesrine et al. 2019), with direct and deleterious 
effects on cardiac and vascular structure and function (Lanfranchi & Somers, 2001).  
1.1.1 OSA diagnosis − Polysomnography 
The gold-standard method for assessing the presence and severity of OSA is 
polysomnography (Chesson, Ferber et al. 1997, Boyd, Upender et al. 2016). 
Polysomnography monitors a set of physiological variables during an overnight sleep study, 
including the number of apnoeas and hypopnoeas, the percentage of arterial oxygen 
desaturations, heart rate, airflow, eye movements and muscle tone (Flemons, Littner et al. 
2003, Pamidi, Aronsohn et al. 2010). An apnoea is defined as the complete cessation of 
airflow for a minimum of 10 seconds (Patil, Schneider et al. 2007, Gharibeh and Mehra 
2010), whereas a hypopnoea is an airflow reduction of at least 30% below baseline for 10 
seconds or more, accompanied by a drop in blood oxygen saturation (of at least 3% or 4%) 
and/or a measured arousal in the brain (Ruehland, Rochford et al. 2009). The respiratory 
events and arousals can occur over 120 times per hour (Chiang 2006). The severity of OSA is 
rated according to the apnoea-hypopnoea index (AHI), which is the average number of 
apnoeas and hypopnoeas per hour of sleep (Vasu, Grewal et al. 2012). An AHI score of < 5 is 
considered normal, and OSA suffers are categorised as mild, moderate and severe with AHI 
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scores of 5 – 15, 15 – 30 and > 30, respectively (Badran, Ayas et al. 2014). During an apnoea 
or hypopnoea, OSA patients undergo varying levels of hypoxemia/hypercapnia, leading to 
the oxyhaemoglobin saturation dropping to 95% in mild sufferers or below 60% in very 
severe cases (Chiang 2006, Badran, Ayas et al. 2014). Another widely-used scale of OSA 
severity is the oxygen desaturation index (ODI), which measures the number of times per 
hour of sleep that the blood's oxygen level drops by at least 3% or 4% (Berry, Budhiraja et al. 
2012). 
1.1.2 OSA treatment − Continuous positive airway pressure 
 CPAP is the most commonly prescribed treatment for OSA (Sullivan, Berthon-Jones et al. 
1981, Patel, White et al. 2003, Kushida, Littner et al. 2006, Chowdhury, Wedderburn et al. 
2012). A CPAP machine consists of a facemask, a tube and a device that blows air (positive 
pressure) into the tube (Sahni and Wung 1998). The positive air pressure provided by the 
CPAP machine can prevent closure of the pharynx and larynx by distending the upper airway 
(Gaon, Lee et al. 1999). CPAP treatment supports an uninterrupted sleep by reducing the 
number of apnoeas and hypopnoeas, and normalising the sleep architecture (Sullivan, 
Berthon-Jones et al. 1981). CPAP treatment has been reported to reduce daytime sleepiness 
(Cohen‐Zion, Stepnowsky et al. 2001, Marshall, Barnes et al. 2006), reduce systemic blood 
pressure (Bazzano, Khan et al. 2007, Marin, Agusti et al. 2012), improve daytime 
productivity and daily function (Weaver and Grunstein 2008), improve quality of life 
(Kandasamy, Almaghaslah et al. 2019), elevate mood and psychological well-being (Giles, 
Lasserson et al. 2006, Hobzova, Hubackova et al. 2017), and reduce the incidence of 
automobile accidents (Gay, Weaver et al. 2006, Weaver and Grunstein 2008). Dewan and 
colleagues (2015) claimed that early treatment with CPAP can maximise functional recovery 
and minimise residual injury (Dewan, Nieto et al. 2015). CPAP treatment is not limited to 
moderate and severe OSA; it has been widely used to treat mild OSA, respiratory failure in 
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preterm infants (Sahni and Wung 1998), upper airway resistance syndrome, and snoring 
(Kushida, Littner et al. 2006). 
While CPAP is an effective treatment for OSA, many patients find the apparatus 
uncomfortable to use. Consequently, CPAP uptake is only around 50%, and of those who 
begin CPAP treatment, adherence is between 30% and 80% (Weaver and Grunstein 2008, 
Weaver and Sawyer 2010, Park, Kim et al. 2017). Even among adherent users of CPAP, it is 
only used for an average of 4 hours per night. A recent study showed that nearly 40% of 
regular CPAP users developed oral symptoms, such as dry mouth and poor oral health 
(Tsuda, Moritsuchi et al. 2016).  
1.1.3 Risk factors for development and exacerbation of OSA 
The prevalence of OSA in the overall population has been estimated to range between 2.1% 
and 36.5% (Table 1.2), with the wide variability being due to differences in risk between 
genders, ethnicity and age (Senaratna, Perret et al. 2017), as well as to differences between 
studies in the patient selection criteria used. Risk factors for OSA include older age, male 
gender, postmenopausal state, and obesity (Young, Peppard et al. 2002, Lee, Nagubadi et al. 
2008, Punjabi 2008, Lam, Sharma et al. 2010, Gislason and Sunnergren 2014). The 
prevalence of OSA has been estimated to be 3 – 10% in adults aged less than 40 years, 10 – 
20% in older adults (Punjabi 2008, Simpson, Hillman et al. 2013, Gislason and Sunnergren 
2014), with this value increasing to 78% in females and 90% in males aged 60 – 85 
(Senaratna, Perret et al. 2017). In a population-based study OSA prevalence was found to be 
nearly 50% in persons 60 − 70 years of age, while being less than 10% in those aged 30 − 39 
(Durán, Esnaola et al. 2001).  
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Table 1.2 OSA prevalence in different genders and ethnicity. 
Country Ethnicity 
Prevalence of OSA (AHI ≥ 5) 
Study 
Age range Men Women 
United States White 30 – 60 24% 9% (Young, Palta et al. 1993) 
Australia White 40 – 65 126% /  
3% 
− (Bearpark, Elliott et al. 
1995) 
Spain White 30 – 70 26.2% 28.0% (Durán, Esnaola et al. 
2001) 
Poland White 30 – 75 36.5% 18.5% (Pływaczewski, Bednarek 
et al. 2008) 
China Chinese 30 – 60 4.1% − (Ip, Lam et al. 2001) 
China Chinese 30 – 60 − 2.1% (Ip, Lam et al. 2004) 
India Indian 35 – 65 7.5% − (Udwadia, Doshi et al. 
2004) 
India Indian 30 – 65 13.5% 5.5% (Reddy, Kadhiravan et al. 
2009) 
Korea Korean 40 – 69 4.5% 3.2% (Kim, In et al. 2004) 
1 RDI (respiratory disturbance index) ≥ 5 with / without excessive daytime sleepiness. 
Updated based on (Punjabi 2008). 
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Most studies have reported that OSA is more common in males, although the estimated 
prevalence varies greatly (Table 1.2; Figure 1.1). A study of employees 30 − 60 years old 
reported that 4% of men and 2% of women met the criteria of AHI ≥ 5 (Young, Palta et al. 
1993); while in a review paper, OSA prevalence in the general population was estimated to 
be 3 − 7% in adult men and 2 − 5% in adult women (Punjabi 2008). The prevalence of OSA 
has also been studied in women, where it is estimated to be 0.6% in premenopausal women, 
0.5% in postmenopausal women receiving hormone replacement therapy and 2.7% in 
postmenopausal women without hormone replacement therapy (Bixler, Vgontzas et al. 2001).  
 
Figure 1.1 Estimated prevalence in Australia of moderate-to-severe OSA (AHI ≥ 15), 
stratified by age and gender. 
The OSA prevalence among Australians shows a trend to increase with age, and to be more 
prevalent among men than women. Based on (Economics 2011). 
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Obesity is one of the major risk factors for OSA (Hamilton and Naughton 2013). In a 
worldwide study of obesity in 106 countries (approximately 88% of the world population) in 
2005, the prevalence of overweight adults (BMI > 25 kg/m2) was estimated to be 23.2% (937 
million), and obese adults (BMI > 30 kg/m2) to be 9.8% (396 million) (Kelly, Yang et al. 
2008). The global prevalence of obesity has doubled between 1980 and 2015 in more than 70 
countries, with obesity (BMI > 30 kg/m2) affecting 5.0% of children and 12.0% of adults 
worldwide, in a global longitudinal study over 25 years in 195 countries (Collaborators 
2017). It was estimated that nearly 108 million children and more than 600 million adults 
were obese worldwide in 2015 (Collaborators 2017). Moreover by 2030 the number of 
overweight and obese adults was projected to be 1.35 billion and 570 million respectively 
(Kelly, Yang et al. 2008).  
OSA worsens with weight gain and improves with weight loss (Peppard, Young et al. 2000). 
A longitudinal study investigated the independent association between weight change and 
change in sleep-disordered breathing severity over a 4-year period in 690 middle-aged 
participants (mean age 46 years; 56% male); a 10% weight gain was found to be associated 
with a 32% mean increase in AHI score, and a 6-fold increased risk of developing moderate 
to severe sleep-disordered breathing (Peppard, Young et al. 2000). Conversely, weight loss 
improved OSA, with a 10% weight loss being associated with a 26% mean reduction in the 
AHI (Peppard, Young et al. 2000).  
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1.1.4 Intermittent hypoxia (IH) 
OSA is characterised by repeated upper airway collapse during sleep, resulting in intermittent 
hypoxia (IH) and sleep fragmentation (Jun and Polotsky 2007, Gharibeh and Mehra 2010, 
Vijayan 2012). While IH can be regarded as ‘repetitive hypoxia interspersed with episodes of 
normoxia’, IH elicits very different systemic and cellular responses when compared to 
sustained hypoxia (Neubauer 2001, Chiang 2006). The recurrent cycles of hypoxemia with 
reoxygenation during IH in OSA have been suggested to contribute to ischemia-reperfusion 
injury (Dewan, Nieto et al. 2015). An example of ischemia-reperfusion injury is when a 
person has a cardiac arrest and is then resuscitated; the resumption of oxidative metabolism 
causes an increased production of reactive oxygen species, and the consequent oxidative 
stress can injure the brain (Suzuki, Jain et al. 2006, Dewan, Nieto et al. 2015). IH involves 
innumerable episodes of ischemia-reperfusion, and the rates of reactive oxygen species 
production following each episode of IH are estimated to be as much as 100-fold higher than 
basal levels; it is this feature that differentiates between sustained hypoxia and IH (Michiels, 
Tellier et al. 2016). 
Sustained hypoxia has been reported to be associated with the rapid stabilisation of the 
transcriptional hypoxia-inducible factor-1 (Ryan, Taylor et al. 2005, Chiang 2006), a sensor 
of systemic hypoxia, which mediates the expression of many proteins in response to hypoxic 
stress (Punjabi and Polotsky 2005, Lavie 2009), resulting in increased expression of 
erythropoietin, vascular endothelial growth factor, and inducible nitric oxide synthase, all of 
which contribute to an adaptive phenotype (Ryan, Taylor et al. 2005, Chiang 2006). By 
contrast, intermittent hypoxia does not provide the conditions needed to stabilise hypoxia-
inducible factor-1, and instead nuclear factor-κB becomes activated, which leads to the 
activation of an inflammatory phenotype and increased production of inflammatory mediators 
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(Ryan, Taylor et al. 2005, Chiang 2006). OSA patients often exhibit chronic low-grade 
inflammation, possibly because IH upregulates the expression of transcription factors such as 
nuclear factor-κB, and proinflammatory cytokines, including tumour necrosis factor-α, 
interleukin-6 and interleukin-8 (Calvin, Albuquerque et al. 2009). There is evidence that 
plasma tumour necrosis factor-α and interleukin-6 are upregulated in patients with OSA, 
independently of obesity (Vgontzas, Papanicolaou et al. 2000). 
1.1.5 Oxidative stress 
The fluctuation of blood oxygen saturation in OSA is similar to the conditions of hypoxia-
reoxygenation and ischemia-reperfusion (Dewan, Nieto et al. 2015), which involve an initial 
restriction of blood supply (ischemia), resulting in limited oxygen availability (hypoxia) to an 
organ, that is subsequently followed by the restoration of perfusion and corresponding 
reoxygenation (Eltzschig and Eckle 2011). The hypoxia-reoxygenation or ischemia-
reperfusion cycles initiate various processes that lead to the overproduction of reactive 
oxygen species (Hung, Skepper et al. 2001, Kaminski, Bonda et al. 2002, Prabhakar 2002, 
Xu, Chi et al. 2004), such as superoxide anion radical (O2−), hydroxyl radical (·OH) and 
hydrogen peroxide (H2O2) (Suzuki, Jain et al. 2006, Bolisetty and Jaimes 2013, Zorov, 
Juhaszova et al. 2014, Bhattacharya 2015). Reactive oxygen species are mainly produced by 
mitochondria, and their production peaks during ischemia-reperfusion events (Kalogeris, Bao 
et al. 2014, Lavie 2015). These chemically unstable free radicals have a dual action in cells 
(Kalogeris, Bao et al. 2014, Lavie 2015), on one hand they function as signal transduction 
mediators (Suzuki, Jain et al. 2006), while on the other hand they oxidise lipids, proteins and 
DNA (Suzuki, Jain et al. 2006, Birben, Sahiner et al. 2012, Finosh and Jayabalan 2013, He, 
He et al. 2017), leading to inflammation, cellular apoptosis and tissue damage (Uttara, Singh 
et al. 2009).  
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The cellular antioxidant system is the defence mechanism against free radicals; oxidative 
stress occurs when the rate of production of reactive oxygen species exceeds the capacity of 
the antioxidant systems to quench free radicals (Birben, Sahiner et al. 2012, Bhattacharya 
2015, Liguori, Russo et al. 2018). Oxidative stress has been implicated as the cause of 
pathological tissue damage in cardiovascular disease, diabetes, cancer, ageing, Alzheimer’s 
and Parkinson’s disease (Dhalla, Temsah et al. 2000, Sayre, Smith et al. 2001, Dalle-Donne, 
Rossi et al. 2006, Valko, Leibfritz et al. 2007, Uttara, Singh et al. 2009, Liguori, Russo et al. 
2018).  
1.1.5.1 The relationship between oxidative stress and inflammation 
Mitochondria are the intracellular organelles responsible for breaking down glucose in the 
presence of oxygen to create energy, and are key regulators of the health, integrity and 
function of cells (Lin and Beal 2006, Lavie 2015). Mitochondrial dysfunction and oxidative 
stress have been suggested to play central roles in ageing and neurodegenerative diseases 
(Lin and Beal 2006). Ageing is characterised by a progressive decline in the effective 
function of molecules, cells, tissues and organs in biological organisms over time (Campisi 
2013, Liguori, Russo et al. 2018), leading to a host of pathologies including atherosclerosis, 
heart failure, pulmonary insufficiency, renal failure, osteoporosis and neurodegeneration 
(Campisi 2013). More than 300 hypotheses have been proposed to explain the ageing process 
(Medvedev 1990, Tosato, Zamboni et al. 2007), of interest here is the “free radical 
hypothesis” or the “oxidative stress hypothesis”, which posit that the accumulation of 
structural damage to macromolecules (lipids, DNA and proteins) caused by oxidative stress 
leads to functional losses (Beckman and Ames 1998).  
The gradual accumulation of mutations in mitochondrial DNA (mtDNA) is thought to 
contribute to the ageing process by impairing the function of mitochondria and antioxidant 
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systems, leading to an increase in the net production of ROS (Lin and Beal 2006). 
Alzheimer’s disease (AD) has been reported to be associated with increased free radical 
damage to nDNA (nuclear DNA), and a 3-fold higher level of oxidative damage to mtDNA 
compared with age-matched controls (Mecocci, MacGarvey et al. 1994). AD has been linked 
to mitochondrial abnormalities that contribute to the production of free radicals (Christen 
2000). Interestingly, mitochondrial dysfunction has also been reported in OSA/IH, where it is 
associated with increased oxidative stress (Douglas, Ryu et al. 2010, Lavie 2015). 
Mitochondria are the primary source of cellular reactive oxygen species (Kalogeris, Bao et al. 
2014) and these are rapidly detoxified through the action of the antioxidant enzymes 
superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and glutathione 
reductase (GR), which are supported by reserves of antioxidant molecules (e.g. glutathione 
(GSH), nicotinamide adenine dinucleotide phosphate (NADPH), ascorbate and alpha-
tocophorol) (Finosh and Jayabalan 2013). The cellular antioxidant defense action is 
illustrated in Figure 1.2. Oxidative stress occurs when an oxidative burst from mitochondria 
temporarily exceeds the capacity of endogenous antioxidant systems (Birben, Sahiner et al. 
2012, Salim 2017). In such instances, the reactive oxygen species are able to oxidise nearby 
proteins, lipids and DNA, particularly those within mitochondria (Birben, Sahiner et al. 2012, 
Finosh and Jayabalan 2013). The molecular damage sustained during oxidative stress needs 
to be repaired, and this need is signalled by the release of pro-inflammatory molecules from 
the injured cells. Neuroinflammation can be either beneficial or deleterious depending on the 
duration of the inflammatory response. Acute inflammation is a defensive response that leads 
to the repair of injured cells, whereas a chronic inflammatory response can cause neuronal 
degeneration, and may eventually lead to the development of neurodegenerative diseases, 
such as AD (Morales, Guzmán-Martínez et al. 2014).  
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Figure 1.2 The relationship between oxidative stress and neuroinflammation. 
Increased production of reactive oxygen species resulting from mitochondrial dysfunction 
exceeds the antioxidant capacity, leading to oxidative stress, which then can induce 
neuroinflammation. The chronic neuroinflammation can cause neuronal death and 
neurodegeneration. Modified from (Finosh and Jayabalan 2013, Morales, Guzmán-Martínez 
et al. 2014). 
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1.1.5.2 Oxidative stress in OSA patients and in animal models of OSA 
The levels of oxidised lipids, proteins and nucleic acids that are present in tissues have been 
used as markers of the extent of oxidative stress recently experienced by those tissues 
(Thérond, Bonnefont-Rousselot et al. 2000, Griffiths, Møller et al. 2002). These markers 
include plasma malondialdehyde for lipid hydroperoxidation, plasma 2,4-
dinitrophenylhydrazine for carbonylated proteins, urinary o,o'-dityrosine for amino acid 
oxidation, and urinary 8-OH-2-desoyxguanosine for oxidative DNA damage (Thérond, 
Bonnefont-Rousselot et al. 2000, Jordan, Cohrs et al. 2006). Since cellular antioxidant 
systems can be upregulated or downregulated in response to increased oxidative stress, 
changes in the balance of antioxidant systems can serve as indirect indicators of oxidative 
stress (Griffiths, Møller et al. 2002, Gozal and Kheirandish-Gozal 2008). Antioxidant enzyme 
activities that have been used to assess oxidative stress levels include superoxide dismutase, 
glutathione peroxidase and catalase (Thérond, Bonnefont-Rousselot et al. 2000, Griffiths, 
Møller et al. 2002, Jordan, Cohrs et al. 2006). 
Increased titres of markers of oxidative stress and inflammation have been detected in the 
blood of OSA patients (Gozal and Kheirandish-Gozal 2008, Sales, Bruin et al. 2013, Lavie 
2015, Lira and De Sousa Rodrigues 2016, Macey, Sarma et al. 2017). Urinary excretion of 8-
hydroxy-2′-deoxyguanosine was tested in OSA patients as an in vivo marker of oxidative 
stress, and were found to correlate with several indices of OSA severity including AHI, ODI, 
AI (apnoea index), the duration of oxygen saturation < 90% and respiratory arousal index 
(Yamauchi, Nakano et al. 2005). However, when adjusted for numerous confounding factors 
(BMI, age, gender, smoke, diastolic blood pressure, glycosylated haemoglobin, total 
cholesterol), only ODI showed a significant correlation, suggesting that ODI is a robust 
predictor of oxidative stress in OSA (Yamauchi, Nakano et al. 2005), perhaps because ODI 
reflects the frequency of episodes of hypoxemia/reoxygenation. In another study, 
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concentrations of 8-isoprostane, an oxidative stress marker, in the morning exhaled 
condensate and plasma, were positively correlated with the AHI, and the levels of  8-
isoprostane were reduced after two nights of CPAP therapy (Carpagnano, Kharitonov et al. 
2003).  
Enzyme-linked immunosorbent assays,  have revealed significantly higher levels of 
proinflammatory cytokines (tumour necrosis factor-α and interleukin-6) and decreased levels 
of anti-inflammatory cytokines (interleukin-10)  in OSA patients compared to controls 
(Alberti, Sarchielli et al. 2003). Furthermore, 8-isoprostaglandin F2α, intercellular adhesion 
molecule 1, tumour necrosis factor-α and interleukin-6 are all significantly elevated in OSA 
patients, regardless of the presence of excessive daytime sleepiness (De la Peña Bravo, 
Serpero et al. 2007). Antioxidant capacity has been investigated in OSA patients; while no 
significant difference was found between the OSA and healthy control groups, severe OSA 
patients (AHI > 20) had a lower antioxidant capacity that was negatively correlated with 
AHI, indicating that oxidative stress increases with OSA severity (Christou, Moulas et al. 
2003). It has been suggested therefore, that oxidative stress is an important treatment target 
for OSA (Zhang and Veasey 2012).  
In animal models of OSA, chronic exposure to IH during sleep is achieved by an 
environmental chamber which simulates the hypoxia/reoxygenation patterns of OSA. 
Animals subjected to these regimes of IH have consistently demonstrated evidence of 
oxidative stress (Row, Liu et al. 2003, Shan, Chi et al. 2007, Hung, Tipoe et al. 2008), 
increased lipid peroxidation and oxidative injury (Veasey, Davis et al. 2004, Zhan, Fenik et 
al. 2005, Sanfilippo-Cohn, Lai et al. 2006). In rats for instance, two weeks of exposure to IH 
resulted in an increased production of reactive oxygen species (Shan, Chi et al. 2007), and 
increases in brain malondialdehyde levels (Row, Liu et al. 2003). The latter study reported 
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that malondialdehyde production in the cerebral cortex was correlated with spatial learning 
deficits, and the administration of an antioxidant attenuated these deficits (Row, Liu et al. 
2003). Another IH study in rats identified significantly increased levels of malondialdehyde, 
mRNA expression of inflammatory mediators, including tumour necrosis factor-α, inducible 
nitric oxide synthase, cyclooxygenase-2 and decreased levels of antioxidant enzymes, 
including glutathione peroxidase, superoxide dismutase and catalase in the IH group when 
compared with the normoxic controls (Hung, Tipoe et al. 2008). In IH rats treated with the 
antioxidant melatonin, serum malondialdehyde levels were reduced, the expression of 
inflammatory mediators decreased, and the titres of antioxidant enzymes rose (Hung, Tipoe et 
al. 2008).  
Collectively, the findings reviewed above demonstrate that IH and OSA are associated with 
increased levels of oxidative stress and systemic inflammation, and that administration of 
antioxidants and CPAP treatment can help to attenuate this stress. However, there is not yet a 
clear consensus on whether OSA causes oxidative stress, since a number of recent studies 
have failed to find an association. For example, no significant difference in lipid-based 
oxidative stress markers and lipophilic antioxidant levels was found in moderate-to-severe 
OSA patients with 8 weeks CPAP treatment compared to a sham CPAP group (Sivam, 
Witting et al. 2015). Moreover, 2 weeks of CPAP withdrawal resulted in the return of OSA in 
regular CPAP users, yet the increased ODI and blood pressure were not associated with 
hypoxia‐induced blood protein marker levels or endothelial‐derived inflammatory substances 
or urinary oxidative stress markers (Turnbull, Akoumianakis et al. 2017). Furthermore, 
increased inflammatory markers, but not oxidative stress markers were observed in OSA 
patients with daytime sleepiness compared to a control group (Andaku, D'Almeida et al. 
2015).  
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1.1.6 Cognitive impairment 
Numerous studies have shown that untreated OSA patients have deficits in their cognitive 
functions, such as impaired judgment, slower reaction time, and impairments in visuospatial 
learning ability, working memory, sustained attention, vigilance and alertness, and executive 
functioning (Salorio, White et al. 2002, Ferini-Strambi, Baietto et al. 2003, Lim, Bardwell et 
al. 2007, Daulatzai 2015). It has been reported that the extent of cognitive impairments in 
OSA patients is related to the severity of OSA, as indicated by the AHI (Naëgelé, Thouvard 
et al. 1995). Although there are many confounding factors (e.g. obesity and age) that can 
influence cognitive outcomes in OSA studies, studies of cognitive function in healthy 
individuals at high altitude (sustained hypoxia) have shown similar patterns of cognitive 
impairment. One study reported worsened mood, attention, visual and working memory, 
concentration, executive functions and altered sleep patterns in healthy subjects exposed to a 
simulated altitude of 4,500 m for two days (Aquino Lemos, Antunes et al. 2012). A more 
recent study directly exposed healthy participants to mild hypoxia (10% O2) and elicited 
severe neurocognitive deficits in memory, speed of processing, executive functioning, 
attention, cognitive flexibility and task learning (Turner, Barker-Collo et al. 2015). Since 
these results were obtained under conditions of sustained hypoxia, where the production of 
reactive oxygen species is low, they introduce the interesting possibility that oxidative stress 
may not necessarily be the sole cause of cognitive impairment in OSA. 
In a paediatric study, children with severe OSA were found to have a significantly lower IQ 
and displayed significant deficits in executive functioning when compared to control children 
matched for age, gender and ethnicity (Halbower, Degaonkar et al. 2006). Executive 
functions are responsible for volition, planning, purposeful action and monitoring effective 
performance (Ferini-Strambi, Marelli et al. 2013), and is one of the most consistently affected 
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domains in OSA (Saunamäki and Jehkonen 2007). It has been reported that impaired 
attention, visuospatial learning, and motor performance in OSA patients returns to normal 
levels after 15 days of CPAP treatment, whereas executive functions and constructional 
abilities do not improve, indicating that some cognitive domains are refractory to CPAP 
treatment (Ferini-Strambi, Baietto et al. 2003). Other studies have confirmed that executive 
function seems not to benefit from CPAP treatment (Saunamäki and Jehkonen 2007, Lau, 
Eskes et al. 2010). 
A recent study affirmed the association between OSA frequency and severity of cognitive 
impairments and affective changes, with a moderate positive correlation  (r = 0.333, p = 
0.038) between OSA severity (AHI) and the Epworth Sleepiness Scale (ESS). Moreover, 
compared to the healthy control group, OSA patients demonstrated deficiencies in several 
cognitive domains, including attention, memory and executive function (Bilyukov, Nikolov 
et al. 2018). Similarly, in aged OSA patients (55 – 89 years) with mild cognitive impairment 
(MCI), significantly reduced attention and global cognition were observed in patients who 
did not use CPAP compared to CPAP adherents, after follow-up intervals of 6 months and 1 
year (Richards, Gooneratne et al. 2019). Impaired verbal episodic memory has been reported 
in aged OSA patients with MCI and depression, and the severity of OSA was associated with 
microvascular damage and lesions, implicating cerebral microvascular pathology in the 
cognitive decline (Kerner, Roose et al. 2017). Furthermore, the involvement of vascular 
factors in cognitive performance was suggested in another study, where improved OSA after 
CPAP treatment was associated with favourable hemodynamic changes accompanied by 
improved verbal memory (Buratti, Viticchi et al. 2017).  
Animal IH models have also revealed cognitive deficits, including spatial learning and 
working memory deficits (Gozal, Daniel et al. 2001, Row, Kheirandish et al. 2002, Gozal, 
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Row et al. 2003, Row, Liu et al. 2003, Row, Kheirandish et al. 2007). Impaired spatial 
learning has been shown in rats exposed to chronic episodic hypoxia, in which 
O2 concentrations in the chamber were cycled between 10 − 21% during daylight, and 
remained at normal levels (21%) during the night (Gozal, Daniel et al. 2001). Mice exposed 
to IH after 14 days displayed worse information retention and recognition memory, consistent 
with impairments in short-term memory (Kim, Martinez et al. 2015). Another study reported 
impaired spatial learning in rats after 7 days of IH exposure, and followed by a partial 
functional recovery starting at 14 days, despite continuing IH exposure (Gozal, Row et al. 
2003). Rat pups exposed to IH from postnatal (PN) day 10 until PN day 30 displayed 
significant spatial learning impairments, and male rats but not females displayed increased 
locomotor activity in the open field, indicating that exposure to IH at a developmental stage 
equivalent to early childhood induces substantial learning impairments and gender-dependent 
hyperactivity (Row, Kheirandish et al. 2002). Exposure of adult rats to IH for 14 days 
impaired their working memory with respect to controls (Row, Kheirandish et al. 2007).  
1.2 OSA effects on the brain 
The human brain comprises only 2% of the total body mass, yet it consumes 20% of total 
body oxygen and utilises 25% of total body glucose, largely because the central nervous 
system (CNS) is almost entirely dependent on the aerobic metabolism of glucose for the 
production of energy  (Bélanger, Allaman et al. 2011). Differences in the regional density of 
microvessels determines, to a large extent, the regional blood flow and influences the surface 
area available for oxygen exchange, as well as the diffusion distance required for the 
exchange of substrates between brain tissue and blood (Ingraham, Forbes et al. 2008). That 
the brain is highly dependent on its microvascular network for oxygen supply is evidenced by 
the fact that all cells are located within 100 µm of a capillary (Alberts, Johnson et al. 2002, 
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Zakrzewicz, Secomb et al. 2002), due to the passive diffusion limit for oxygen (Carmeliet 
and Jain 2000). The capillary bed of the brain is a dense network, with the average distances 
between adjacent capillaries being just 40 μm (Zlokovic 2005, Fu and Liu 2013, Volkov, 
Margaryants et al. 2017), and the average distance of a neuron to a capillary ranging between 
8 – 23 μm (Lovick, Brown et al. 1999, Tsai, Kaufhold et al. 2009, Gould, Tsai et al. 2017). 
Given this dependency on blood supply, even small reductions in cerebral blood flow (CBF), 
as frequently occurs in OSA, can lead to transient hypoxia.  
1.2.1 Hypoxic injury to the hippocampus 
The hippocampus is located in the inferomedial medial part of the temporal lobe and is 
widely regarded as the centre of brain networks associated with memory consolidation and 
retrieval, long-term memory, novelty detection, pattern discrimination, spatial navigation, as 
well as regulation of emotion, fear, anxiety and stress (Bartsch and Wulff 2015). The 
hippocampus is organised into specialised subfields (Figure 1.3), including the four subfields 
of the cornu ammonis area (CA1 – CA4), as well as the dentate gyrus and the subiculum 
(Bartsch and Wulff 2015, Schmidt-Kastner 2015). The hippocampus is among the first 
regions of the brain to suffer from various insults, such as ischemia, ageing and AD 
(Robinson 2001, Bartsch and Wulff 2015).  
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Figure 1.3 Schematic diagram of the primary regions of the human hippocampus. 
Coronal cross-section of the hippocampus, which includes the fimbria as illustrated in yellow, 
dentate gyrus in pink, CA4 (dentate gyrus + hilus), CA3, CA2, CA1, and the subiculum. Note 
the location of alveus, prosubiculum, entorhinal cortex and collateral sulcus, which will be 
investigated in Chapters 3, 4, 5 and 6. Diagram is modified from (Yang, Kim et al. 2008). 
The hippocampus is extremely sensitive to hypoxic injury, and hypoxia contributes to 
hippocampal atrophy in OSA patients (Gale and Hopkins 2004). Magnetic resonance imaging 
(MRI) studies have detected volumetric loss of grey matter in the hippocampus of OSA 
patients (Morrell, McRobbie et al. 2003, Gale and Hopkins 2004, Yaouhi, Bertran et al. 2009, 
Canessa, Castronovo et al. 2011, Torelli, Moscufo et al. 2011). Reduced grey matter volume 
has been shown in the hippocampus of OSA patients before CPAP treatment (Canessa, 
Castronovo et al. 2011). After 3-month CPAP treatment, grey matter volume had increased in 
the hippocampus (left subiculum and bilateral entorhinal cortex) and was accompanied by a 
significant improvement in verbal and visuospatial short-term memory (Canessa, Castronovo 
et al. 2011).  
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In a recent study of the regional volume changes in the hippocampus of OSA patients, 
increased volume was observed mainly in the CA1 and subiculum region, while CA3/dentate 
gyrus showed decreased volume; furthermore, males with OSA had similar volume variations 
bilaterally, whereas females only displayed significant changes on the right side; it was 
speculated that the sex-specific hippocampal changes may account for some sex-related OSA 
symptoms, such as depression (Macey, Prasad et al. 2018). In another study, there was 
significantly increased left hippocampus volume after CPAP treatment in male OSA patients, 
specifically in the anterior dentate gyrus, which may indicate neurogenesis as a result of 
diminished oxidative stress (Kim, Joo et al. 2016). In contrast, OSA in children had no 
significant effect on the volume (macrostructure) of the dentate gyrus, whereas decreased 
mean diffusivity (microstructure) was correlated with increased AHI (Spearman's r = - 0.50, 
p = 0.008), arousal index (r = - 0.44, p = 0.017) and decreased verbal learning capacity (r = 
0.54, p = 0.004); suggesting that disrupted microstructure may be a better indicator of 
neurocognitive impairment than the macrostructure (Cha, Zea-Hernandez et al. 2017). 
A number of reports are available regarding the regional vulnerability of the hippocampus, 
with the CA1 region being more commonly affected than other regions (Fung, Xi et al. 2009, 
Fung, Xi et al. 2012). The CA1 region has been reported to be the most vulnerable 
hippocampal region to hypoxia (Kreisman, Soliman et al. 2000), while CA2 and CA3 are 
more resistant to hypoxic injury (Hung, Tipoe et al. 2008). The same pattern of regional 
vulnerability in the hippocampus is seen in patients with hippocampal ischemia, 
neuroinflammation and other neurological conditions, including AD (Pulsinelli, Brierley et 
al. 1982, Bartsch, Döhring et al. 2015, Bartsch and Wulff 2015, Schmidt-Kastner 2015). In 
AD, the CA1 is affected before the subiculum, CA2, CA3 and CA4/dentate gyrus (West, 
Coleman et al. 1994, Kril, Hodges et al. 2004, Chételat, Fouquet et al. 2008). 
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Neural injury and impaired neural function are assumed to be the main factors that contribute 
to the cognitive deficits observed in animals that have been exposed to hypoxia (Goldbart, 
Row et al. 2003, Zhu, Fenik et al. 2007). Studies of animal models of IH have reported 
cognitive impairments and neuronal loss in the hippocampus (Lim and Veasey 2010), with 
increased excitability of CA1 neurons and apoptosis (Fung, Xi et al. 2009, Fung, Xi et al. 
2012). Another hypoxia study of rats found that apoptosis within the cortex and CA1 region 
of the hippocampus is time-dependent, but no degenerative effect was seen in the CA3 region 
(Gozal, Daniel et al. 2001). Pyramidal neurons in the CA1 have been reported to be highly 
vulnerable to hypoxia-ischemia, whereas neurons in the CA3 region and dentate gyrus are 
more resistant (Kreisman, Soliman et al. 2000). Interestingly, the vulnerability of the CA1 
increases with age: in old rats (20 − 22 months old) exposed to IH, CA1 neurons 
demonstrated greater sensitivity to hypoxia than those in young rats (3 – 4 months old), and 
this was accompanied by a greater decline in performance on spatial tasks (Gozal, Row et al. 
2003).  
A study of the proteins differentially expressed in the CA1 and CA3 provided initial insights 
into mechanisms underlying different susceptibility of neural tissue to hypoxia: in rats 
exposed for 6 h to IH, 32 proteins in the CA1 region were up-regulated in contrast to 7 
proteins in the more resistant CA3 area; two pro-apoptotic proteins, α-synuclein and 
doublecortin-like kinase, were increased by more than 2-fold in CA1, but not in CA3; 
expression of heat shock protein 70 was increased 1.6-fold in the CA1 region while it was 
decreased (0.56-fold) in the CA3, suggesting a greater intrinsic stress response in the 
vulnerable CA1 region (Gozal, Gozal et al. 2002). These findings were supported by a later 
study in which slices of living rat brain were exposed to paraquat to induce oxidative stress; 
neurons in the CA1 were found to be more sensitive to oxidative stress than CA3 neurons 
(Wang, Zaidi et al. 2009). Comparison of neurons from these two regions in basal conditions 
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revealed that CA1 neurons have a higher expression of genes associated with stress and 
inflammation and a lower expression of genes associated with energy generation. They 
concluded that the vulnerability of CA1 neurons is due to low intrinsic energy reserves 
coupled with high intrinsic levels of stress (Wang, Zaidi et al. 2009). 
1.2.2 Cerebral blood flow (CBF) adaptation to short-term and long-term hypoxia 
The entire brain is more vulnerable than other organs to hypoxia, and irreversible damage of 
the CNS can be caused by only 2 – 3 min of inadequate oxygen supply (Yoshihara, Takuwa 
et al. 2013). In acute hypoxia, the systemic blood flow is redistributed to preferentially supply 
the brain and heart (Faraci, Kilgore Jr et al. 1984, Boero, Ascher et al. 1999), and 
consequently CBF is elevated in response to hypoxia (Beck and Krieglstein 1987, Dahlgren 
1990, LaManna, Vendel et al. 1992, Xu, Puchowicz et al. 2004). Rats exposed to 7% O2 for 
30 minutes displayed an increased regional CBF of 50 – 90% in the grey matter and up to 
180% in the white matter (Beck and Krieglstein 1987). Similarly, rats kept in hypobaric 
chambers (0.5 atm) for one day had a significantly higher blood flow in all brain regions 
(frontal cortex 2.39-fold increase, parietal cortex 2.57-fold increase, hippocampus 2.52-fold 
increase, brainstem 2.50-fold increase, cerebellum 1.56-fold increase) (Xu, Puchowicz et al. 
2004). The blood flow in the frontal cortex (2.23-fold) and hippocampus (1.95-fold) were still 
elevated on day 2 of exposure; blood flow returned to baseline in all regions by day 4 of 
exposure and then remained unchanged for the remainder of the hypoxic period (Xu, 
Puchowicz et al. 2004). By contrast, decreased rates of CBF have been recorded in OSA 
patients during wakefulness (Joo, Tae et al. 2007, Innes, Kelly et al. 2015), demonstrating a 
difference between OSA patients and animal models of IH or sustained hypoxia. 
It has been proposed that there are three main adaptations of the brain in response to 
sustained hypoxia.  Initially CBF increases by as much as two-fold, mostly due to 
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vasodilation (Xu and LaManna 2006). After a few days of exposure, CBF begins to fall as the 
oxygen-carrying capacity of the blood improves (an increase in hemocrit). After two weeks 
of exposure to hypoxia, the brain capillary density has increased as a result of angiogenesis, 
and by three weeks post-hypoxia exposure the CBF returns to the prehypoxia baseline level 
(Xu and LaManna 2006).  
Chronic changes in blood flow are thought to alter the architecture of blood vessels (Rudic, 
Shesely et al. 1998). Blood flow generates mechanical forces on the vascular wall: 
circumferential stress is related to pressure and vessel dimensions (diameter and thickness), 
while longitudinal shear stress acts on the blood-endothelium interface (Lehoux and Tedgui 
2003). Changes in mechanical stress caused by changes in blood flow are detected by 
receptors on vascular cells and sustained activation triggers signals that lead to adaptive 
transformations of the vessel wall (Lehoux and Tedgui 2003). Sustained increases in blood 
flow are associated with an increase in lumen diameter in normal conduit vessels, while 
decreased blood flow is associated with a decrease in lumen diameter (Rudic, Shesely et al. 
1998). A 70% reduction in the rate of blood flow has been reported to lead to a 21% decrease 
in the diameter of the rabbit's carotid artery within 2 weeks (Langille and O'Donnell 1986). 
1.3 Hypoxia and adaptations of the cerebral microvasculature  
The cerebral vasculature is composed of arteries and arterioles, which deliver blood rich in 
oxygen and glucose to the brain; a capillary bed, consisting of capillaries and post-capillary 
venules that are essential for oxygen and nutrient exchange with the neuropil; and venules 
and veins that drain waste metabolites, including carbon dioxide from the brain (Kalaria 
1996, Daneman and Prat 2015). The capillary bed or 'microvasculature' is unique as it not 
only supplies blood to the brain, but also directly interacts with glial cells and neurons (Del 
Zoppo and Milner 2006), forming a functional neurovascular unit, an integrated system that 
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maintains brain homeostasis by selective permeability of some molecules and regulation of 
the CBF (Islam and Mohamed 2015). The neurovascular unit is composed of a capillary 
segment with its associated endothelial cells, pericytes, astrocytes, neurons and microglial 
cells, as illustrated in Figure 1.4. Astrocytes act as intermediaries between neurons and the 
microvasculature; they control vessel diameter, and hence blood flow, in response to the 
metabolic requirements of neurons in their vicinity (Daneman and Prat 2015). The research in 
the present thesis focuses on the capillaries of the brain which comprise more than 60% of the 
cerebral microvasculature (Del Zoppo and Milner 2006) and have a combined length of 650 
km and a total surface area of 10 – 20 m2 (Cecchelli, Berezowski et al. 2007). 
Chapter 1 Literature Review 
31 
 
 
Figure 1.4 Schematic representation of the neurovascular unit. 
The neurovascular unit permits bidirectional communication between the cerebral 
microvasculature and neurons via the intermediary astrocytes, with the astrocyte endfeet 
almost completely ensheathing the vascular tube, which is formed by a single endothelial cell 
folding onto itself, leaving a gap that is sealed by tight junction proteins. Pericytes are located 
on the abluminal surface of the endothelium between the basement membrane and astrocyte 
endfeet. Notice the Virchow-Robin space indicated by the black wavy lines, it is the 
perivascular space between the penetrating artery/venule and brain tissue that narrows and 
disappears as the penetrating artery branches into an arteriole and then a capillary. Redrawn 
and modified from (Jessen, Munk et al. 2015). 
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A feature of the neurovascular unit that distinguishes it from vasculature in other tissue is the 
presence of the blood–brain barrier (BBB) (Lawther, Kumar et al. 2011, Blanchette and 
Daneman 2015). The BBB is selectively permeable to the paracellular diffusion of a limited 
number of compounds from the blood to brain (Luissint, Artus et al. 2012). The BBB and 
was first identified following injection of dyes into the blood stream with the observation that 
these dyes would accumulate in peripheral tissues at a much greater concentration than in the 
CNS (Serlin, Shelef et al. 2015). The BBB forms an interface (0.3 – 0.5 μm thick) between 
the systemic blood circulation and the CNS (Zlokovic 2005). Its functions include protecting 
the CNS from an influx of blood cells, stabilizing the internal environment of the CNS by 
regulating the transport of nutrients and toxic substances into and out of the CNS, and 
establishing a consistent ionic environment that is favourable to neurotransmission (Daneman 
and Prat 2015).  
The BBB consists of endothelial cells that form the walls of the blood vessels, adjoined by 
tight cell-to-cell junction proteins, basement membrane, pericytes which are embedded within 
the basement membrane that can often span several endothelial cells, as well as astrocyte 
endfeet which ensheath the vessels (Daneman and Prat 2015, Serlin, Shelef et al. 2015). The 
capillary is formed by a single endothelial cell that folds onto itself, forming the lumen of the 
vessel, which is semipermeable, allowing for regulated transport of fluids and solutes into 
and out of the blood (Aird 2007).  
There are two main categories of transporters expressed by capillary endothelial cells, the 
efflux transporters at the abluminal (brain-facing) side, which transport potentially toxic 
molecules across the cell membrane towards the blood, and the highly specific nutrient 
transporters at the luminal (blood-facing) side, such as glucose transporter-1 (GluT-1), which 
facilitates the transfer of glucose from blood into the neuropil (Zlokovic 2005, Daneman and 
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Prat 2015). Tight junctions seal the adjacent endothelial cells and form a diffusion barrier, 
which prevents most blood-borne substances from freely entering the brain. The tight 
junctions contain the junction adhesion molecules claudin and occludin, as well as a number 
of cytoplasmic accessory proteins (Ballabh, Braun et al. 2004). The basement membrane 
separates the endothelium from pericytes and astrocytes, with pericytes situated on the outer 
side of the basement membrane (Zlokovic 2005). Pericytes maintain vascular integrity and 
contribute to vascular remodelling as well as tight junction formation (Balabanov and 
Dore‐Duffy 1998). Astrocytic end-feet tightly ensheath the vessel walls and play a role in the 
induction and maintenance of the tight junction barriers (Ballabh, Braun et al. 2004). 
The BBB is critical for maintaining brain homeostasis, assisting in proper neuronal function, 
and protecting neurons from agents that could be injurious (Daneman and Prat 2015). 
Dysfunction of the BBB can lead to altered ion regulation and signalling dyshomeostasis, and 
entry of plasma components, immune cells and molecules into the CNS, which increase the 
risk of neuronal dysfunction and degeneration (Daneman 2012, Daneman and Prat 2015). 
Disruption of the BBB has been identified in stroke, epilepsy, multiple sclerosis, brain 
trauma, tumours and AD, using both brain imaging in human patients and analysis of post-
mortem brain samples (Zlokovic 2008, Daneman 2012, Blanchette and Daneman 2015, 
Daneman and Prat 2015). It is not known whether the BBB is disrupted in OSA. 
1.3.1 Angiogenesis in response to hypoxia 
'Angiogenesis' refers to a process whereby new capillaries bud from existing microvessels 
(Grant and Kleinman 1997, Yoo and Kwon 2013) to increase capillary density and decrease 
the intercapillary diffusion distances, resulting in improved tissue oxygenation (Harik, Hritz 
et al. 1995, LaManna, Chavez et al. 2004, Boroujerdi, Welser-Alves et al. 2015). 
Angiogenesis is a complex multistep process that plays a central role in various physiological 
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conditions, such as trauma, wound healing, tissue repair, ischemia and hypoxia (Yoo and 
Kwon 2013). Hypoxia is a strong trigger of angiogenesis (Carmeliet and Jain 2000, Rey and 
Semenza 2010, Krock, Skuli et al. 2011, Zimna and Kurpisz 2015), and promotes vessel 
growth by upregulating hypoxia-inducible factors (Rey and Semenza 2010, Hashimoto and 
Shibasaki 2015), that mediate multiple proangiogenic pathways.  
Different levels of oxygen availability and blood flow combine to determine the vascular 
response (Table 1.3). During normoxia and normal flow, expression levels of vascular 
endothelial growth factor and angiopoietin-2 are low, while the constitutively expressed 
angiopoietin-1 activates Tie-2 (tyrosine-protein kinase receptor TIE-2), leading to vessel 
stabilisation as occurs in a mature, quiescent blood vessel. By contrast, in hypoxic conditions 
with low rates of blood flow, the expression of both vascular endothelial growth factor and 
angiopoietin-2 are induced, the combination of Tie-2 with angiopoietin-1 is replaced by 
angiopoietin-2, resulting in a diminishment of the stabilising effect of Tie-2 on the vascular 
wall, allowing vascular endothelial growth factor to stimulate enlargement of existing vessels 
and/or the formation of new vessels. Finally, under normoxic and low flow conditions, as 
occurs in redundant vessels that are underperfused in a well-oxygenated environment, 
vascular endothelial growth factor expression is suppressed but angiopoietin-2 expression is 
increased, the limited growth factors and destabilised vessel wall finally resulting in 
apoptosis and vessel regression (Zakrzewicz, Secomb et al. 2002).  
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Table 1.3 Vascular responses to different levels of oxygen and blood flow. 
Combined 
conditions 
Oxygen level Blood flow level Vascular 
reaction Normoxia Hypoxia Normal flow Low flow 
 VGEF ↓ VGEF ↑ 
Ang-2 ↓  
Ang-1 − 
Ang-2 ↑   
Ang-1 − 
 
 
VEGF-
R1/R2 ↓ 
VEGF-  
R1/R2 ↑ 
Tie-2 ↑  Tie-2 ↓  
Normoxia + 
Normal flow 
    Stabilisation 
Hypoxia + 
Low flow 
    Angiogenesis 
Normoxia + 
Low flow 
    Regression 
Normoxia and normal flow leads to vessel stabilisation, not proliferation. Hypoxia and low 
flow lead to angiogenesis, vascular proliferation, enlargement of existing vessels and/or 
formation of new vessels. Normoxia and low flow leads to regression, loss of structure, 
destabilised vessel wall and apoptosis. Modified from (Zakrzewicz, Secomb et al. 2002). 
VEGF: vascular endothelial growth factor; VEGF-R1/R2: vascular endothelial growth factor 
receptor 1/receptor 2; Ang-: angiopoietin-; Tie-2: Tyrosine-protein kinase receptor.  
 
 
Chapter 1 Literature Review 
36 
 
Two types of angiogenesis have been identified: sprouting angiogenesis and intussusception 
angiogenesis (Zakrzewicz, Secomb, & Pries, 2002), as illustrated in Figure 1.5. Sprouting 
angiogenesis is the basic mechanism for the growth of new blood vessels, it starts with local 
vasodilation and increased vascular permeability (Djonov, Baum et al. 2003), leading to a 
localised disruption of the basement membrane. The endothelial cells are activated by 
vascular endothelial growth factor to become tip cells that invade the surrounding 
extravascular matrix; they reorganise to form a vascular lumen that fuses with another 
capillary and stabilises into non-leaky mature endothelium that becomes enveloped by 
pericytes (Djonov, Baum et al. 2003, Prior, Yang et al. 2004, De Spiegelaere, Casteleyn et al. 
2012).  
Intussusception angiogenesis, also known as splitting angiogenesis, begins with endothelial 
cells forming an involution that extends down the centre of the vessel lumen to separate a 
vessel into two parallel capillaries (Zakrzewicz, Secomb et al. 2002, Mentzer and Konerding 
2014). Intussusception angiogenesis is faster and metabolically cheaper than sprouting 
angiogenesis, as it is the reorganization of existing cells, allowing the capillary to grow 
‘within itself’ without the need for endothelial migration and proliferation. Furthermore, the 
basement membrane may remain intact, which prevents the vessels from becoming leaky (De 
Spiegelaere, Casteleyn et al. 2012). Sprouting angiogenesis precedes intussuception 
angiogenesis and is only responsible for the formation of new vessels, whereas 
intussusception angiogenesis is considered as a general mechanism for vascular remodelling 
and pruning (Makanya, Hlushchuk et al. 2009, De Spiegelaere, Casteleyn et al. 2012).  
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Figure 1.5 Schematic representation of sprouting and intussusception angiogenesis. 
Sprouting angiogenesis is localised at the abluminal aspect of vessels, endothelial cells are 
activated to become tip cells in reponse to vascular endothelial growth factor produced by 
hypoxic cells; a new blood vessel sprout is composed of one leading tip cell and many stalk 
cells, tip cells project into the degraded extracellular matrix through a disrupted BM. 
Intussusceptive angiogenesis is determined by the direction of pillar extension (red solid 
arrow head), a cylindrical microstructure that spans the capillary lumen, intussusceptive 
pillars may project across the vessel lumen with an intact basement membrane. i) pillar 
growth toward the vessel angle results in the vascular remodelling to vessel bifurcation;  ii) 
pillar extension down the axis of the vessel results in vascular splitting to vessel duplication; 
and iii) asymmetric pillar growth leads to vascular pruning of a redundant or energetically 
inefficient vessel. Based on (Prior, Yang et al. 2004, De Spiegelaere, Casteleyn et al. 2012, 
Mentzer and Konerding 2014). 
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In the rodent brain, the process of hypoxia-induced angiogenesis takes about three weeks to 
reach completion (Ndubuizu, Tsipis et al. 2010). Hypoxia-inducible factor1α rapidly 
accumulates during the onset of hypoxia and remains significantly elevated for at least 14 
days, before returning to near baseline levels after 21 days (Chávez, Agani et al. 2000). 
Similarly, vascular endothelial growth factor mRNA expression increases 2-fold after 12 h 
exposure to hypoxia and reaches a maximum of 5-fold after 2-7 days before returning to 
normoxic levels after 21 days (Kuo, Benhayon et al. 1999).  
Animal studies have consistently documented increased capillary density in response to 
exposure to chronic hypoxia (LaManna, Chavez et al. 2004). One study reported an increased 
capillary density of 60% in the rat cerebral cortex after 3 weeks of hypobaric hypoxia (0.5 
atm, equivalent to 10% normobaric oxygen), which progressively decreased to prehypoxic 
levels after 3 weeks of normoxic recovery (Pichiule and LaManna 2002). In another study, 
mice were placed into a hypobaric chamber maintained at 0.4 atm which is equivalent to 8% 
normobaric oxygen; over the course of 14 days, increased capillary density was found with 
two different endothelial cell markers, CD31 and CD105, in both the brainstem and the 
cerebral cortex (Milner, Hung et al. 2008). In a chronic mild hypoxia model, mice exposed to 
8% O2 for 14 days had significantly increased total vascular area in the frontal lobe and this 
was followed by a vascular pruning response after two weeks of recovery in normoxic 
conditions (Boroujerdi, Welser-Alves et al. 2015). 
There is remarkable difference between vascular responses to sustained hypoxia and 
intermittent hypoxia. Sustained hypoxia is associated with the rapid stabilisation of hypoxia-
inducible factor-1 (Ryan, Taylor et al. 2005, Chiang 2006), resulting in increased expression 
of vascular endothelial growth factor (Ryan, Taylor et al. 2005, Chiang 2006). By contrast, 
IH cannot maintain the stabilisation of hypoxia-inducible factor-1 (Ryan, Taylor et al. 2005, 
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Chiang 2006), so vascular endothelial growth factor is expressed at lower levels than in 
sustained hypoxia and the stimulus for angiogenesis is weaker. In a study using the 
endothelial cell marker, GluT-1, where mice were subjected to either IH (11% O2, 4-min 
cycles) or continuous hypoxia (11% O2) for 2 weeks, the capillary density in the cerebral 
cortex was increased by 18% and  32%, and in the hippocampus by 20% and 38%, 
respectively (Kanaan, Farahani et al. 2006). However, it is not known whether the same 
extent of angiogensis occurs in the hippocampus of OSA patients.  
In the adult brain, mature capillaries display high electrical resistance and a tight BBB, due to 
tight junction proteins and the influence of astrocyte endfeet (Engelhardt 2003, Ballabh, 
Braun et al. 2004). These characteristics also contribute to angiogenesis in response to 
hypoxia. In a study by (Boroujerdi, Welser-Alves et al. 2015), mice exposed continuously to 
8% O2 for 14 days had an increased expression of the tight junction protein Claudin 5; two 
weeks of recovery resulted in fragmentation of Claudin 5 and the vascular pruning response. 
In another study, mice exposed to 0.4 atm (equivalent to 8% O2) for 14 days showed an 
increased number of vessels positive for Claudin 5 by immunofluorescence, while western 
blotting revealed a 3.1-fold increase in the expression of Claudin 5 (Li, Welser et al. 2010).  
In a technically challenging study, a closed cranial window was placed over the left parietal 
cortex of living mice which were then exposed to hypoxia (8 – 9% O2) for up to 21 days. The 
study observed vessel sprouts after 7 – 14 days of hypoxia exposure, and after 14 – 21 days 
of hypoxia, the sprouting vessels had created new connections with existing capillaries to 
restore and increase the regional blood flow (Masamoto, Takuwa et al. 2014). In another 
animal study, significant BBB leakage was observed with sodium fluorescein, a fluorescent 
tracer that does not cross an intact BBB. After exposure to normobaric hypoxia (8% O2) for 
24 h, there was 2-fold increase in fluorescence intensity compared to normoxic controls, 
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suggesting that vascular permeability in the brain had increased as a result of hypoxic injury 
(Schoch, Fischer et al. 2002). Such BBB leakage has been suggested to alter the CNS 
microenvironment during IH, perturbing neuronal function and contributing to cognitive 
impairment (Lim and Pack 2014).  
The contribution of hypoxia to angiogenesis is demonstrated in retinopathy of prematurity, a 
leading cause of blindness and visual impairment in premature infants (Chen and Smith 
2007). Retinopathy of prematurity occurs when premature babies are given supplemental 
oxygen to breathe to compensate for their underdeveloped lungs; this additional oxygen 
retards developmental angiogenesis and may lead to a partial regression of existing vessels, 
resulting in the periphery of the immature retina being under-vascularised (Hellström, Smith 
et al. 2013). Once the baby is transferred to ambient air, the retinal tissue becomes hypoxic 
due to its inadequate blood supply. The hypoxic tissue then stimulates pathological 
angiogenesis with the newly-formed vessels being leaky and perfusing the retina poorly, 
leading to fibrous scar formation and retinal detachment (Hellström, Smith et al. 2013). 
Retinopathy of prematurity provides direct evidence that chronic hypoxia induces 
angiogenesis (although abnormal) in human eyes, however it is not known whether similar 
angiogenesis occurs in the adult human brain in response to chronic intermittent hypoxia in 
OSA. 
1.3.2 Angioadaptation in response to hypoxia  
Microvessels respond to both metabolic and hemodynamic stimuli, and hypoxia promotes 
vasodilation that leads to an increase of blood flow and oxygen supply (Reglin and Pries 
2014). Capillary dilation is an immediate response to hypoxia; it not only helps to 
accommodate the increased volume of blood flow, it also reduces the resistance that occurs 
on the walls of vessels due to shearing stress  (Boero, Ascher et al. 1999). Vessel diameter 
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adaptation occurs in two ways, short-term changes in smooth-muscle tone and structural, 
long-term changes (vascular remodelling) (Reglin and Pries 2014). 
In a mouse hypobaric hypoxia model (455 Torr; equivalent to 0.6 atm; 12% normobaric 
oxygen), 28-days of exposure significantly increased the internal capillary diameter in several 
regions of the brain, including the CA1 stratum oriens (1.18-fold) in the hippocampus (Boero, 
Ascher et al. 1999). In another study, mice were exposed to continuous hypoxia (either 8% or 
10% O2) for up to 1 month and longitudinal in vivo microvasculature within a living mouse 
somatosensory cortex was imaged with two-photon microscopy. Compared to the pre-
hypoxic levels, mean capillary diameters were increased 1.4-fold and 1.2-fold after one week 
of exposure to 8% or 10% O2, respectively; after three weeks of exposure the mean capillary 
diameter had increased further to 1.8- and 1.4-fold, respectively (Yoshihara, Takuwa et al. 
2013). With the same imaging method, another study exposed mice to three weeks of 
normobaric hypoxia (8 − 9% O2) and observed a 1.6-fold increase (4.7 to 7.3 µm) in 
parenchymal capillary diameters compared with pre-hypoxic values (Masamoto, Takuwa et 
al. 2014). 
In chronic hypoxia, capillaries appear more elongated, dilated and have more a winding 
course (i.e. 'tortuous') than those in normoxic controls (Boero, Ascher et al. 1999). In an 
animal hypobaric hypoxia model (0.6 atm, 12% O2), capillary length per unit volume of 
tissue (Lv) was found to be significantly increased after 28 days of exposure throughout the 
brain, including in hippocampal regions: subiculum (1.58-fold), CA1 (1.33 − 1.54-fold), CA3 
(1.28 − 1.47-fold) and dentate gyrus (1.23 − 1.34-fold) (Boero, Ascher et al. 1999). 
Moreover, significant increases in capillary surface area per unit volume of tissue were 
observed (Boero, Ascher et al. 1999). However, in another study, 21 days of exposure to 8% 
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O2 did not alter the average length of the individual capillaries (< 7 μm in diameter) 
(Yoshihara, Takuwa et al. 2013).  
In a mouse model of IH, the extent of angiogenesis was found to vary in response to the 
severity of hypoxia (Lim, Brady et al. 2016). The total capillary length in the hippocampus 
was significantly greater in mice subjected to very severe IH (SaO2 nadir 37%) for 2 weeks 
(12 h/day) compared to those in the continuous air (SaO2 95%) and severe IH (SaO2 nadir 
61%), while no significant difference was found between the control and severe IH groups 
(Lim, Brady et al. 2016). These results indicate that under very severe conditions, IH can 
trigger adaptive changes in the microvasculature of the hippocampus. However, it is unclear 
how relevant the results from this animal study are to the IH experienced by humans with 
OSA. Exposure of young adult mice to 2 weeks of IH may not produce comparable outcomes 
to the decades of exposure to IH experienced by patients with untreated OSA. Furthermore, 
the severity of hypoxia used by Lim and colleagues (2016) was extreme; humans with severe 
OSA may experience a few instances where the nadir SaO2 falls below 80% (Badran, Ayas et 
al. 2014), yet Lim et al induced nadirs of 61% and 37% every minute for 12 hours per day 
(Lim, Brady et al. 2016). Finally, there is evidence that microvessels in the brains of young 
adults demonstrate greater adaptability to hypoxia than those in aged brains, as discussed 
below.  
1.3.3 Aged microvasculature in response to hypoxia  
The balance between capillary density/oxygen delivery and metabolic demand decreases with 
age (LaManna, Chavez et al. 2004) as microvessels lose their plasticity (Casoli, Spagna et al. 
1996, Riddle, Sonntag et al. 2003, Burke and Barnes 2006, Topiwala and Ebmeier 2012). The 
limited capacity of old capillaries to respond to increases in neural activity causes 
mismatches between blood flow and metabolic needs, resulting in synaptic and neurovascular 
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injury, which has been suggested to contribute to age-related neuropathology (Riddle, 
Sonntag et al. 2003, LaManna, Chavez et al. 2004, Ingraham, Forbes et al. 2008, Harb, 
Whiteus et al. 2013). Decreased cerebral microvascular density has been reported in aged 
subjects compared to young controls, and many of the remaining vessels displayed abnormal 
morphological alterations (Riddle, Sonntag et al. 2003, Petcu, Smith et al. 2010). 
Different vessel formation events have been reported between young and old mice in 
response to normobaric hypoxia for 28 days (Harb, Whiteus et al. 2013). When young mice 
(4 – 6-week-old) were exposed to 10% O2 for 28 days, a considerable degree of angiogenesis 
was observed. In contrast, adult mice (3 – 4 months old ) and aged mice (22 – 25 months old) 
exposed to 10% O2 for 28 days did not differ significantly from control mice that had been 
exposed to normoxia, suggesting that the cerebral microvasculature loses its plasticity by 
adulthood and is less responsive to metabolic perturbation (Harb, Whiteus et al. 2013). 
Similarly, after exposure to chronic hypoxia (11% O2) for 4 weeks, young adult rats (4-
month-old) displayed a 35 – 40% increase in the number of microvessels in all subregions of 
the hippocampus, whereas aged rats (30-month-old) displayed more modest capillary growth: 
20% increase in the dentate gyrus, 15% in the CA3, and only 6 – 7% in the CA1 region 
(Ingraham, Forbes et al. 2008).  
Not all studies have detected age differences in respect to microvascular adaptiveness to 
hypoxia. Ndubuizu and colleagues (2010) observed an increase in the  density of cerebral 
microvessels in 24-month old rats exposed to chronic hypoxia (8% O2 for 3 weeks), that was 
accompanied by increased mRNA and protein levels of vascular endothelial growth factor 
(Ndubuizu, Tsipis et al. 2010). Compared to normoxic controls, microvessel density 
increased by 48% in cerebral cortex, 53% in the corpus callosum, 35% in the striatum and 
60% in the CA1 region of the hippocampus; while microvessel density in young rats (3 
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months old) increased by 41%, 61%, 44% and 47% respectively, demonstrating no 
significant difference in the angiogenic response between young and aged rats (Ndubuizu, 
Tsipis et al. 2010). 
In a survival rate study, all young mice (4-month-old) survived throughout 3 weeks of 
exposure to hypoxia (8% O2), whereas one third of the aged mice (24 months old) died 
between 8 – 12 days of exposure (Benderro and Lamanna 2011). It was speculated that the 
increased mortality was due to a slower rate of angiogenesis in the old mice, since after the 
first week of hypoxia capillary density in the young mice had increased by 29% compared to 
13% in the aged mice (Benderro and Lamanna 2011). However, by the second week of 
exposure there was no significant difference between the young and aged mice (42% vs. 
33%) (Benderro and Lamanna 2011).  
Taken together, results from animal hypoxia models disagree as to whether the angiogenic 
response becomes impaired with age, or merely slowed. At present no data are available 
concerning adaptive changes to IH in adult human brains so it remains unclear whether 
results obtained from rodent models of continuous hypoxia or IH have ecological relevance 
to OSA in aged humans. 
1.4. Neurodegeneration and microvascular disease 
As noted previously, the brain is dependent on a sufficient supply of blood, and when the 
blood supply does not meet the metabolic demands of the tissue, neurons are unable to 
function normally and may degenerate (Figure 1.6). Reduced CBF, as occurs during normal 
ageing in association with the presence of vascular risk factors such as cardiac disease, 
stroke, atherosclerosis, diabetes mellitus and hypertension can result in cerebral 
hypoperfusion, which when it reaches a critical threshold, will promote brain capillary 
degeneration and energy crisis (De la Torre 1999). The damaged capillary ultrastructure 
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begins in specific brain regions, such as the hippocampal CA1, leading to decreased glucose 
transport and compromised neuronal metabolism (De la Torre 1999), which may partly 
explain the selective vulnerability of the CA1 region. Cerebral hypoperfusion has been 
regarded as an early feature of AD (De la Torre 1999, Love and Miners 2016). 
 
Figure 1.6 Hypothesised interrelationships between degenerative changes in blood 
vessels and cognitive dysfunction. 
Reduced CBF in the cerebral microvascular network is associated with aberrations in the 
capillary ultrastructure, such as local thickening of the basement membrane, partial 
obstruction or compression. These microvascular aberrations disturb the regular passage of 
blood when the usual shape of the vascular lumen becomes irregular, leading to 
microturbulence which compromises glucose transport across the BBB. Thus, the presence of 
these microvascular pathologies is indicative of suboptimal CBF and neuronal 
dysfunction. Based on (Farkas and Luiten 2001). 
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Cerebral microvascular pathology has been suggested to precede age-related 
neurodegeneration (Brown and Thore 2011), and the neurodegenerative processes may be 
aggravated by the presence of microvascular and macrovascular pathologies (Blair, 
Hernandez et al. 2017, Umemura, Kawamura et al. 2017, Jaswal, Swardfager et al. 2018). It 
has been suggested that impaired cognition during normal ageing may be partly due to the 
capillary changes in the hippocampus (Keuker, Luiten et al. 2000). 
AD is an example of an age-related neurodegenerative disorder that is associated with 
microvascular dysfunction (Zlokovic 2005, Zlokovic 2011). Vascular 
deficiency/hypoperfusion has been associated with brain atrophy, dementia and the 
accumulation of Aβ in the brain (De la Torre 1999, Hagino, Kobayashi et al. 2004, Bouras, 
Kövari et al. 2006, Love and Miners 2016). Several ultrastructural and morphological 
alterations to the microvasculature have been reported in ageing and neurodegenerative 
disorders, including reduced packing density, increased numbers of fragmented vessels, 
perivascular collagen deposits, basement membrane thickening, string vessels, tortuous 
arterioles, twisted capillaries, marked changes in the vessel diameter and increased 
irregularity of capillary surfaces (Kalaria 1996, Moody, Brown et al. 1997, Farkas and Luiten 
2001, Zlokovic 2008, Bell and Zlokovic 2009).  
1.4.1 String vessels are indicators of degenerated capillaries 
String vessels are thin tissue strands, 1 − 2 µm wide that join one capillary to another. They 
do not carry blood and they mark the location of capillaries that have collapsed and regressed 
(Challa, Thore et al. 2002), hence they are common after cerebral ischemia (Reinecke, 
Kuwabara et al. 1962). String vessels consist mainly of Collagen IV, one of the basement 
membrane connective tissue components (Brown 2010), and they are negative for CD34 
(Challa, Thore et al. 2004). They can be found in human brains of all ages from preterm 
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babies to the very old, and they seem to eventually degrade and disappear because fewer 
string vessels are present in very old brains (Brown 2010). Exceptions include the grey matter 
of AD patients, which contains twice as many string vessels as the brains of age-matched 
healthy controls, and the brains of ApoE ε4 carriers, which have more string vessels than 
non-ε4 carriers (Hunter, Kwan et al. 2012). There were significantly more string vessels (4.0 
per mm2) in the white matter of AD individuals compared to the control group (1.4 per mm2), 
as well as greater total string vessel length (0.29 vs. 0.10 mm/mm2) (Challa, Thore et al. 
2004). 
Although mostly reported in the CNS, string vessels can occur in any tissue where capillaries 
have died due to cessation of blood flow (Brown 2010). It is possible that string vessels 
develop as a result of reduced metabolism and CBF (Challa, Thore et al. 2004), while the 
formation of string vessels might further shut down blood flow and glucose supply to the 
brain, which may exacerbate neurodegeneration and the progression of AD (De la Torre 
1999, Love and Miners 2016). Given that decreased regional CBF has been reported in OSA 
patients (Joo, Tae et al. 2007, Innes, Kelly et al. 2015), it is possible that the brains of OSA 
patients contain higher than normal numbers of string vessels, and that their density increases 
with OSA severity. However, these possibilities have not yet been investigated.  
1.4.2 Thickened basement membranes in vessels from aged brains 
Endothelial basement membrane is a structural component of the BBB, and creates a 
selectively permeable boundary between the brain parenchyma and CBF (Zarow, Barron et 
al. 1997). Basement membrane consists mainly Collagen IV (Farkas and Luiten 2001), that 
arranges into a cross-linked, three-dimensional matrix that fills the space between the 
vascular endothelium, and the pericytes and perivascular  astrocytes (Zarow, Barron et al. 
1997). The basement membrane becomes thicker with age (Serot, Foliguet et al. 2001), and 
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localised thickenings of the basement membrane become relatively common in old age 
(Farkas and Luiten 2001). For instance, a low frequency of thickenings of the basement 
membrane was observed in the frontoparietal motor cortex of rats aged 16, 24 and 30 months, 
whereas between the age of 30 − 32 months approximately 10% of all cortical microvessels 
exhibited basement membrane thickenings (De Jong, Traver et al. 1992). The percentage of 
capillaries with basement membrane thickenings in the hippocampus was low (28 ± 6%) in 
young monkeys (1 – 6 years), and higher (71 ± 5%)  in aged rhesus monkeys (29 – 31 years) 
(Keuker, Luiten et al. 2000). 
Variations in vascular diameter caused by constrictions and dilations directly influence blood 
flow by altering vascular resistance. A consistent vessel diameter is essential for the efficient 
flow of blood, and the existence of narrowed segments of lumen due to a thickened basement 
membrane will slow the CBF (Farkas and Luiten 2001). Thus, increases in basement 
membrane thickness are likely to contribute to age-related declines in regional CBF, and 
consequent reductions in cognitive functioning. 
1.4.3 Tortuous vessels in aged and AD brains 
During old age the course of arterioles through the deep white matter of the brain can 
transform from a linear one to a more winding, circuitous course that can include coils, loops 
and spirals (Farkas and Luiten 2001). The irregular course of the vessel implies altered 
haemodynamics that will inevitably impede CBF (Kalaria 1996). These 'tortuous' vessels are 
a result of reduced elasticity of the vessel walls combined with shrinkage of the tissue they 
supply. The vessels follow a recurved course in order to accommodate their excess length  
(Del Corso, Moruzzo et al. 1998). Tortuous vessels are rarely seen in preterm babies, children 
or young adults, and their number starts to increase after middle age (Thore, Anstrom et al. 
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2007). Tortuous microvessels are also common in AD, presumably as a result of 
neurodegeneration and while matter loss (Thore, Anstrom et al. 2007). 
In addition to being a marker of neurodegeneration and brain shrinkage, tortuous vessels are 
less efficient at delivering blood and therefore can contribute to neuronal dysfunction, thus 
leading to a vicious cycle of neurodegeneration and tissue shrinkage. Since areas of the 
human hippocampus are known to undergo shrinkage in OSA, and the extent of this 
shrinkage is associated with OSA severity (Owen, Benediktsdottir et al. 2019), it would be 
important to investigate the brains of OSA patients for the presence of tortuous vessels. 
1.5 Oxidative stress and corpora amylacea (CoA) 
While abnormalities in the cerebral microvasculature are an important feature of ageing and 
neuropathological disease, another important marker of these conditions can be found in 
corpora amylacea (CoA). Under the light microscope CoA appear as featureless spherical 
bodies with diameters ranging from 5 to 50 μm (Cavanagh 1999, Rohn 2015, Pisa, Alonso et 
al. 2018), although a few can be measured down to 2 μm (Cavanagh 1998) or up to 100 μm 
(Michaels and Levene 1957). Under the microscope the individual profiles of CoA are 
generally oval or elliptical, but they can have a more complex profile if they fuse into an 
aggregate (Cavanagh 1999). A 3-dimensional investigation claimed that 70% of CoA are 
interconnected into highly branched large aggregates, some of which are enclosed by the 
basement membranes of astrocytes (Pirici, Margaritescu et al. 2014). This claim has not yet 
been verified. CoA have been reported in various organs of many species (Cavanagh 1999) 
and consist of a polyglucosan core surrounded by an ubiquitinated outer shell (Nam, Kim et 
al. 2012). For this reason CoA are also referred to as 'polyglucosan bodies', as CoA are 
predominantly composed of glucose polymers (over 85% are hexoses), with a minor 
component (4 − 5%) of proteins (Abel, Hebb et al. 2010, Pisa, Alonso et al. 2018), suggesting 
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that a defect in glucose metabolism may cause CoA formation (Cavanagh 1999, Augé, Duran 
et al. 2018, Navarro, Genoud et al. 2018).  
CoA were first described by Virchow in 1851 who regarded them as precipitation products of 
proteins (Stam and Roukema 1973). CoA are autofluorescent and can be positively stained 
with various histochemical stains including hematoxylin and eosin (H & E), periodic acid-
schiff (PAS), luxol fast blue and cresyl violet (Cissé and Schipper 1995, Buervenich, Olson et 
al. 2001, Cherian, Radhakrishnan et al. 2003, Nam, Kim et al. 2012, Estupiñán-Díaz, 
Morales-Chacón et al. 2015, Augé, Cabezón et al. 2017); they react negatively for lipids, 
DNA and RNA, but positively for many proteins, such as tubulin, tau, glial fibrillary acidic 
protein (GFAP), neurofilament, amyloid, heat shock protein, ubiquitin and ferritin (Cavanagh 
1999). 
1.5.1 Association between CoA and neurodegenerative diseases 
Various conditions have been suggested to favour the development of CoA including ageing, 
chronic hypoxia, multiple sclerosis, temporal lobe epilepsy, dementia, neuronal 
degeneration, AD and Parkinson’s disease (Cavanagh 1999, Estupiñán-Díaz, Morales-
Chacón et al. 2015, Rohn 2015, Augé, Cabezón et al. 2017, Augé, Duran et al. 2018, Pisa, 
Alonso et al. 2018). Hyperglycemia in diabetes may facilitate the formation of CoA by 
increasing the availability of unused glucose polymers, the main component of CoA (Nam, 
Kim et al. 2012). In normal human brains CoA increase in number with age: CoA are rarely 
seen in persons younger than 40 years (Cavanagh 1999), yet their numbers climb rapidly after 
the fourth or fifth decade (Mizutani, Satoh et al. 1987, Mrak, Griffin et al. 1997, Cavanagh 
1998, Keller 2006, Augé, Cabezón et al. 2017). Qualitative observations indicate that CoA 
become more numerous and larger with age (Cavanagh 1999), although no systematic 
quantitative data exist to support this view.  
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The biochemical and elemental composition of the proteins in CoA of normal ageing and 
neurodegenerative diseased brains have been investigated. CoA showed positive reactions 
with antibodies to ubiquitin, heat shock proteins (HSP) 28 and 70, which may be the result of 
sustained physiological stress (Cissé, Perry et al. 1993). Furthermore, 24 proteins were 
identified in a proteomic analysis of CoA from multiple sclerosis brain lesions that may be of 
neuronal origin, including proteins from the cell membrane, endoplasmic reticulum, 
mitochondria, cytosol and nucleus, which regulate apoptosis and senescence, as well as 
enzymatic pathways (Selmaj, Pawlowska et al. 2008). Another study indicated that the 
proteins in CoA differ between normal ageing and AD, with those from normal brains being 
immunoreactive for proteins associated with neuronal cytoskeleton and cell injury, whereas 
in AD they were derived from both neurons and glia (Singhrao, Neal et al. 1993). Indeed, a 
recent study argued the molecular composition of CoA was in dynamic change during the 
progression of mild cognitive impairment to severe AD (Bathini, Mottas et al. 2019).  
1.5.2 CoA distribution patterns in ageing and neurodegeneration 
Two broad patterns of CoA distribution have been described. The first involves CoA being 
concentrated in the periventricular, perivascular, subpial and subependymal regions 
(Cavanagh 1999, Nishio, Morioka et al. 2001, Meng, Zhang et al. 2009, Abel, Hebb et al. 
2010, Rohn 2015). The second pattern involves CoA being predominantly located in the deep 
neuropil of the hippocampus cornu ammonis (CA) subfields(Erdamar, Zhu et al. 2000, 
Kawamura, Morioka et al. 2002, Cherian, Radhakrishnan et al. 2003, Uckermann, Galli et al. 
2017, Navarro, Genoud et al. 2018), away from the pial surface and ventricles. 
With regards to the first pattern, CoA are frequently seen near blood vessels, especially the 
medium and large blood vessels, and are often found in the Virchow–Robin spaces, 
suggesting an association between CoA and the vasculature (Cavanagh 1999, Navarro, 
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Genoud et al. 2018). CoA are also found beneath the pial surface in areas that are close to the 
CSF (Meng, Zhang et al. 2009, Maurizi 2010, Nam, Kim et al. 2012), such as the pial border 
of the hippocampus, and in the subependymal zones of the ventricles (Cavanagh 1999, 
Erdamar, Zhu et al. 2000). For instance, CoA were reported in the periventricular regions of 
the hippocampus in three aged subjects without any neurodegenerative diseases (Augé, 
Bechmann et al. 2019), and within perivascular and subpial regions in four aged AD patients 
and one aged patient with vascular dementia (Augé, Duran et al. 2018). CoA distribution in 
the lateral temporal lobes was similar to the cerebral ageing pattern, with a high density of 
CoA in perivascular regions in  temporal lobe epilepsy and focal cortical dysplasia 
(Estupiñán-Díaz, Morales-Chacón et al. 2015).  
The second pattern of distribution is distinctive and is commonly reported in 
neurodegenerative diseases. Previous studies have described abundant CoA in the dentate 
gyrus, CA4, CA3, CA1, of the hippocampus of patients with temporal lobe epilepsy (Cherian, 
Radhakrishnan et al. 2003), complex partial seizures and Ammon's horn sclerosis (Erdamar, 
Zhu et al. 2000) and Parkinson’s disease (Navarro, Genoud et al. 2018). CoA were found to 
accumulate in the CA1 and CA3 regions of hippocampus in patients with temporal mesial 
epilepsy (Uckermann, Galli et al. 2017). CoA in the hippocampal sclerosis specimens were 
mainly located in the CA1 subregion and their numbers were inversely correlated with 
neuronal density (Van Paesschen, Revesz et al. 1997). CoA deposition has also been found in 
the hippocampus of patients with temporal lobe epilepsy, and mostly in the CA1 and CA2 
regions (Kawamura, Morioka et al. 2002).  
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1.5.3 CoA may have many origins 
The origin(s) of CoA remains elusive, and has been considered in many different ways over 
the years. At least five hypotheses have been advanced to account for their origin, none of 
which are mutually exclusive (Rohn 2015, Augé, Cabezón et al. 2017). The first hypothesis 
notes that while CoA are regarded to be a benign indicator of the ageing process, they may 
represent one of the earliest, though non-specific indicators of neurodegeneration (Singhrao, 
Neal et al. 1993, Rohn 2015). Various reports have demonstrated that the proteins in CoA 
originate from dying neurons, oligodendrocytes and astrocytes. The degenerated cytoskeletal 
elements and proteins in CoA have been identified to be of neuronal origin (Cavanagh 1999, 
Selmaj, Pawlowska et al. 2008), while myelin basic proteins and proteolipid proteins in CoA 
indicate an oligodendroglial origin (Singhrao, Neal et al. 1994, Cavanagh 1999). Cerebral 
CoA are found within astrocytic endfeet or as extracellular deposits (Anzil, Herrlinger et al. 
1974). That dying axons are a major component of CoA is supported by the fact that large 
numbers of CoA were present where axons had degenerated, while lesions with preserved 
axons had no CoA (Selmaj, Pawlowska et al. 2008).  
The second hypothesis of CoA formation stems from the discovery of proteins within CoA 
that originate from the blood (Meng, Zhang et al. 2009, Pisa, Alonso et al. 2016). It posits 
that when the BBB is compromised, serum proteins leak into the brain and are subsequently 
collected into CoA. It is supported by the fact that many neurodegenerative diseases that 
favour CoA formation, such as AD, multiple sclerosis, and temporal lobe sclerosis, are also 
accompanied by vascular compromise (Meng, Zhang et al. 2009). It is further supported by 
the observation of CoA in vascular dementia patients (Meng, Zhang et al. 2009), and by 
substantial numbers of CoA in the choroid plexus in conditions where the tight junctions have 
been destroyed (Nam, Kim et al. 2012). Finally, CoA have been immunostained with purified 
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IgMs, which are considered to be natural antibodies that cannot pass through the BBB into 
the brain parenchyma under normal physiological conditions, therefore implicating a 
disrupted BBB (Augé, Cabezón et al. 2017). Since OSA has been suggested to involve a 
disrupted BBB (Lim and Pack 2014), it might be expected that OSA will feature increased 
numbers of CoA near blood vessels, as a function of OSA severity. 
A third hypothesis relates to CoA being indirectly caused by microbial infections, based on 
the observation of fungal and bacterial proteins within some CoA. For instance, CoA 
immunoreactive to antifungal antibodies (Candida famata, C. albicans, C. glabrata, 
Syncephalastrun racemosum and Phoma betae) have been observed in the entorhinal cortex 
and hippocampus of AD patients, whereas CoA in control subjects were almost devoid of 
fungal immunoreactivity (Pisa, Alonso et al. 2016). It has been suggested that CoA are not 
formed by infectious agents; instead the concurrent inflammation may trigger the formation 
of CoA, with some fungal proteins becoming incorporated in these inclusions (Pisa, Alonso 
et al. 2016). As cells infected by blood-borne pathogens tend to be concentrated near blood 
vessels, the perivascular distribution of CoA is consistent with this microbial hypothesis 
(Pisa, Alonso et al. 2018). Moreover, the evidence of natural IgM antibodies in CoA supports 
a link between the natural immune system and CoA (Augé, Cabezón et al. 2017, Augé, 
Pelegrí et al. 2018).   
A fourth hypothesis posits that CoA are a component of the glio-pial clearance system that 
removes waste molecules across the glial-limiting lamina (Sbarbati, Carner et al. 1996). Thus 
CoA may function as containers that sequester potentially hazardous or residual cellular 
products, to be later eliminated via phagocytic processes or other mechanisms of the innate 
immune system (Augé, Cabezón et al. 2017). It is notable that CoA often aggregate in the 
Virchow–Robin spaces around penetrating arteries in the white matter, formed when pial 
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arteries penetrate the brain parenchyma (Cavanagh 1999), suggesting the involvement of the 
glymphatic clearance system in eliminating CoA. This idea is supported by the close 
proximity of CoA to blood vessels (37% CoA were within 5 µm of the closest blood 
vessel, and 77% within 10 µm distance), and the glymphatic drainage system (92.6% of 
observed CoA were located within a glymphatic area) (Navarro, Genoud et al. 2018). The 
glymphatic system is a recently discovered macroscopic waste clearance system in the CNS, 
that utilises the Virchow–Robin space (refer Figure 1.5) (Jessen, Munk et al. 2015). This 
metabolite waste removal system is most active during sleep when neurotoxic waste products 
are cleared from the brain, and it is largely deactivated upon wakefulness (Jessen, Munk et al. 
2015). The glymphatic system has been shown to be important for the disposal of soluble 
proteins, lipids and glucose (Thrane, Thrane et al. 2013, Lundgaard, Li et al. 2015). The 
operation of the glymphatic system is affected by neurodegenerative disorders, and low 
activity of glymphatic function in turn contributes to these pathologies (Jessen, Munk et al. 
2015). Since OSA involves profound disruptions of sleep, it offers the opportunity to 
investigate whether there are more CoA in the hippocampus of severe OSA patients, 
particularly in the Virchow–Robin spaces and near the pial surface. 
The fifth hypothesis links CoA formation to oxidative stress (Keller 2006). Cell culture 
studies have shown that upregulated expression of the oxidative stress marker heme 
oxygenase-1 promotes the transformation of normal mitochondria into CoA-like inclusions in 
ageing astroglia (Cissé and Schipper 1995, Sahlas, Liberman et al. 2002). It has been 
proposed that reactive oxygen species cause a cellular stress response in astrocytes that leads 
to an upregulation of heme oxygenase-1, heat shock proteins (HSP 27, 72, 90) as well as 
ubiquitin (Cissé and Schipper 1995), leading to the opening of the mitochondrial permeability 
transition pore and mitochondrial swelling (Sahlas, Liberman et al. 2002). The abnormal 
mitochondria engage in macroautophagy and incorporate lysosomes as well as peroxidative-
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positive inclusions to form Gomori-positive granules (Cissé and Schipper 1995, Sahlas, 
Liberman et al. 2002), which are regarded to be structural precursors of CoA (Cissé and 
Schipper 1995). In support of this hypothesis, CoA have been reported to be more frequent in 
degenerative conditions that are characterised by oxidative stress and mitochondrial 
dysfunction, including AD, Huntington’s disease, Friedreich’s ataxia and amyotrophic lateral 
sclerosis (Sahlas, Liberman et al. 2002). Since OSA has been associated with increased 
oxidative stress (Lavie 2003, Lavie 2015, Passali, Corallo et al. 2015, Sforza and Roche 
2016) and mitochondrial dysfunction (Lavie 2015), it is reasonable to suppose that increased 
OSA severity will be associated with an increased burden of CoA, particularly in the 
hippocampus which is particularly vulnerable to oxidative stress. 
The most recent hypothesis relating to the formation of CoA incorporates features from 
several of the hypotheses mentioned above. It proposes that CoA originate in the astrocytic 
endfeet, and their formation are tightly linked to the neurovascular unit and the glymphatic 
system (Navarro, Genoud et al. 2018). It is postulated that CoA may originate from 
insufficient lysosomal degradation within astroglia. Small lysosomal aggregates (immature 
CoA, intracellular inclusions without a membrane of its own) can be cleared by the 
perivascular system (glymphatic system) under normal conditions. However, when CoA 
increase in size by incorporating more waste materials, they disrupt the cell membrane and 
enter the extracellular space where they are surrounded by cell debris that gradually adds to 
their volume. These extracellular CoA cannot be cleared and remain close to blood vessels 
and the glymphatic drainage system (Navarro, Genoud et al. 2018).  
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1.6 Summary 
OSA is characterised by recurring episodes of non-breathing during sleep, resulting in 
chronic intermittent hypoxia, which induces several consequences such as hemodynamic, 
oxidative and immune-inflammatory alterations (sections 1.1.4 & 1.1.5). OSA has been 
linked to chronically elevated blood pressure and altered regional cerebral blood flow; both 
have been reported to induce functional and structural alterations of the vascular endothelium 
through shear stress (section 1.2.2). The cerebral vascular system plays a significant role in 
brain homeostasis, with the brain being highly dependent on the adequate circulation of blood 
for the provision of oxygen and nutrients. Consequently, the chronic intermittent hypoxia and 
altered cerebral blood flow in OSA can place a great burden on the normal function of 
hippocampus, which subserves cognition and memory (section 1.2.1).  
Hypoxia is a well-known stimulus for angiogenesis (section 1.3.1) and vascular remodelling 
(section 1.3.2), and animal IH models have shown increased cerebral angiogenesis and 
vascular remodelling in various brain regions. Taking all the current reports on cerebral 
microvasculture into consideration, most of them were animal models (young subjects) of 
continuous hypoxia or intermittent hypoxia; virtually nothing is known about the capacity of 
the aged human vascular system to respond to the chronic IH of OSA. 
Microvascular aberrations and ultrastructure capillary damage have been suggested to be 
detrimental to the transport of oxygen and nutrients to the neuropil (section 1.4). Among 
those studies that have investigated changes in microvascular morphology, most were limited 
to qualitative observations on the distribution of the appearance of the vasculature, rather than 
on quantitative measurements. The present microvascular morphology reports in humans 
have been concerned with the effects of ageing or AD, and nothing is known about the 
microvascular morphology alterations in OSA patients. It would be important to investigate 
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the cerebral microvascular abnormalities in the hippocampus of OSA patients, as it may 
indicate which subregions are most prone to vascular insufficiency, and consequent 
disruption of neuronal function. 
There are abundant reports on the distribution of CoA in the aged human brain, and the 
density and size of CoA are believed to increase with ageing. CoA deposit in the 
periventricular, perivascular and subpial regions of CNS, demonstrating a relationship 
between CoA and CSF and blood vessels. The nature of this relationship may become clearer 
if the spatial distribution, packing density and size of CoA in different subregions of the brain 
were investigated in a systematic way. Based on their molecular contents, at least five 
different hypotheses have been formulated to explain the formation of CoA, and while each 
are supported by evidence, none are conclusive. Proposed causes of CoA include 
neurodegeneration, BBB leakage, infection, oxidative stress, and glio-pial clearance of waste 
metabolites. Most of these hypotheses predict that the burden of CoA should increase as a 
function of OSA severity, so an examination of brain tissue from OSA patients may provide 
insights into the origins of these enigmatic structures.  
1.7 Thesis aims and hypothesis 
The overall aim of the present thesis was to investigate the microvascular alterations and CoA 
burden in post-mortem hippocampus of OSA patients. Specifically, it investigated the effects 
of increased OSA severity (based on ODI) on angiogenesis, microvascular remodelling, 
microvascular abnormalities, as well as CoA distribution, density and size in hippocampal 
subregions. The effects of regular CPAP use and advancing age were also investigated. These 
data provided insights into the validity of the various hypotheses that have speculated about 
the formation of CoA. 
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Four specific aims were as follows (Figure 1.7): 
A1 
 
A2 
 
A3 
 
A4.1 
 
A4.2 
 
  
Figure 1.7 Schematic illustration of the research aims of the present thesis.  
Each of the four data chapters (Chapters 3 – 6) are associated with a different aim (A1 – A4). 
The arrows indicate the main independent variables that will be considered in relation to that 
aim. 
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Aim 1: To investigate the effects of OSA severity, regular CPAP use and advancing age on 
angiogenesis and microvascular remodelling in the hippocampus (Chapter 3). 
Aim 2: To investigate the effects of OSA severity, regular CPAP use and advancing age on 
microvascular abnormalities in the hippocampus (Chapter 4). 
Aim 3: To investigate the effect of advancing age on the distribution, density and size of 
CoA in the hippocampus (Chapter 5). 
Aim 4: To investigate whether OSA severity, AD pathology, neuropil loss or demyelination 
contribute to the distribution, density or size of CoA in the hippocampus, and whether regular 
CPAP use can ameliorate the CoA burden (Chapter 6). 
The working hypothesis: There will be increased angiogenesis / microvascular remodelling 
/ microvascular abnormalities / CoA burden in response to OSA severity. Increasing patient 
age will strengthen these changes, and they will be attenuated by regular CPAP use. 
The results obtained through these studies are likely to provide new insights into the 
adaptability of the hippocampal microvasculature in OSA, as well as indicating which 
subregions are likely to be vulnerable to vascular insufficiency. These results will also help to 
elucidate the distribution, size and progression of CoA in the hippocampus, as well as 
providing insights into their origins. 
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Chapter 2 Materials and Methods 
2.1 Ethics approvals 
All four research projects in this thesis used post-mortem brain tissues kindly provided by 
Professors Thorarinn Gislason and Bryndis Benediktsdottir of Landspitali University 
Hospital, Iceland. This project was approved by the National Bioethics Committee, Iceland, 
reference number 09-087-CM (Appendix A) for the brain tissue samples (formalin-fixed and 
paraffin-embedded) and corresponding medical records to be examined at RMIT University, 
Melbourne, Australia. The research investigations conducted on these samples were approved 
by the RMIT Human Research Ethics Committee (Appendix B, reference number ASEHAPP 
71-16). 
2.2 Materials 
Ethanol, sodium chloride, sodium dihydrogen orthophosphate, disodium hydrogen phosphate 
and sodium acetate were sourced from Merck Millipore. Bovine albumin serum (BSA), goat 
serum, diaminobenzidine-nickel sulphate (DAB-Ni), ethylenediaminetetraacetic acid 
(EDTA), tris hydrochloric acid (Tris-HCl), sodium dodecyl sulphate (SDS) were sourced 
from Sigma Aldrich Australia. Ethanolamine, hydrogen peroxide (H2O2) and Tween 20, were 
from BDH. Histolene and Depex were from Grale HSD. Triton X-100 was from APS 
Finechem. RevealIt antigen retrieval solution was from ImmunoSolutions. Streptavidin-
biotinylated horseradish peroxidase (RPN1051) was from GE Healthcare. 
2.3 OSA diagnosis 
In Iceland, the diagnosis of OSA and CPAP treatment both began in 1987. The OSA 
diagnoses are based on whole night polysomnography. OSA severity measurement has 
always been determined by the number of apnoeas and hypopnoeas per hour (AHI). More 
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recently, the number of events involving a 4% decrease in oxygen saturation per hour (ODI) 
has been measured. Due to the archival nature (incomplete and older records), not all of the 
AHI records were fully retrieved or comparable, whereas all of the ODI records were 
recovered. Therefore, ODI was used as the measure of OSA severity in the present study. 
Between 1987 and 2014, a total of 8,853 OSA patients (18 years and older) were registered in 
Iceland for the diagnosis of OSA (total population 320,000). In March 2014,  7,531 
registrants were alive, 5,436 males and 2,075 females. Of those that had died, consents were 
received from 121 patients for donation autopsies at the Department of Pathology, 
Landspitali University Hospital; 61 of them included brain tissues and were sent to RMIT 
University for research purposes.  
The cases selected for study had undergone one or more overnight sleep study using 
international clinical guidelines for the diagnosis of OSA. Exclusion criteria were: dementia, 
head trauma, stroke, multiple sclerosis, cerebral infection, pulmonary disease, as well as 
treatment for OSA other than CPAP. Tissues were coded to mask the patients’ identity. 
Among the 61 brain blocks examined at RMIT University, 35 blocks contained hippocampal 
brain tissues, and of these one was excluded due to a diagnosis of AD. Of the remaining 34 
blocks, 3 had been fully depleted by previous research studies undertaken in our laboratory.  
The the hippocampal series examined in the present study consisted of autopsy tissue from 31 
patients (16 males and 15 females). Seventeen patients were  confirmed to have used CPAP 
regularly until they died, of the remainder, 3 patients were known not to have ever used 
CPAP, while 11 patients were not using CPAP at the time of death, although they may or 
may not have used CPAP at some point between OSA diagnosis and death. For the purposes 
of the present study, only those patients who had regularly used CPAP were considered as the 
CPAP group, and all other patients were considered as the non-CPAP group. While the 
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regular CPAP users were known to have received CPAP treatment up until their death, their 
nightly usage data were not available. 
2.3.1 OSA severity descriptive statistics 
The severity of OSA, as measured by ODI in the present study, ranged from 4.1 − 92.2 
events/h sleep. The total samples were divided into two groups at the median ODI value of 20 
events/h sleep. The 15 patients with an ODI value of less than 20 events/h sleep were 
considered to have mild-moderate OSA, namely the 'low OSA' group, while those with an 
ODI value of equal to or greater than 20 events/h sleep (16 patients) were considered to have 
moderate-severe OSA, the 'high OSA' group. Records relating to body-mass index (BMI) 
were available for 27 of these 31 patients. These two groups were well matched for age at 
death, time lived after OSA diagnosis and BMI, as shown in Table 2.1.  
Table 2.1 Descriptive statistics of sample group stratified by OSA severity. 
 Low OSA High OSA p value 
n 15 16  
Gender M = 7, F = 8 M = 8, F = 8  
CPAP users Y = 6, N = 9 Y = 11, N = 5  
Age at death (years) 66.0 ± 2.8 68.2 ± 2.9 0.589 
Time lived after OSA 
diagnosis (years) 
8.6 ± 1.2 6.8 ± 1.7 0.397 
BMI (kg/m2) 28.7 ± 1.0 (n = 14) 30.6 ± 2.1 (n = 13) 0.410 
ODI (events/h sleep) 10.3 ± 1.3 42.4 ± 4.9 0.001 
Abbreviations: M, male; F, female; Y, yes for regular CPAP use; N, No/not sure for CPAP 
use. Unpaired 2-tailed t-tests between low OSA (ODI < 20 events/h sleep) vs. high OSA 
(ODI ≥ 20 events/h sleep). Mean ± SEM. 
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2.3.2 CPAP use descriptive statistics 
The total samples were also stratified by CPAP use; details of the descriptive statistics for 
these groups are provided in Table 2.2. Regular CPAP users were significantly older and had 
higher BMIs than non-CPAP users. No significant differences were found in terms of time 
lived after OSA diagnosis or OSA severity (ODI). 
Table 2.2 Descriptive statistics of sample group stratified by CPAP use. 
 
Non-CPAP users CPAP users p value 
n 14 17  
Gender M = 9, F = 5 M = 6, F = 11  
OSA group L = 9, H = 5 L = 6, H = 11  
Age at death (years) 63.3 ± 2.7 70.3  ± 2.7 0.085 
Time lived after OSA 
diagnosis (years) 
8.3 ± 5.6 7.4 ± 6.5 0.597 
BMI kg/m2 26.3 ± 1.2 (n=12) 32.3 ± 1.5 (n=14) 0.006 
ODI (events/h sleep) 19.5 ± 6.2 32.9 ± 4.6 0.087 
Abbreviations: M, male; F, female; L, low OSA (ODI < 20 events/h sleep); H, high OSA 
(ODI ≥ 20 events/h sleep). Unpaired 2-tailed t-tests between non-CPAP users vs. CPAP users. 
Mean ± SEM.  
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2.3.3 Age at death descriptive statistics 
The effect of age was investigated by dividing the data into two groups based on the median 
age of the samples: age < 67.5 years and age > 67.5 years, the descriptive statistics are 
provided in Table 2.3. The older group had a significantly higher mean OSA severity than the 
younger group, but the groups did not differ on any of the other parameters. 
Table 2.3 Descriptive statistics of sample group stratified by age at death. 
 Age < 67.5 years Age > 67.5 years p value 
n 16 15  
Gender M = 7, F = 8 M = 8, F = 7  
CPAP use Y = 5, N = 10 Y = 4, N = 11  
OSA group L = 9, H = 6 L = 6, H = 9  
Time lived after OSA 
diagnosis (years) 
7.6 ± 1.4 7.8 ± 1.6 0.936 
BMI kg/m2 27.9 ± 1.2 (n=15) 31.8 ± 1.9 (n=12) 0.084 
ODI (events/h sleep) 18.5 ± 3.7 35.9 ± 6.4 0.023 
Abbreviations: M, male; F, female; Y, yes for regular CPAP use; N, No/not sure for CPAP 
use; L, low OSA group (ODI < 20 events/h sleep); H, high OSA group (ODI ≥ 20 events/h 
sleep). Unpaired 2-tailed t-tests between OSA patients aged < 67.5 years vs. those aged > 
67.5 years. Mean ± SEM.  
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2.4 Brain samples 
Brain tissues from dead patients were dissected by experienced pathologists in Iceland. The 
post-mortem interval was not recorded. Dissected brain tissues were post-fixed in 10% 
formalin, subsequently dehydrated in graded ethanol, embedded in paraffin wax and 
archived. After being shipped to RMIT University, brain blocks that contained hippocampal 
tissue (e.g. the wall of lateral ventricle, fimbria, parahippocampal gyrus and collateral sulcus) 
were selected. The investigated hippocampal regions are illustrated with diagrams in the 
following four chapters. 
2.5 Sectioning 
Formalin-fixed paraffin-embedded tissue blocks were sectioned at 20 µm with a microtome 
at RMIT University. Sections were then mounted onto glass microscope slides and allowed to 
dry in a 37°C oven overnight. Note that paraffin sections of brain are more commonly cut at 
5 − 10 µm thickness; however, the present study chose the 20 µm thickness because the 
greater thickness affords superior visualization of capillaries and corpora amylacea (CoA). 
2.6 Immunohistochemistry 
The immunohistochemistry protocol was refined by a previous researcher in our laboratory 
(Owen, Benediktsdottir et al. 2019). Sections were deparaffinised with histolene (2 × 10 min) 
and graded ethanol solutions (100% 3 min, 95% 3 min, 70% 3 min, distilled water rinse 1 
min), and then treated with antigen retrieval buffer for 40 min at 85ºC in a water bath. 
Sections were then incubated with blocking solution (0.1 M phosphate buffered saline (PBS), 
0.1 g BSA, 10% Triton X-100 and 1% ethanolamine) for 3 h at room temperature. Tissue 
sections were incubated with primary solutions of primary antibodies in a humidified 
chamber for 16.5 h at room temperature overnight. On the next day, sections were collected 
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out of the container and then incubated for 3 h with solutions of secondary antibodies diluted 
at 1 in 300. Between each of the above steps, sections were washed for 3 × 10 min in 0.1 M 
PBS. After tertiary incubation with a solution of streptavidin-biotinylated horseradish 
peroxidase (SB-HRP) diluted at 1 in 300 for 3 h, sections were washed for 2 × 5 min in 0.1 M 
PBS then for 2 × 10 min in 0.175 M sodium acetate buffer (NaOAc). Sections were then 
incubated for 10 min in a 0.05% solution of the chromogen DAB diluted in NaOAc buffer, 
then in 0.05% DAB in NaOAc buffer with 0.004% H2O2 for another 15 min to visualise the 
chain of antibodies bound to the tissue. Immunolabelled sections were then washed in 
NaOAc buffer for 2 × 5 min then 0.1 M PBS for 2 × 10 min and left overnight in 0.1M PBS 
at 4°C. On the following day, sections were dehydrated in graded ethanol (70% 10 min, 95% 
10 min, 100% 2 × 5 min) and histolene (2 × 10 min) before being coverslipped with Depex. 
Details about immunohistochemistry diluents and antibodies are provided in Tables 2.4 and 
2.5.  
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Table 2.4 Immunohistochemistry dilution protocol. 
 Blocking (3 h) Primary (16.5 h) Secondary (4 h) Tertiary (3 h) 
1% BSA     
4% Goat serum     
10% Triton X-100     
1% Ethanolamine     
1st antibody 
(Rabbit) 
 
1 
  
Goat anti-Rabbit     
SB-HRP2     
1Control slides were incubated without primary antibody. 2Streptavidin-biotinylated 
horseradish peroxidase. 
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Table 2.5 Details of immunohistochemistry antibodies. 
Antibody Company Product no. Dilution Description 
Anti-   
CD34 
Abcam ab81289 1 in 5,000 
Cell-surface adhesion factor; 
expressed by vascular 
endothelial cells 
Anti-
Claudin 5 
Abcam ab131259 1 in 5,000 
Tight junction protein 
between adjacent vascular 
endothelial cells 
Anti-
Collagen IV 
Abcam ab6586 1 in 20,000 
Key component of the basal 
membrane of blood vessels 
Anti-GluT-1 Abcam ab15309 1 in 2,000 
Primary glucose transporter; 
expressed by vascular 
endothelial cells 
Anti-   
VWF 
Abcam ab6994 1 in 50,000 
Aids clot formation; 
expressed by vascular 
endothelial cells 
Anti- 
Rabbit IgG 
Vector BA-1000 1 in 300 Secondary 
SB-HRP 
GE 
Healthcare 
RPN1051 1 in 300 Tertiary 
VWF, von-Willebrand factor; SB-HRP, streptavidin-biotinylated horseradish peroxidase.       
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2.7 Image acquisition and processing 
Micrographs were taken with an Olympus AX-60 microscope and Olympus DP73 camera at 
a final magnification of 400 × (objective lens 10 ×, ocular lens 20 ×, magnification changer 2 
×). Micrographs were taken with Olympus software CellSens using the ‘Acquisition’ feature 
at predetermined regions of the hippocampus with the same settings of magnification, 
illumination and exposure duration for all micrographs. Images were saved at a resolution of 
1600 × 1200 pixels. 
Scanning images of brain sections were viewed under an Olympus Virtual Microscopy Slide 
Scanning System (VS120) and Olympus VS-ASW-S5 software at objective magnification of 
20 × (microscope: VS-BX), camera adapter of 0.5 × (camera: VC50) and camera adapter of 1 
× (camera: Hamamatsu ORCA-Flash 4.0). Micrographs at investigated regions were captured 
with the ‘Crop’ tool in Olympus CellSens software at a resolution of 1600 × 1200 pixels.  
The examiner (CX) was blinded to the OSA severity of the samples when taking the 
micrographs. 
2.8 Image processing and analysis 
As the methods of image analysis were different in each of the following four chapters, 
relevant methodological details are provided in each chapter. 
2.9 Statistical analysis  
Statistical analysis was performed using the IBM Statistical Package for the Social Sciences 
(SPSS version 21). A Shapiro-Wilk test was first conducted to examine whether the data 
were normally distributed. Normality tests of sample parameters showed that ODI had a non-
normal distribution, while age, BMI and time alive between OSA diagnosis and death were 
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normally distributed. A significant correlation between age and ODI was found for the 
samples (r2 = 0.175, p = 0.019), while no further significant correlations were found between 
the sample parameters. 
Unpaired 2-tailed t-tests were performed to compare the differences between two groups, one 
way ANOVAs were performed for comparison between more than two groups, while 
Levene's test was included as a measure of whether the variances of the compared groups 
were equal; Tukey's HSD post hoc test was used with equal variances while the Games-
Howell post hoc test was used with unequal variances. Bivariate Pearson’s correlation was 
performed to reveal the strength of linkage of two continuous-level variables. Data and 
figures were present as Mean ± SEM. * p < 0.05 was considered to be significant with equal 
variances, alternatively, # p < 0.05 indicates significant difference with unequal variances. 
Note: Chapters 3, 4 5 and 6 have been organised and structured as draft manuscripts to be 
published shortly after the examination of this thesis. For this reason, some aspects of the 
introduction and methods of these chapters restate key concepts and details. 
Throughout this thesis, ratios are calculated using the unrounded data values. Hence the 
derived ratios may differ slightly from ratios calculated from the rounded values given in the 
text. 
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Chapter 3 Microvascular remodelling in the hippocampus of obstructive sleep apnoea 
patients 
3.0 Abstract 
Obstructive sleep apnoea (OSA) is characterised by chronic intermittent hypoxia. The brain is 
a highly vascularised organ and is sensitive to minor fluctuations in the availability of 
oxygen. Hypoxia is a well-known stimulus for angiogenesis in the developing nervous 
system and is characterised by an increase in the number of blood vessels. The present study 
investigated whether angiogenesis occurs in the hippocampus of OSA patients. 
Immunohistochemistry was used to identify microvessels in the hippocampus and 
surrounding regions from patients with OSA. When stratified by OSA severity, the mean 
blood vessel count in the low OSA group (ODI < 20 events/h sleep) was not significantly 
different from that in the high OSA group (ODI ≥ 20 events/h sleep). There were 
significantly larger vessel diameters (µm) in the high OSA group in the fimbria (8.4 ± 0.2 vs. 
6.8 ± 0.2, p < 0.001) and CA4 regions (7.8 ± 0.3 vs. 7.1 ± 0.2, p = 0.027). Additionally, 
increased vessel length (µm) was found in the fimbria region (51.1 ± 1.8 vs. 45.0 ± 1.9, p = 
0.026) in the high OSA group when compared to the low OSA group. Thus, remodelled 
vasculature (increased vessel diameter and length), rather than angiogenesis (increase in 
vessel numbers), accounts for a significant increase (1.24 − 1.33-fold) in the area percentage 
occupied by blood vessels in the high OSA group in the fimbria (2.85 ± 0.26 vs. 2.14 ± 0.14, 
p = 0.026) and CA4 regions (6.12 ± 1.49 vs. 4.95 ± 0.82, p = 0.015). The present study found 
evidence of microvascular remodelling in the hippocampus of patients with moderate-severe 
OSA; mostly in the fimbria and CA4 regions, which could not be reversed by regular CPAP 
treatment. The limited capacity of microvessels to remodel in response to hypoxia in the CA1 
region might underpin the selective vulnerability of this region to hypoxic injury. 
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3.1 Introduction 
Obstructive sleep apnoea (OSA), one of the most severe types of sleep-disordered breathing, 
is characterised by recurrent episodes of upper airway collapse during sleep (Dempsey, 
Veasey et al. 2010), leading to frequent episodes of hypoxia, arousals, sleep disruption and 
sleep fragmentation (Malhotra and White 2002, Azagra-Calero, Espinar-Escalona et al. 2012, 
Kielb, Ancoli-Israel et al. 2012). OSA sufferers have reported symptoms of daytime 
sleepiness, morning headache, fatigue or tiredness, depression and anxiety, as well as 
memory loss (Kasai, Floras et al. 2012, Phillips and O’Driscoll 2013). OSA is widely 
recognised as a major public health problem due to its adverse impacts on health and quality 
of life (Leger, Bayon et al. 2012). Continuous positive airway pressure (CPAP), delivered 
through a facemask worn during sleep, prevents the collapse of the upper airway and supports 
an uninterrupted sleep (Sullivan, Berthon-Jones et al. 1981). CPAP has been proven to 
successfully improve daytime productivity and daily function, elevate mood and 
psychological well-being, and reduce daytime sleepiness in people with moderate and severe 
OSA (Gay, Weaver et al. 2006).  
The hippocampus plays an essential role in memory consolidation, as well as contributing to 
other aspects of cognition (Bartsch and Wulff 2015). Additionally, the hippocampus is 
extremely sensitive to hypoxic injury, and hypoxia has been implicated in the hippocampal 
atrophy commonly observed in OSA patients with in vivo brain imaging (Morrell, McRobbie 
et al. 2003, Gale and Hopkins 2004, Yaouhi, Bertran et al. 2009, Canessa, Castronovo et al. 
2011, Torelli, Moscufo et al. 2011). In association with this atrophy, OSA patients are 
frequently found to have cognitive impairment and memory deficits (Naëgelé, Thouvard et al. 
1995, Salorio, White et al. 2002, Ferini-Strambi, Baietto et al. 2003, Lim, Bardwell et al. 
2007). This atrophy can be partly reversed by regular CPAP use: studies have reported 
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significant improvements in memory and cognitive function (Canessa, Castronovo et al. 
2011, Rosenzweig, Glasser et al. 2016) that paralleled increased grey matter volume in the 
hippocampus after three months of CPAP treatment (Canessa, Castronovo et al. 2011). 
Neural injury and impaired neural function have been assumed to be responsible for the 
cognitive deficits resulting from OSA (Goldbart, Row et al. 2003, Zhu, Fenik et al. 2007). 
Considering the essential role that cerebral microvasculature plays in supporting neuronal 
function (Ingraham, Forbes et al. 2008, Andreone, Lacoste et al. 2015), it is important to 
examine the adaptive response of capillaries in the hippocampus of OSA patients. 
A key research study has investigated the effect of different severities of intermittent hypoxia 
(IH) on the dorsal hippocampal microvasculature of the mouse (Lim, Brady et al. 2016). Lim 
and colleagues (2016) subjected young adult mice to one of three conditions: sham 
(continuous air, SaO2 95%), severe IH (SaO2 nadir 61%), and very severe IH (SaO2 nadir 
37%) for 2 weeks (12 h/day). Hippocampal capillaries were immunolabelled for CD31. It 
was reported that the total capillary length in the very severe group was significantly greater 
than those in the sham group (p = 0.004), and the severe group (p = 0.05), while no 
significant difference was found between the sham and severe group (p = 0.202) (Lim, Brady 
et al. 2016). mRNA expression for GluT-1 (glucose transporter type 1) on capillary walls was 
significantly increased in the very severe group compared with the sham group (p = 0.014), 
while no significant differences were found between the severe group vs. sham group (p = 
0.102), or the severe group vs. very severe group (p = 0.353) (Lim, Brady et al. 2016). 
Moreover, capillaries in different hippocampal regions showed differences in GluT-1 protein 
expression: the very severe group had the highest GluT-1 expression among those three 
groups in the CA1 (p = 0.024), CA3 (p = 0.002), and the perforant pathway (p = 0.017), but 
not in the dentate gyrus (p = 0.095) (Lim, Brady et al. 2016). This research indicates that the 
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extent of angiogenesis can vary in different parts of the hippocampus in response to IH, and 
that the severity of IH is an important driver (Lim, Brady et al. 2016).  
While (Lim, Brady et al. 2016) is an important study, it is limited in several respects. First it 
is an animal study that investigated the effects of IH for a relatively short duration (2 weeks) 
compared to decades in patients with OSA. Second, Lim and colleagues (2016) only 
investigated vessel length, and neglected other parameters such as vessel count, vessel 
diameter and area fraction. Third, the degree of hypoxia induced in this study was extreme 
and is not representative of human experience. In patients with severe OSA, the nadir SaO2 
may drop to below 80% for a few times during the night (Badran, Ayas et al. 2014), however 
Lim and colleagues (2016) repeatedly induced nadirs of 61% and 37% for every minute of 
the sleep period. In view of these limitations, it is unclear whether similar capillary 
remodelling would occur in the hippocampus of humans with OSA. 
Both angiogenesis, the generation of new blood vessels, and vascular remodelling in terms of 
altered vessel diameter and length, have been reported to occur in animal models in response 
to hypoxia (refer section 1.3). Given the substantial IH that patients with severe OSA may 
experience every night, it seems likely that angiogenesis and/or vascular remodelling occurs 
in moderate-severe OSA. However, no data are available to confirm this likelihood. 
Furthermore, it is not known whether different subregions of the hippocampus undergo 
angiogenesis and vascular remodelling to the same extent. The aim of the present study was 
to investigate the effect of OSA severity on angiogenesis and microvascular remodelling in 
the hippocampus, and to relate these measures to CPAP use and patient age. 
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3.2 Materials and Method 
3.2.1 Study samples 
The study sample consisted of 30 of the 31 patients from the Iceland cohort described 
previously (section 2.3), one sample was excluded due to resistance of this tissue to 
immunocytochemistry, which resulted in faint staining or no staining for most blood vessel 
markers. The detailed descriptive statistics are provided in Tables 2.1 − 2.3. The study 
samples were divided into two groups, a low OSA group (ODI < 20 events/h sleep; 
equivalent to mild-moderate OSA) and a high OSA group (ODI ≥ 20 events/h sleep; 
equivalent to moderate-severe OSA). There were equal sample sizes for both groups (15 
patients in each). 
3.2.2 Tissue processing 
Hippocampal blocks were sectioned at 20 μm on a microtome as described in section 2.5 for 
immunohistochemistry. 
3.2.3 Immunohistochemistry 
The immunohistochemistry protocol followed that previously described in section 2.6. 
Briefly, sections were deparaffinised prior to treatment with antigen retrieval buffer for 40 
min at 85ºC. After blocking, sections were incubated with primary antibodies for 16.5 h 
overnight. Primary antibodies were visualised by using a biotinylated secondary antibody and 
streptavidin-biotinylated horseradish peroxidase (SB-HRP), which reacted with DAB-Ni to 
demonstrate the localisation of the antigen. Following this, sections were rinsed and cover-
slipped. 
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Five capillary markers were investigated in the current study. CD34 is a cell-surface adhesion 
factor, expressed by vascular endothelial cells, that labels both established and newly-formed 
blood vessels. Von-Willebrand factor (VWF), aids clot formation following vascular injury 
and is synthesised by vascular endothelial cells. Claudin 5 is a tight junction protein that seals 
the BBB by bonding adjacent vascular endothelial cells. GluT-1 is the primary glucose 
transporter expressed by vascular endothelial cells, while Collagen IV is a key component of 
the basal membrane of blood vessels. The concentrations of the primary antibodies used in 
this study are detailed in Table 2.5. 
3.2.4 Double immunofluorescence 
Sections underwent the same deparaffination and antigen retrieval steps as for normal 
immunohistochemistry, while PBS-Tween 20 (0.05%) was used instead of PBS for the 
washing steps. After antigen retrieval, slides were washed in PBS-Tween 20 for 3 × 10 min, 
followed by 1st serum blocking (4% goat serum) for 3 h at room temperature, first primary 
antibody (Collagen IV; Abcam ab6586 diluted 1 in 20,000, made in rabbit) was incubated 
overnight for 18 h. On the second day, slides were washed with PBS-Tween 20 for 3 × 10 
min, and the first secondary fluorescent antibody (goat anti-rabbit IgG H & L (Alexa Fluor® 
647); Abcam ab150083, diluted 1 in 200) was incubated for 30 min at room temperature. 
After washing, slides were kept in PBS-Tween 20 in the dark at 4°C overnight. On the third 
day, slides were washed in PBS-Tween 20 for 10 min and were blocked for the second time 
(3 h at room temperature, 4% rabbit serum to block free binding sites of the anti-rabbit 
immunoglobulin), followed by the second 18 h primary antibody incubation (GluT-1; Abcam 
ab15309 diluted 1 in 2,000, made in rabbit). On the fourth day, slides underwent triple 10 min 
PBS-Tween 20 washing, and the second 30 min secondary antibody incubation (goat anti-
rabbit IgG H & L (Alexa Fluor® 488); Abcam ab150077 diluted 1 in 100), after which 
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sections were washed with PBS-Tween 20 for 3 × 10 min and were kept in the dark at 4°C 
overnight. On the fifth day, slides were washed in PBS-Tween 20 for another 10 min, cover 
slipped with BrightMount and sealed with clear nail polish. Slides were kept horizontally in 
the dark at 4°C for long term storage. 
3.3.5 Histological analysis of hippocampal microvasculature 
Five regions of the hippocampus and overlying cortex were investigated: fimbria, Cornu 
Ammonis 4 (CA4 or hilus), Cornu Ammonis 1 (CA1), subiculum and collateral sulcus (near 
the apex), as illustrated in Figure 3.1 A. Micrographs were taken at every hippocampal region 
(unless a part of the tissue was missing) with an Olympus AX-60 microscope and Olympus 
DP73 camera at a final magnification of 400 × (objective lens 10 ×, ocular lens 20 ×, 
magnification changer 2 ×) using Olympus CellSens software at a resolution of 1600 × 1200 
pixels. Regions were identified by referring to adjacent cresyl violet-stained sections that had 
been prepared by a previous researcher in our laboratory (Owen, Benediktsdottir et al. 2019).  
Four parameters were investigated: 1) vessel count, the total number of labelled profiles in 
the image; 2) area fraction (%), the proportion of the image occupied by all labelled profiles; 
3) vessel diameter (µm), the mean of the diameters of all selected profiles; 4) vessel length 
(µm), the mean of the length of all selected profiles. These parameters are illustrated in 
Figure 3.1 B − E. 
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Figure 3.1 Micrographs that illustrate the hippocampal regions investigated and 
parameters that were measured.  
A, Micrographs were taken at five hippocampal locations as indicated by the frames in the 
cresyl violet-stained micrograph. B, Vessel count was defined by the enclosed outline count 
of one vessel segment. C, Area fraction (%) was defined as the proportion of the image area 
occupied by vessels. D, Vessel diameter was defined as the mean diameter of a vessel 
segment when measured perpendicularly to the centre line at one pixel intervals. E, Vessel 
length was defined as the length along the centre line from the beginning to the end. 
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In order to measure vessel count and area fraction, the original RGB (red-green-blue) 
micrographs were converted into greyscale images, auto-contrasted in Photoshop software 
and then analysed with Olympus CellSens software using the ‘Count and Measure’ feature. 
The threshold level was adjusted manually until all labelled profiles were selected, as 
determined by visual inspection. Profiles inside the image and those contacting a border were 
selected if they were greater than 100 pixels in size. Data were then exported into Excel for 
further analysis.  
Due to a limitation of the algorithm in the CellSens software which is designed for 
round/oval-shaped objects such as cells, the vessel diameter and length were analysed with 
software that had been specifically developed for blood vessels: the Automated Retinal Image 
Analyzer (ARIA) v1.0 (Bankhead, Scholfield et al. 2012). ARIA automatically recognises 
and generates a centreline and two edge lines along each vessel segment (Figure 3.1 B). 
Diameters for each vessel segment were tested perpendicularly along the centreline at 1 pixel 
intervals (Figure 3.1 D). Vessel length was defined as the Euclidean distance along the 
centreline (Figure 3.1 E). Detailed data were retrieved by a separate routine, and then 
converted from pixels into micrometres (µm). 
3.2.6 Statistical analysis 
Statistical analysis was performed using the IBM Statistical Package for the Social Sciences 
(SPSS version 21). Unpaired 2-tailed t-tests were performed to compare the low OSA and 
high OSA groups, non-CPAP users to regular CPAP users, and OSA patients aged < 67.5 vs. 
those aged > 67.5 years. One-way ANOVAs with post hoc multiple comparisons were used 
to compare among the five blood vessel markers. p < 0.05 was considered significant (* with 
equal variances; # with unequal variances). GraphPad Prism 7 was used to generate graphs, 
presented as Mean ± SEM 
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3.3 Results  
3.3.1 Immunohistochemistry of the hippocampal microvasculature 
Figure 3.2 shows the representative immunohistochemistry staining results of five blood 
vessel markers from the low and high OSA groups in the CA4 region: CD34 (A & B), VWF 
(C & D), Claudin 5 (E & F), GluT-1 (G & H), and Collagen IV (I & J). In a small number of 
cases the brain tissue in the investigated regions was missing, consequently not all of the 30 
brain sections contained all five hippocampal regions, therefore the sample size in different 
hippocampal regions varies from 23 to 30 (Table 3.1). 
Table 3.1 Sample sizes for each of the hippocampal regions and markers studied. 
Marker Fimbria CA4 CA1 Subiculum Collateral sulcus 
CD34 27 29 29 28 23 
VWF 28 30 30 30 24 
Claudin 5 27 29 29 29 23 
GluT-1 29 30 30 29 24 
Collagen IV 27 29 29 27 23 
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Figure 3.2 Representative images for five blood vessel markers in the CA4 region.  
Blood vessels immunostained for CD34 (A & B), VWF (C & D), Claudin 5 (E & F), GluT-1 
(G & H) and Collagen IV (I & J) in the low (A, C, E, G & I) and high (B, D, F, H & J) OSA 
groups.  
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3.3.2 The effect of OSA severity on hippocampal angiogenesis and microvascular 
remodelling 
3.3.2.1 Increased mean blood vessel counts in the high OSA group  
For each of the five blood vessel markers, the total number of blood vessels counted per 
image was investigated in each of the five hippocampal regions (Figure 3.3 A − E). No 
significant differences were found between the mean vessel counts of the low and high OSA 
groups in the fimbria, CA4, CA1, subiculum or collateral sulcus regions, however there were 
significantly more Claudin 5-positive blood vessels (1.24-fold) in the subiculum region in the 
high OSA group when compared to the low OSA group (143.9 ± 7.2 vs. 116.4 ± 7.2, t (27) = 
2.686, p = 0.012; Figure 3.3 D). 
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Figure 3.3 Comparison of mean vessel counts between the low and high OSA groups. 
Mean vessel counts in the low (ODI < 20 events/h sleep; blank bars) and high (ODI ≥ 20 
events/h sleep; striped bars) OSA groups in the fimbria (A), CA4 (B), CA1 (C), subiculum (D) 
and collateral sulcus (E). Unpaired 2-tailed t-tests between low vs. high OSA groups. Mean ± 
SEM. 
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3.3.2.2 Increased mean vessel diameters in the high OSA group  
The mean vessel diameter (µm) in the high OSA group was significantly larger than in the 
low OSA group when immunolabelled for Collagen IV in the fimbria region (1.23-fold; 8.4 ± 
0.2 vs. 6.8 ± 0.2, t (25) = 5.370, p < 0.001; Figure 3.4 A) and CA4 region (1.11-fold; 7.8 ± 
0.3 vs. 7.1 ± 0.2, t (27) = 2.336, p = 0.027; Figure 3.4 B). Furthermore, one-way ANOVA 
tests revealed that the vessels stained with Collagen IV had significantly wider diameters 
(1.20 − 1.46-fold) than those labelled with CD34, VWF, Claudin 5 or GluT-1 across all five 
hippocampal regions investigated. Details of the post hoc multiple comparison (Tukey HSD) 
results are shown in Table 3.2. 
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Figure 3.4 Comparison of mean vessel diameters between low and high OSA groups. 
Mean vessel diameters (µm) in the low (ODI < 20 events/h sleep; blank bars) and high (ODI 
≥ 20 events/h sleep; striped bars) OSA groups in the fimbria (A), CA4 (B), CA1 (C), 
subiculum (D) and collateral sulcus (E). Unpaired 2-tailed t-tests between low vs. high OSA 
groups. Mean ± SEM. 
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Table 3.2 The mean diameters of microvessels labelled with Collagen IV are larger than 
those labelled with the other four vessel markers in all five hippocampal regions 
investigated. 
Region (I) Group (J) Group Mean Diff. (I − J) ± SEM p value 
Fimbria 
(N = 138) 
Collagen IV 
CD34 2.39 ± 0.28 < 0.001 
VWF 1.28 ± 0.28 < 0.001 
Claudin 5 1.90 ± 0.28 < 0.001 
GluT-1 1.61 ± 0.27 < 0.001 
CA4 
(N = 147) 
Collagen IV 
CD34 2.28 ± 0.22 < 0.001 
VWF 1.71 ± 0.22 < 0.001 
Claudin 5 1.83 ± 0.22 < 0.001 
GluT-1 1.66 ± 0.22 < 0.001 
CA1 
(N = 147) 
Collagen IV 
CD34 2.08 ± 0.23 < 0.001 
VWF 1.65 ± 0.23 < 0.001 
Claudin 5 1.73 ± 0.23 < 0.001 
GluT-1 1.67 ± 0.23 < 0.001 
Subiculum 
(N = 143) 
Collagen IV 
CD34 2.07 ± 0.24 < 0.001 
VWF 1.44 ± 0.23 < 0.001 
Claudin 5 1.49 ± 0.24 < 0.001 
GluT-1 1.51 ± 0.24 < 0.001 
Collateral 
Sulcus 
(N = 117) 
Collagen IV 
CD34 2.07 ± 0.26 < 0.001 
VWF 1.60 ± 0.26 < 0.001 
Claudin 5 1.78 ± 0.26 < 0.001 
GluT-1 1.71 ± 0.26 < 0.001 
Mean difference in diameter is expressed in µm. One-way ANOVA with post hoc test for 
multiple comparisons between group I and group J, namely, Collagen IV compared to CD34, 
VWF, Claudin 5 and GluT-1. Tukey HSD post hoc test was used, as Levene’s test revealed 
equal variances. 
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3.3.2.3 Increased mean vessel lengths in the high OSA group 
In sections immunolabelled for Collagen IV, the mean vessel length (µm) in the fimbria 
region was significantly greater in the high OSA group (1.14-fold) than in the low OSA 
group (51.1 ± 1.8 vs. 45.0 ± 1.9, t (25) = 2.372, p = 0.026; Figure 3.5 A). No significant 
differences between the two groups were found in any of the five regions with the other four 
markers.  
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Figure 3.5 Comparison of mean vessel lengths between the low and high OSA groups. 
Mean vessel length (µm) in the low (ODI < 20 events/h sleep; blank bars) and high (ODI ≥ 
20 events/h sleep; striped bars) OSA groups in the fimbria (A), CA4 (B), CA1 (C), subiculum 
(D) and collateral sulcus (E) region. Unpaired 2-tailed t-tests between low vs. high OSA 
groups. Mean ± SEM. 
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3.3.2.4 Increased area fraction (% vessel density) in the high OSA group 
The percentage of the full image occupied by labelled blood vessels was investigated and the 
results are shown in Figure 3.6. In sections immunolabelled with Collagen IV, the high OSA 
group had a significantly greater area fraction than the low OSA group, in both the fimbria 
region (1.33-fold; 2.85 ± 0.26 vs. 2.14 ± 0.14, t (19.9) = 2.401, p = 0.026#, unequal variances; 
Figure 3.6 A) and the CA4 region (1.24-fold; 6.12 ± 0.38 vs. 4.95 ± 0.22, t (22.0) = 2.649, p = 
0.015#, unequal variances; Figure 3.6 B). One-way ANOVAs corrected for post hoc multiple 
comparisons (Tukey's honestly significant difference (HSD) with equal variances or Games-
Howell with unequal variances) showed that the area fraction of blood vessels 
immunostained for Collagen IV was significantly greater (1.32 − 1.99-fold) than those 
immunostained for CD34, VWF, Claudin 5 and GluT-1 in all 5 regions (Table 3.3). 
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Figure 3.6 Comparison of mean area fraction (%) between the low and high OSA 
groups. 
Mean area fraction (%) in the low (ODI < 20 events/h sleep; blank bars) and high (ODI ≥ 20 
events/h sleep; striped bars) OSA groups in the fimbria (A), CA4 (B), CA1 (C), subiculum (D) 
and collateral sulcus (E). Unpaired 2-tailed t-tests between low vs. high OSA groups. Mean ± 
SEM. 
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Table 3.3 The mean area fractions (%) occupied by microvessels labelled with Collagen 
IV are larger than those labelled with the other four vessel markers in all five 
hippocampal regions investigated. 
Region (I) Group (J) Group Mean Diff. (I − J) ± SEM p value 
Fimbria2 
(N = 138) 
Collagen IV 
CD34 1.18 ± 0.18 < 0.001 
VWF 1.25 ± 0.19 < 0.001 
Claudin 5 0.98 ± 0.18 < 0.001 
GluT-1 0.72 ± 0.19 0.004 
CA41 
(N = 147) 
Collagen IV 
CD34 2.48 ± 0.31 < 0.001 
VWF 2.58 ± 0.31 < 0.001 
Claudin 5 1.72 ± 0.31 < 0.001 
GluT-1 1.67 ± 0.31 < 0.001 
CA12 
(N = 147) 
Collagen IV 
CD34 2.51 ± 0.36 < 0.001 
VWF 2.17 ± 0.37 < 0.001 
Claudin 5 1.35 ± 0.44 0.026 
GluT-1 1.69 ± 0.39 0.001 
Subiculum2 
(N = 143) 
Collagen IV 
CD34 2.75 ± 0.40 < 0.001 
VWF 2.29 ± 0.42 < 0.001 
Claudin 5 1.96 ± 0.45 0.001 
GluT-1 2.41 ± 0.41 < 0.001 
Collateral 
Sulcus1 
(N = 117) 
Collagen IV 
CD34 3.20 ± 0.36 < 0.001 
VWF 2.65 ± 0.36 < 0.001 
Claudin 5 2.88 ± 0.36 < 0.001 
GluT-1 2.72 ± 0.36 < 0.001 
One-way ANOVA with post hoc tests for multiple comparisons between group I and group J, 
namely, collagen IV compared to CD34, VWF, Claudin 5 and GluT-1. 1 Tukey's HSD post hoc 
test was used when Levene's test revealed equal variances; 2 Games-Howell post hoc test was 
used for samples with unequal variances. 
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3.3.2.5 Double immunofluorescence (Collagen IV & GluT-1) 
One-way ANOVA tests showed that both the area fraction and diameter of the capillaries 
immunolabelled for Collagen IV were significantly larger than those immunolabelled with 
the other 4 markers (Tables 3.2 and 3.3). There are two possible explanations for this 
phenomenon: one is that the markers label different subpopulations of blood vessels, with 
Collagen IV marking the largest blood vessels and the other markers preferentially labelling 
smaller vessels. Alternatively, the markers may bind to different parts of the same vessel, 
with Collagen IV marking the abluminal surface and the other markers labelling the luminal 
surface of vessel walls.  
To distinguish between these possibilities, double immunofluorescence was performed with 
Collagen IV and GluT-1. It was found that most vessel segments were immunolabelled for 
both Collagen IV and GluT-1, as shown in Figure 3.7 A. It is evident that Collagen IV marks 
the abluminal surface while GluT-1 marks the luminal surface (Figure 3.7 B); in a few cases, 
vessels were stained only with Collagen IV, possibly indicating that the glucose transporters 
were absent from these vessel segments. 
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Figure 3.7 Double immunofluorescence micrographs of microvessels labelled for 
Collagen IV and GluT-1.  
A selection of high magnification images from the hippocampus showing both transversely 
and longitudinally transected microvessels that have been immunolabelled with Collagen IV 
(red) and GluT-1 (green), with yellow indicating colocalisation. Note that GluT-1 is 
expressed at the luminal surface of the microvessels while Collagen IV is expressed at the 
abluminal surface. In (C) the white arrow points to a degenerating vessel that lacks GluT-1 
expression. In (D) the white arrowhead indicates a 'string vessel' that represents a later stage 
of degeneration, as detailed in Chapter 4. 
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3.3.3 The effect of regular CPAP use on hippocampal angiogenesis and microvascular 
remodelling 
Changes in area fraction (%) demonstrate whether there has been a reduction or increase in 
the amount of vascularisation of tissue. The effect of regular CPAP treatment on the mean 
area fraction of blood vessels immunostained for Collagen IV (the most consistent and 
strongly labelling marker) was investigated by comparing non-CPAP users to regular CPAP 
users in the low and high OSA groups (Figure 3.8). The mean area fraction in the subiculum 
region was found to be significantly lower (4.28 ± 0.30 vs. 6.50 ± 0.55, t (11) = -3.003, p = 
0.012; Figure 3.8 D) in regular CPAP users than in non-CPAP users in the low OSA group. 
However, no other significant differences were found between non-CPAP users and regular 
CPAP users in the low or high OSA groups in any of the five regions. 
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Figure 3.8 The effect of regular CPAP use on mean area fraction (vessel density). 
Mean area fraction (%) stained with Collagen IV in the non-CPAP users (blank bars) and 
CPAP users (striped bars) in low (ODI < 20 events/h sleep; purple coloured) and high (ODI ≥ 
20 events/h sleep; pink coloured) OSA groups in the fimbria (A), CA4 (B), CA1 (C), 
subiculum (D) and collateral sulcus (E). Unpaired 2-tailed t-tests between non-CPAP users 
vs. CPAP users. Mean ± SEM. 
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3.3.4 The effect of advanced age on hippocampal angiogenesis and microvascular 
remodelling 
The influence of advanced age on angiogenesis and microvascular remodelling was 
investigated within five hippocampal regions, with the fimbria region being most sensitive to 
the effect of age (Figure 3.9). In the fimbria, patients older than 67.5 years had significantly 
fewer blood vessels immunolabelled with CD34 (68.3 ± 3.9 vs. 80.8 ± 4.3, t (25) = - 2.153, p 
= 0.041; Figure 3.9 A), larger vessel diameters immunolabelled with Collagen IV (8.0 ± 0.3 
vs. 7.2 ± 0.3, t (25) = 2.174, p = 0.039; Figure 3.9 B), and a greater area fraction when 
immunolabelled with VWF (1.44 ± 0.14 vs. 1.08 ± 0.09, t (26) = 2.132, p = 0.043; Figure 3.9 
D), Claudin 5 (1.70 ± 0.12 vs. 1.35 ± 0.10, t (25) = 2.238, p = 0.034; Figure 3.9 D) or 
Collagen IV (2.84 ± 0.26 vs. 2.15 ± 0.15, t (20.5) = 2.342, p = 0.029#, unequal variances; 
Figure 3.9 D). There was no significant difference between the two groups in the fimbria with 
regards to mean vessel length (Figure 3.9 C); however, when immunolabelled with GluT-1, 
the mean vessel length in the subiculum region was significantly longer (45.1 ± 2.2 vs. 39.4 ± 
1.4, t (27) = 2.195, p = 0.037; Figure 3.9 E). 
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Figure 3.9 The effect of advanced age on angiogenesis and microvascular remodelling. 
Microvasculature in patients younger than 67.5 years (blank bars) and older than 67.5 years 
(grid bars). Graphs A-D represent the fimbria: mean vessel count (A), mean vessel diameter 
(B), mean vessel length (C), and mean area fraction (D). E, Mean vessel length in the 
subiculum region. Unpaired 2-tailed t-tests between OSA patients aged < 67.5 years vs. those 
aged > 67.5 years. Mean ± SEM. 
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3.3.5 Summary 
The present study found that:  
i) Microvascular remodelling (increased capillary diameter and length) occurs in the fimbria 
and CA4 region in response to increased severity of OSA. These changes account for an 
increased area fraction. There is no increase in vessel count in the fimbria or CA4 region.  
ii) CPAP treatment does not reverse the microvascular remodelling in the fimbria or CA4 
region.  
iii) While advanced age is associated with fewer capillaries, the individual vessels are dilated 
and elongated, and age contributes to the OSA severity effect in the fimbria region.  
iv) Apart from vessel count in the subiculum, the CA1, subiculum and collateral sulcus 
regions demonstrated no changes on any of the microvascular parameters measured, in 
response to increased severity of OSA.  
These findings are summarised diagrammatically in Table 3.4 
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Table 3.4 Summary of microvascular remodelling in the hippocampus of OSA patients. 
Parameter Marker Region OSA severity CPAP use Age 
Vessel count Claudin 5 Subiculum  − − 
CD34 Fimbria − −  
Vessel diameter Collagen IV Fimbria  −  
Collagen IV CA4  − − 
Vessel length Collagen IV Fimbria  − − 
GluT-1 Subiculum − −  
Area fraction 
(%) 
Collagen IV Fimbria  −  
Collagen IV CA4  − − 
Collagen IV Subiculum −  − 
VWF Fimbria − −  
Claudin 5 Fimbria − −  
   = Increased;       = Decreased;  − , No change. 
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3.4 Discussion 
This is the first study to examine whether angiogenesis and microvascular remodelling occur 
in the hippocampus of OSA patients. Our data revealed that angiogenesis does not occur in 
OSA patients, although there is evidence that vessels are remodelled in some subregions of 
the hippocampus. There were significant differences between the high OSA and low OSA 
groups. In the fimbria and CA4 region, the high OSA group had significantly wider vessel 
diameters (1.11 − 1.23-fold larger), longer vessel segments (1.14-fold longer), and a larger 
area fraction (1.24 − 1.33-fold greater). Regular CPAP use did not reverse the microvascular 
remodelling in the fimbria and CA4 that had occurred in response to OSA severity. Older age 
contributed to the increased microvascular remodelling resulting from OSA severity in the 
fimbria region. The fimbria and CA4 regions demonstrated the greatest degree of 
microvascular remodelling in severe OSA, suggesting that these regions are sensitive and 
adaptive to the IH that occurs in OSA. By contrast, the CA1, subiculum and the apex of the 
collateral sulcus displayed few microvascular changes in response to OSA severity, which 
may indicate that these regions have a limited capacity to adapt to IH. 
The regional density of microvessels is a major determinant of blood flow and the consequent 
provision of substrates to specific regions of brain tissue (Ingraham, Forbes et al. 2008). 
These vascular systems are dynamic, and are able to adapt and remodel in response to 
changing metabolic requirements of the tissue (Secomb, Alberding et al. 2013). These 
changes are controlled by hemodynamic and biological signals that induce a process known 
as ‘angioadaptation’, which involves angiogenesis, pruning, remodelling and changes in 
vascular tone (Secomb, Alberding et al. 2013, Reglin and Pries 2014). Angiogenesis involves 
the generation of new blood vessels from existing ones by sprouting or by splitting in two 
(intussusception) to increase vessel density and reduce the intercapillary diffusion distance 
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(Reglin and Pries 2014). The opposing process is vascular pruning/regression which involves 
vessel narrowing and cessation of blood flow, leading to luminal occlusion and retraction, 
and eventually in the degeneration of redundant vessels, and a reduced regional density of 
microvessels (Korn and Augustin 2012). Vascular responses to changed metabolic demands 
can also involve changes in vessel diameter. Second-to-second changes can be 
accommodated by the vasoconstriction and vasodilation of the arteriolar wall due to the 
activity of smooth muscle cells, whereas chronic changes are effected by the expansion and 
proliferation of capillary endothelial cells to increase the normal diameter of the vascular 
lumen in a process known as 'vascular remodelling' (Reglin and Pries 2014).  
The present study found little evidence of increased vessel number (angiogenesis) in the 
hippocampus of patients with high OSA compared to those with low OSA. Furthermore, 
there was no increase in the expression of the primary glucose transporter GluT-1, which 
plays a significant role in carrying glucose across the BBB (Brockmann 2009). These 
findings were unexpected, as studies of animal models of IH have reported both angiogenesis 
and an increased expression of GluT-1. For instance, a study that used immunocytochemistry 
for GluT-1 to label capillaries reported that capillary density in the hippocampus of mice 
exposed to 2 weeks or 4 weeks of IH increased by 1.2-fold and 1.29-fold, respectively, 
compared to normoxic control mice (Kanaan, Farahani et al. 2006). However, that study used 
neonatal mice which may have a greater capacity for angiogenesis than adult humans, since 
the brain in mice continues to grow for several weeks after birth. Furthermore, the mice were 
exposed to IH for 24 h/day throughout the experiment, whereas in humans with OSA the IH 
will typically last for 4 − 6 h/day. Thus it is possible that the more extreme regime of IH 
experienced by the mice triggered angiogenesis. In support of this possibility, another study 
reported that expression of the GluT-1 transporter significantly increased only in those mice 
that were exposed to very severe cyclical IH (SaO2 nadir of 37%), whereas there was no 
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significant difference between sham and severe IH (SaO2 nadir of 61%) groups (Lim, Brady 
et al. 2016). As noted in the introduction, SaO2 nadirs of 37% are far lower than the 
desaturation nadirs experienced by patients with severe OSA. 
The present study found that the subiculum region of the high OSA group had a higher 
number of Claudin 5-immunoreactive vessels (1.24-fold) than the low OSA group. A possible 
explanation of this observation is that severe OSA selectively induced the expression of tight-
junction proteins in the subiculum region. Evidence from animal models has shown that 
continuous hypoxia can induce Claudin 5 expression, however it does not appear to be 
regionally selective  (Boroujerdi, Welser-Alves et al. 2015). An alternative explanation is that 
a limited degree of angiogenesis occurred in the subiculum region in the high OSA group. 
Indeed, in the subiculum, every one of the five vessel markers used in this study exhibited 
higher numbers of vessels for the high OSA group (Figure 3.3 D), although the differences 
did not reach statistical significance for the other four markers. Such systematic differences 
were not apparent for the other regions of the hippocampus.  
In addition to angiogenesis, another adaptation to hypoxia is an increase in the diameter of 
blood vessels, as this increases the flow of blood, thereby improving the provision of oxygen 
to local tissues (Boero, Ascher et al. 1999). Increased blood flow can trigger structural and 
functional changes in vascular cells that are equipped with receptors to detect and respond to 
the mechanical forces (Lehoux & Tedgui, 2003). Vascular remodelling has been observed in 
various situations where the local pressure and flow are altered, such as in arterial 
hypertension and atherosclerosis (Lehoux & Tedgui, 2003). The present study found 
evidence for microvascular remodelling in the fimbria and CA4 regions. Immunolabelling for 
Collagen IV revealed that the mean vessel diameter and the mean vessel length in the fimbria 
were significantly larger (1.23-fold and 1.14-fold, respectively) in the high OSA group 
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compared to the low OSA group. Similarly, in the CA4 region the mean vessel diameter was 
increased 1.11-fold. These changes are consistent with a previous report of a 1.6-fold increase 
in capillary diameters in a mouse hypoxia model (Masamoto, Takuwa et al. 2014). 
While increases in vessel number indicate angiogenesis, and increases in vessel diameter or 
length indicate vascular remodelling, the most effective way to determine whether the tissue 
has acquired a more extensive blood supply is to compare the proportion of the tissue that is 
occupied by blood vessels (area fraction). Since area fraction indicates the total vessel area in 
relation to the surrounding tissue area, an increased area fraction can result from an increased 
vessel count or vessel size, and also from tissue shrinkage (Harik, Hritz et al. 1995). As there 
is a reduction of grey matter volume in some parts of the hippocampus in OSA patients 
(Owen, Benediktsdottir et al. 2019), there was a possibility that an increased area fraction 
would be found in the absence of changes in vessel size. However the results of the present 
study revealed that only the fimbria and CA4 regions, when labelled for Collagen IV, 
exhibited increases in area fraction in the high OSA group. The magnitude of these changes 
(1.33-fold and 1.24-fold, respectively) was comparable to those seen for vessel diameter, 
leading us to conclude that the increased area fraction in these two regions is likely to be due 
to microvascular remodelling rather than tissue shrinkage.  
Regional differences in area fraction can provide an insight into regional differences in 
metabolic demand, since vessel density is expected to be higher in regions where the 
metabolic demand is higher. The present study revealed that Collagen IV consistently 
produced the highest area fraction for each of the five hippocampal regions, in both groups of 
subjects. When the area fractions of the high OSA group are compared, the highest fraction is 
found in the collateral sulcus region (~ 6.5%), followed by the subiculum (~ 6.0%), CA4 (~ 
6.0%), CA1 (~ 5.5%) and fimbria regions (~ 2.5%). Since the neuropil in the collateral sulcus 
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region is thicker than in the other regions, it would be expected to have a higher metabolic 
requirement, and similarly, as much of the fimbria consists of axons, it might be expected to 
have the lowest metabolic demands.   
Compared to other brain regions, the hippocampus is selectively vulnerable to ischemia 
(Kirino 2000, Bartsch, Döhring et al. 2015), with the CA1 region being particularly 
vulnerable (West, Coleman et al. 1994, Chételat, Fouquet et al. 2008). Animal hypoxia 
models have consistently reported neuronal apoptosis in the CA1 region (Gozal, Daniel et al. 
2001, Gozal, Gozal et al. 2002, Fung, Xi et al. 2009). The results of the present study hint at 
why the CA1 region is vulnerable. First it has the lowest microvascular area fraction of the 
four grey matter regions examined, and second, unlike the CA4 and fimbria, it did not exhibit 
any increase in area fraction in the high OSA group. These observations raise the possibility 
that the CA1 region not only receives less blood flow, it is also constrained from undergoing 
microvascular remodelling in response to intermittent hypoxia. 
One unanticipated finding of the present study was that profiles labelled with Collagen IV 
occupied a far greater fraction of the field of view, and individual vessels had a wider 
diameter in all regions examined, when compared to profiles labelled with the other four 
antibodies (Tables 3.2 and 3.3). This may be due to the different locations of the Collagen IV 
and GluT-1 proteins on vessel walls; as Collagen IV is a key component of the basal 
membrane (Farkas and Luiten 2001), while GluT-1 is an influx transporter, which is 
expressed on the luminal (blood-facing) sides of the BBB (Zlokovic 2005, Daneman and Prat 
2015). This interpretation is in line with the present study’s double immunofluorescence 
results, with Collagen IV labelling the outside border of the vessel while GluT-1 labelled the 
inside border. The similar results of four blood vessel markers (CD34, VWF, Claudin 5 and 
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GluT-1) suggests that they are all located on the luminal surface of microvessels; future 
research is needed to confirm this novel finding. 
CPAP treatment has been proven to significantly attenuate OSA-related symptoms in people 
with moderate and severe OSA (Giles, Lasserson et al. 2006, Hobzova, Hubackova et al. 
2017).  For instance, capillary density in the cerebral cortex of rats increased by 60% after 3 
weeks of hypoxia exposure, and after reverting to a normoxic environment, vessel density 
reduced to prehypoxic levels within 3 weeks (Pichiule and LaManna 2002). However, the 
present study found no significant difference between non-CPAP users and regular CPAP 
users in the two areas that had shown an increase in area fraction in response to OSA 
severity: the CA4 and fimbria. A possible explanation for this lack of effect is that in elderly 
brains, the collagen fibrils that compose vascular walls lose their elasticity, and consequently 
are more resistant to remodelling. Age-related differences in vessel formation have been 
reported in mice exposed to 10% O2 for 28 days; young adult mice (24- to 150-days old) 
displayed extensive angiogenesis, whereas older mice (4- to 5-months old) displayed no 
microvascular changes, suggesting that aged cerebral vasculature loses its plasticity and is 
more resistant to remodelling (Harb, Whiteus et al. 2013). 
Interestingly, in the present study, Collagen IV immunostaining in the subiculum revealed 
that CPAP users in the low OSA group had a significantly smaller area fraction (0.66-fold) 
than CPAP non-users in the low OSA group. A reduced area fraction may result from tissue 
expansion, and indeed, MRI studies have shown that the grey matter volume in the subiculum 
region of OSA patients increases after 3 months of CPAP treatment (Canessa, Castronovo et 
al. 2011). However, such tissue expansion would be expected to reduce the area fraction for 
all five vascular markers, and this was not observed. Therefore it seems more likely that this 
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result for Collagen IV was a spurious outcome, that arose due to the small sample size in that 
group (n = 6). 
In the present study, the fimbria of older patients (> 67.5 years) was found to have increases 
in vessel diameter and length, as well as an increased area fraction, but a decreased number of 
vessels. These results suggest that while microvascular remodelling can occur, angiogenesis 
in response to hypoxia is impaired, which is in agreement with the idea of age-related 
diminishment of the capability for angiogenesis in the brain (Rivard, Fabre et al. 1999, 
Ingraham, Forbes et al. 2008, Brown 2010), possibly due to the weakened hypoxia-inducible 
factor-1 responsiveness to hypoxia and reduced vascular endothelial growth factor expression 
with ageing (Frenkel-Denkberg, Gershon et al. 1999, Rivard, Berthou-Soulie et al. 2000, 
Chavez and LaManna 2003). 
There are several unavoidable methodological limitations of the present research that will be 
fully discussed in Chapter 7. Nonetheless, the strikingly similar mean values and small error 
bars for tissue labelled with CD34, VWF, Claudin 5 and GluT-1 in the CA4, CA1 and 
subiculum regions supports the reliability of the methodology used in the present study, and 
provides confidence in the reliability of the three main conclusions of this study: i) increased 
OSA severity does not stimulate angiogenesis; ii) increased OSA severity stimulates 
microvascular remodelling in the CA4 and fimbria, but not in other regions; iii) this 
microvascular remodelling is not reversed by CPAP treatment.  
The reduced responsiveness of the hippocampal microvessels to OSA severity contrasts with 
the greater microvascular plasticity observed in animal models of OSA. The diminished 
responsiveness of the vasculature in humans may underpin the vulnerability of the 
hippocampus to hypoxic injury, particularly in the most unresponsive regions: the CA1, 
collateral sulcus and subiculum. 
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Chapter 4 Microvascular abnormalities in the hippocampus of obstructive sleep apnoea 
patients 
4.0 Abstract 
Obstructive sleep apnoea (OSA) involves the repeated cessation of breathing or reductions in 
airflow during sleep; consequently causing intermittent episodes of tissue hypoxia, with the 
brain being most strongly affected due to its dependence on oxidative metabolism. The 
periods of reoxygenation are thought to be associated with the production of reactive oxygen 
species, which are believed to damage the endothelial cells on capillary walls causing 
microvascular abnormalities. The present study aimed to investigate whether, in the 
hippocampus of OSA patients, the incidence of microvascular abnormalities is associated 
with increased OSA severity, and if so, whether regular CPAP use is protective. 3513 vessel 
segments from 5 regions of the hippocampus were analysed. In four of the regions, the 
proportion of microvessels that had an abnormal morphology did not differ significantly 
between the low and high OSA groups. By contrast, there were significantly more string 
vessels (4.3 ± 0.9 vs. 1.7 ± 0.4, p = 0.014), narrowing vessels (3.5 ± 1.0 vs. 0.9 ± 0.3, p = 
0.024), strictures (2.6 ± 0.4 vs. 1.1 ± 0.2, p = 0.002) and total abnormalities (10.3 ± 1.5 vs. 3.7 
± 0.6, p = 0.001) in the CA1 region of the high OSA group than in the low OSA group. 
Moreover the degree of vessel width variability in the high OSA group (1.7 ± 0.1 vs. 1.4 ± 
0.1, p = 0.021) was significantly greater in the CA1 region. No significant differences 
between the low and high OSA groups were found for the number of tortuous vessels in any 
of the five regions. There were no significant differences on any of the measures of 
microvascular abnormality between regular CPAP users and non-CPAP users. It is concluded 
that the CA1 region may be more vulnerable to oxidative stress in moderate-severe OSA than 
other hippocampal regions. Abnormal microvessels are permanent degenerative changes and 
may limit the effectiveness of CPAP to reverse memory impairments 
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4.1 Introduction 
OSA is characterised by chronic intermittent hypoxia (Dempsey, Veasey et al. 2010), which 
has been assumed to be a major contributing factor to the pathogenesis of OSA-related 
comorbidities, such as systemic arterial hypertension, ischemic heart disease, cardiac 
arrhythmias, all of which are associated with vascular dysfunction (Sforza and Roche 2016). 
The chronic cycles of desaturation-reoxygenation are thought to induce oxidative stress 
(Sforza and Roche 2016), trigger persistent systemic inflammation (Garvey, Taylor et al. 
2009), and increase the activity of the sympathetic nervous system due to the stress 
associated with hypoxic episodes (Peng, Overholt et al. 2003). These stressors have the 
potential to injure microvessels and trigger pathological changes in their morphology.  
The hippocampus plays a pivotal role in learning and memory (Bartsch and Wulff 2015), and 
is selectively vulnerable to hypoxic damage (Kirino 2000, Bartsch, Döhring et al. 2015), with 
the CA1 region being the most sensitive subfield (West, Coleman et al. 1994, Chételat, 
Fouquet et al. 2008). Recent research from our laboratory found a reduction in neuropil 
thickness in some parts of the hippocampus as the severity of OSA increased (Owen, 
Benediktsdottir et al. 2019). Significant thinning was found in the grey matter of the dentate 
gyrus and CA1 region as well as loss of white matter in the entorhinal cortex; these regions 
have been linked to memory processing (Owen, Benediktsdottir et al. 2019). Animal models 
of OSA have also reported neuronal loss in the CA1 region of the hippocampus (Gozal, 
Daniel et al. 2001, Gozal, Row et al. 2003, Fung, Xi et al. 2012). 
Pathological changes to the cerebral microvessels precede and accompany impaired cognition 
and neurodegeneration in both normal aged brains and in Alzheimer’s disease (AD) (Brown 
and Thore 2011). Altered vessel morphology may hamper the supply of nutrients, leading to 
compromised neuronal function, disturbed synaptic activity and impaired cognition (Jong, 
Vos et al. 1997).  In AD, several ultrastructural and morphological alterations of the cerebral 
Chapter 4 Microvascular Abnormalities 
 
109 
 
microvessels have been reported, including reduced area fraction, increased numbers of 
fragmented vessels, perivascular collagen deposits, basement membrane thickenings, string 
vessels, tortuous arterioles, twisted capillaries, changes in the vessel diameter, and increased 
irregularity of capillary surfaces (Farkas and Luiten 2001, Zlokovic 2008, Bell and Zlokovic 
2009). Since both AD and OSA involve increased neurodegeneration and oxidative stress in 
the brain (Butterfield, Howard et al. 2001), it is possible that the pathological structural 
changes that occur in cerebral vessels in AD are also present in OSA. 
Shear stress is critical for the survival of vascular endothelial cells and the patency of 
continued vessels (Hunter, Kwan et al. 2012). The loss of shear stress can result from both 
the loss of blood flow and vascular blockage (Hunter, Kwan et al. 2012). String vessels are 
the remnants of capillaries that have collapsed and atrophied due to the lack of shear stress, 
leaving behind the basement membrane connective tissue fibres, mainly composed of 
Collagen IV (Brown 2010). String vessels do not carry blood flow and their increased 
numbers in AD brains (Challa, Thore et al. 2004, Brown 2010), may be related to the 
decreased cerebral blood flow reported in AD (Ries, Horn et al. 1993, Matteis, Silvestrini et 
al. 1998, Ruitenberg, Den Heijer et al. 2005). Neuroimaging studies have reported decreased 
rates of blood flow in the hippocampus and parahippocampal gyrus of moderate-severe OSA 
patients compared to controls (Innes et al 2015; Joo et al 2007). This reduced blood flow 
raises the possibility that string vessels may be more common in the hippocampus in 
moderate-severe OSA.   
In an ultrastructural study of brain tissue from AD patients, most of the terminal arterioles 
displayed irregular shapes and had a series of focal constrictions and dilations, resulting in 
altered vessel diameter along their course (Miyakawa, Uehara et al. 1988). Cerebral arterioles 
in white matter often become tortuous with ageing, and begin to feature coils, loops and 
spirals, which slow blood flow even if the lumen diameter remains constant (Farkas and 
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Luiten 2001). Tortuous vessels are rare in the brains of preterm babies, children and young 
adults, and they start to appear after middle age (Thore, Anstrom et al. 2007). The vessels 
become elongated due to an age-related decrease in elasticity, and since the end points of the 
vessels are fixed, the extra length becomes curved and twisted, forming tortuous vessels (Del 
Corso, Moruzzo et al. 1998). Moreover, the deposition of excessive collagen in vessel walls 
can occlude or narrow the lumina, further slowing blood flow (Brown and Thore 2011). 
Therefore, the presence of abnormal microvessels is indicative of ageing or disease, and in 
turn, such abnormalities contribute to a slowing of blood flow and a consequent decline in 
neuronal function. 
Another human autopsy study of OSA patients found that the more time a patient spent with a 
blood oxygen saturation below 95%, the higher the risk of microinfarcts in the brain (Gelber 
2015). Although microinfarcts are a consequence of cerebrovascular disease, that study did 
not investigate any specific characteristics of the microvasculature. An animal model utilising 
chronic IH demonstrated significant cerebrovascular dysfunction and oxidative stress, 
suggesting that these two factors could account for the increased risk of cerebrovascular 
disease in OSA patients (Capone, Faraco et al. 2012). While the evidence obtained from these 
two studies is consistent with the hypothesis that cerebrovascular changes occur in OSA, 
neither study reported on the structural morphology of the blood vessels. 
The current study aimed to investigate whether the incidence of pathological microvascular 
alterations in the human hippocampus increases in association with an increased severity of 
OSA. Additionally, this study investigated whether the incidence of microvascular 
abnormalities is lower in regular CPAP users, and whether patient age is a contributing 
factor. 
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4.2 Methods 
4.2.1 Study samples 
The study samples consisted of 30 of the 31 patients described in section 2.3; one sample was 
excluded because the tissue was refractory to immunostaining for Collagen IV and GluT-1. 
For detailed descriptive statistics, refer to Tables 2.1 − 2.3.  
4.2.2 Tissue processing 
Formalin-fixed and paraffin-embedded blocks of hippocampal tissues were processed as 
previously described in section 2.5. 
4.2.3 Double immunohistochemistry 
The double-immunohistochemistry protocol was a variant of the single 
immunohistochemistry protocol used elsewhere. Briefly, after deparaffinisation, sections 
were treated with antigen retrieval buffer, followed by 3 h incubation with blocking buffer at 
room temperature. Sections were incubated with solutions of mixed primary antibodies at 
their optimal concentrations (Collagen IV at 1 in 20,000, Abcam ab6586; GluT-1 at 1 in 
2,000, Abcam ab15309) for 16.5 h overnight at room temperature. Following this, sections 
were processed as previously described in section 2.6. 
4.2.4 Image processing 
The slides were scanned with the Olympus Virtual Microscopy Slide Scanning System 
(VS120) (microscope VS-BX; camera: VC50) and Olympus VS-ASW-S5 software at a final 
magnification of 10 × (objective lens 20 ×, camera adapter mag 0.5 ×). Micrographs were 
captured from the full view images with a ‘Crop’ tool in Olympus CellSens software at a 
resolution of 1600 × 1200 pixels, at the same five hippocampal regions as shown in Figure 
3.1 A (fimbria, CA4, CA1, subiculum and collateral sulcus).  
Chapter 4 Microvascular Abnormalities 
 
112 
 
4.2.5 Definition of abnormal microvessels 
The five types of abnormal microvessels quantified in the present study are defined and 
illustrated in Table 4.1. Three of these types have been described by others: string vessel, 
dilated/constricted vessel and tortuous vessel; whereas two types are defined for the first time 
in the present study: narrowing vessel and stricture. While it is not known whether these two 
new types of abnormal vessel are evidence of disease, their irregular profile differs from the 
smooth profile of healthy microvessels, and it can be anticipated that their irregular diameter 
and course will slow or impede blood flow. 
Normal microvessels have fluent walls with a constant diameter that can range from  4 − 10 
µm (data from Chapter 3), and with bifurcations at intervals to form two vessels. A 'string 
vessel' is a thread-like vessel segment linking two normal vessel segments/or an independent 
small vessel segment, with an evenly distributed narrow diameter that is less than 1.5 µm 
(defined in the present study, no data in previous reports). A ‘narrowing vessel’ forms when a 
normal vessel segment gradually tapers, the width at the narrowest point being greater than 
1.5 µm but less than 2.5 µm. In a ‘stricture’ the vessel segment narrows abruptly, but remains 
patent. A 'dilated/constricted vessel' exhibits considerable variation in diameter along its 
length, and for quantitative purposes was defined as having variability in width along its 
length that exceeds the 2-fold standard deviation (the half-width of a 95% confidence 
interval) of all tested diameters. A 'tortuous vessel' is one that follows a sinuous or recurved 
course through the tissue. By convention, the extent of tortuosity of a vessel segment is 
calculated as the length of the segment divided by the distance between the two segment end 
points. In the present study tortuosity was automatically calculated by the algorithms in 
ARIA (Bankhead, Scholfield et al. 2012).  
Chapter 4 Microvascular Abnormalities 
 
113 
 
Table 4.1 Definition of the morphological features of abnormal microvessels. 
Parameter 
 
Description 
 
Diagram 
 
 
Micrograph 
 
Annotation 
 
Normal 
vessel 
Fluent vessel walls with constant widths of 4 − 10 µm. 
  
 
String 
vessel 
Thread-like vessel segment linking two normal vessel 
segments; or an independent small vessel segment. 
Diameter constant, typically less than 1.5 µm.   
Measure by count 
Narrowing 
vessel 
A normal vessel segment narrows gradually, the width at 
the narrowest point is between 1.5 − 2.5 µm. 
  
Measure by count 
Stricture 
The vessel width narrows abruptly, with two vessel walls 
opposing at one point, distance is less than 4 µm.  
 
 
Measure by count 
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Dilated/ 
constricted 
vessel 
The vessel width varies greatly due to multiple dilations 
and constrictions. This is tested multiple times 
perpendicularly to the centre line (the green line) at one 
pixel intervals, as illustrated with the red lines.  
The degree of variability in the width of individual 
vessels was determined as the spread of the 95% 
confidence interval (2-fold standard deviation; 2SD) for 
all perpendicular measures along the vessel length, 
expressed in µm. 
Width variability was determined for every vessel in a 
field of view. This allowed identification of the vessel 
with the greatest degree of variability (maximum width 
variability) and mean width variability of all vessels in a 
field of view. 
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While normal vessels, string vessels, dilated/constricted vessels and tortuous vessels have been reported previously, detailed definitions based on 
quantitative criteria are proposed here. Narrowing vessels and strictures are novel and are defined for the first time in the present study.
Tortuous 
vessel 
The tortuosity of a vessel segment is illustrated as the 
Euclidean distance from A to B (the green line) divided 
by the Euclidean distance between point A and B (the red 
line), therefore a ratio equal to 1.0 indicates a straight 
vessel segment, and higher ratios indicate a less direct 
course. 
The mean tortuosity of a field of view is the average 
tortuosity values of all selected vessel segments.  
The maximum tortuosity is represented by the most 
tortuous vessel segment in the field of view. 
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4.2.6 Analysis of microvascular morphology 
Micrographs were visually inspected for the presence of string vessels, narrowing vessels, 
and strictures. Each type of vessel in a field of view was counted. Specific parameters were 
used to differentiate between string vessels and narrowing vessels. The width of the 
narrowest vessel segment was measured using Olympus CellSens software with the ‘arbitrary 
line’ tool. If the vessel width was ≤ 1.5 µm the vessel was categorised as a string vessel, if it 
was > 1.5 µm the vessel was categorised as a narrowing vessel.  
The vessel width variation of dilated/constricted vessels and vessel tortuosity were analysed 
using ARIA: Automated Retinal Image Analyzer v1.0, a software based upon an algorithm 
for the automated detection and measurement of blood vessels, run from within MATLABTM 
with its associated Image Processing Toolbox (Bankhead, Scholfield et al. 2012). ARIA 
automatically recognises and generates a centreline and two edge lines along each vessel 
segment. Diameters for each vessel segment were tested perpendicularly along the centreline 
every 1 pixel; the standard deviation of diameter measurements from selected vessel 
segments was used to calculate the width variation of vessels that had noticeable dilations and 
constrictions. Segment length was defined as the Euclidean distance along the centreline, the 
tortuosity measure is the segment length divided by the Euclidean distance between the 
vessel segment end points. In order to allow for a minimum length of vessel segment to 
curve, vessels with a centreline of less than 50 pixels were excluded. Data were then exported 
into .csv files via a separate routine. Representative images analysed by ARIA and the output 
window of ARIA are shown in Figure 4.1. 
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Figure 4.1 Representative images of vessel profiles analysed by ARIA. 
A, In this micrograph analysed with ARIA software, a total of 19 vessel segments were 
identified, with the 8th vessel segment being highlighted. B, ARIA main window displaying 
the detailed information for the 8th vessel segment. C, Analysed micrograph with the 13th 
vessel segment being highlighted. D, Detailed information for the 13th vessel segment.  
Notice the significantly greater tortuosity of the 13th vessel segment compared to the 8th vessel 
segment (3.13 vs. 1.02), with the tortuosity of the 8th vessel segment being close to 1.0, 
representing a nearly-straight vessel segment, while the 13th vessel segment is U-shaped, and 
three-times more tortuous.  
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4.2.7 Statistical analysis 
Statistical analysis was performed with the IBM Statistical Package for the Social Sciences 
(SPSS version 21). Independent samples-t tests were performed to compare the measured 
parameters between the low and high OSA groups, non-CPAP users and regular CPAP users, 
as well as in patients grouped by age < 67.5 years and age > 67.5 years. p < 0.05 was 
considered to be significant and significant differences are indicated on graphs by an asterisk 
(*) with equal variances or a hash (#) with unequal variances. GraphPad Prism 7 was used to 
generate graphs, presented as Mean ± SEM. 
4.3 Results 
4.3.1 Microvascular morphology in the hippocampus 
Double immunohistochemistry (Collagen IV combined with GluT-1) provided stronger and 
more consistent staining of vessels than that obtained with the individual antibody markers 
(compare Figure 3.2 G − J with Figure 4.2). Figure 4.2 shows micrographs of tissues that 
have been double-immunostained for Collagen IV and GluT-1 in the five hippocampal 
regions (fimbria, CA4, CA1, subiculum and collateral sulcus) in the low (ODI < 20 events/h 
sleep) and high (ODI ≥ 20 events/h sleep) OSA groups.  
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Figure 4.2 Representative images of microvascular morphology in five hippocampal regions. 
Microvessels double-immunostained for Collagen IV and GluT-1 in the fimbria (A & B), CA4 (C 
& D), CA1 (E & F), subiculum (G & H) and collateral sulcus regions (I & J) in the low (A, C, E, 
G & I) and high (B, D, F, H & J) OSA groups. There is one centreline (blue line) and two edge 
lines (red lines) along every vessel segment, as highlighted in the inset boxes. 
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4.3.2 The effect of OSA severity on microvascular abnormalities 
4.3.2.1 Increased incidence of microvessel abnormalities in the high OSA group 
The total number of all vessel segments automatically selected by ARIA software in 5 
hippocampal regions of 30 OSA patients added to 3513, of these 1658 were found in the low 
OSA group, and 1891 in the high OSA group. There were significantly fewer microvessels in 
the fimbria region than in the other four regions (Table 4.2). 
Table 4.2 Numbers of vessel segments, stratified by group and hippocampal region. 
 Low OSA (n = 15) High OSA (n = 15) Total 
Fimbria 167 128 295 
CA4 363 415 778 
CA1 392 442 834 
Subiculum 392 485 877 
Collateral Sulcus 344 385 729 
Total 1658 1855 3513 
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The numbers of abnormal microvessels in the two groups in the five hippocampal regions are 
shown in Figure 4.3. In the CA1 region the high OSA group had significantly more (2.56-
fold) string vessels (4.3 ± 0.9 vs. 1.7 ± 0.4, t (19.6) = 2.703, p = 0.014#, unequal variances; 
Figure 4.3 A) than the low OSA group. The narrowing vessel count showed a similar trend to 
the string vessel count, with significantly more (3.71-fold) narrowing vessels in the high OSA 
group (3.5 ± 1.0 vs. 0.9 ± 0.3, t (16.3) = 2.483, p = 0.024#, unequal variances; Figure 4.3 B) 
than in the low OSA group in the CA1 region. Moreover, there were significantly more (2.44-
fold) strictures in the high OSA group in the CA1 region (2.6 ± 0.4 vs. 1.1 ± 0.2, t (28) = 
3.490, p = 0.002; Figure 4.3 C).  
As all three types of abnormal vessels were measured in the same way, and as each will limit 
blood flow as a result of a narrowed or constricted vessel lumen, the total number of 
microvascular abnormalities in a standard field of view was measured by combining the 
numbers of all three types of abnormal microvessels together. In the CA1 region, there were 
significantly more (2.82-fold) string + narrowing + strictures (10.3 ± 1.5 vs. 3.7 ± 0.6, t (18.5) 
= 4.202, p = 0.001#, unequal variances; Figure 4.3 D) in the high OSA group than in the low 
OSA group. 
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Figure 4.3 Number of abnormal microvessels per field of view in five hippocampal 
regions. 
Number of string vessel (A), narrowing vessel (B), stricture (C) and total abnormal vessels 
(string + narrowing + strictures) (D) in the low (ODI < 20 events/h sleep; blank bars) and 
high OSA groups (ODI ≥ 20 events/h sleep; striped bars). Unpaired 2-tailed t-tests between 
low vs. high OSA groups. Mean ± SEM. 
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Of the vessels selected for analysis by ARIA, the proportion (%) of total vessels that were 
abnormal microvessels varied between regions, as shown in Table 4.3, with the highest 
proportion of abnormal morphology being observed in the fimbria region. In general, string 
vessels were the most common microvascular abnormality, while strictures were the least 
common.  
Table 4.3 Proportion (%) of total vessels that had an abnormal morphology, stratified 
by group and hippocampal region. 
 String vessel 
(low vs. high) 
Narrowing vessel 
(low vs. high) 
Stricture   
(low vs. high) 
Total abnormalities 
(low vs. high) 
Fimbria 36.5 26.6 13.2 14.8 7.8 10.9 57.5 52.3 
CA4 10.5 7.7 5.2 6.5 4.1 5.5 19.8 19.8 
CA1 6.4 14.5 3.6 11.8 4.1 8.8 14.0 35.1 
Subiculum 11.7 9.9 7.9 8.2 5.6 6.0 25.3 24.1 
Collateral 
Sulcus 
15.1 19.5 9.0 13.0 2.6 4.4 26.7 36.9 
Blue shading indicates the low OSA group, pink shading indicates the high OSA group.  
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4.3.2.2 Increased vessel width variability in the high OSA group 
The vessel width variability between the low and high OSA groups was compared, as shown 
in Figure 4.4. The maximum width variability (max. SD; µm) in the high OSA group was 
larger (1.17 − 1.26-fold) than in the low OSA group, with this difference approaching the 
statistically significant level in the CA1 region (2.3 ± 0.1 vs. 1.9 ± 0.1, t (28) = 1.954, p = 
0.061; Figure 4.4 A); moreover, a significant difference was observed in the subiculum 
region (2.5 ± 0.2 vs. 2.0 ± 0.1, t (28) = 2.334, p = 0.027; Figure 4.4 A). Furthermore, the 
mean width variability (mean 2SD; µm) in the high OSA group was significantly larger 
(1.18-fold) than in the low OSA group in the CA1 region (1.7 ± 0.1 vs. 1.4 ± 0.1, t (28) = 
2.456, p = 0.021; Figure 4.4 B), demonstrating increased vessel width variability in response 
to increased OSA severity.  
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Figure 4.4 Vessel width variability in five hippocampal regions. 
Maximum width variability (A) and mean width variability (B) in the low (ODI < 20 events/h 
sleep; blank bars) and high OSA (ODI ≥ 20 events/h sleep; striped bars) groups. Unpaired 2-
tailed t-tests between the low vs. high OSA groups. Mean ± SEM. 
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4.3.2.3 Equal tortuosity between low and high OSA groups  
The tortuosity of a vessel segment was calculated as the length along the vessel segment 
divided by the straight line distance between the two end points. It is therefore equal to 1.0 
for a perfectly straight vessel segment, and the higher the ratio, the more tortuous the vessel. 
The mean and maximum tortuosity in each field of view was calculated and comparisons 
were made between the low and high OSA groups (Figure 4.5). No significant differences 
were found in the mean tortuosity of vessels between the low and high OSA groups in any of 
the five regions (Figure 4.5 A). Indeed, the mean tortuosity value for all regions was close to 
1.0, indicating that the majority of vessel segments were straight. Although maximum 
tortuosity did not differ between the low and high OSA groups (Figure 4.5 B),  the fimbria 
region had the smallest maximum tortuosity of all five regions tested, probably because the 
length of vessel segments in the fimbria region were relatively short. 
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Figure 4.5 Vessel tortuosity in five hippocampal regions. 
Mean tortuosity (A) and maximum tortuosity (B) of all vessel segments in the low (ODI < 20 
events/h sleep; blank bars) and high OSA (ODI ≥ 20 events/h sleep; striped bars) groups. 
Unpaired 2-tailed t-tests between low vs. high OSA groups. Mean ± SEM. 
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4.3.3 The effect of regular CPAP use on microvascular abnormalities 
The effect of regular CPAP treatment on microvascular abnormalities was investigated by 
comparing the non-CPAP group with the regular CPAP treatment group in the low and high 
OSA groups. The CA1 region had previously been shown to have the largest differences in 
abnormal microvessels between the low and high OSA groups. However, in the CA1 region 
no significant differences were found between regular CPAP users and non-CPAP users with 
respect to the frequency of string vessels (Figure 4.6 A), narrowing vessels (Figure 4.6 B), 
strictures (Figure 4.6 C), total vessel abnormalities (Figure 4.6 D), maximum vessel width 
variation (Figure 4.6 E) or maximum vessel tortuosity (Figure 4.6 F). This result should be 
viewed with caution, since the sample sizes were small. 
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Figure 4.6 The effect of regular CPAP use on the frequency of abnormal microvessels in 
the CA1 region. 
Abnormal microvessel morphology in the CA1 region in the non-CPAP users (blank bars) 
and CPAP users (striped bars) in the low (ODI < 20 events/h sleep; purple colour) and high 
(ODI ≥ 20 events/h sleep; pink colour) OSA groups of string vessel (A), narrowing vessel 
(B), stricture (C), total abnormal vessels (D), maximum width variability (E), mean width 
variability (F), mean vessel tortuosity (G) and maximum vessel tortuosity (H). Unpaired 2-
tailed t-tests between non-CPAP users vs. CPAP users. Mean ± SEM. 
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4.3.4 The effect of advanced age on microvascular abnormalities 
The effect of advanced age on the frequency of abnormal microvessels was analysed by 
comparing tissues from patients aged < 67.5 years with those from patients aged > 67.5 years. 
The detailed descriptive statistics of these two groups are shown in Table 2.3. Overall, age 
had no significant effect on the frequency of string vessels (Figure 4.7 A), strictures (Figure 
4.7 C), total abnormalities (although approaching significant level in the CA4 region, Figure 
4.7 D), the mean and maximum vessel width variation (Figure 4.8 E & F), or the mean and 
maximum vessel tortuosity (Figure 4.7 G & H). However, there were significantly more 
(2.29-fold) narrowing vessels in the CA4 region in persons aged greater than 67.5 years (2.1 
± 0.5 vs. 0.9 ± 0.3, t (22.8) = 2.162, p = 0.041#, unequal variances; Figure 4.7 B). There were 
also twice as many narrowing vessels in the CA1 region in the older group, however this 
difference did not reach significance. 
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Figure 4.7 The effect of advanced age on abnormal microvessels in the hippocampus. 
Abnormal microvessel morphology in the age < 67.5 years (blank bars) and age > 67.5 years 
(grid bars) of string vessel number (A), narrowing vessel number (B), stricture number (C), 
total abnormal vessels number (D), maximum width variability (E), mean width variability 
(F), mean vessel tortuosity (G) and maximum vessel tortuosity (H). Unpaired 2-tailed t-tests 
between OSA patients aged < 67.5 years vs. those aged > 67.5 years. Mean ± SEM. 
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4.3.5 Summary 
The present study found that:  
i) Among the five hippocampal regions examined, the fimbria region had the highest 
proportion of abnormal microvessels, however their number did not differ significantly 
between the low and high OSA groups. 
ii) The CA1 had significantly more abnormal microvessels in the high OSA group than the 
low OSA group. This difference extended to string vessels, narrowing vessels, strictures and 
dilated/constricted vessels. The only other region to have more abnormal vessels in the high 
OSA group was the subiculum, with more dilated/constricted vessels. 
iii) CPAP treatment did not reduce the incidence of microvascular abnormalities.  
iv) The CA4 was only region to show an increase in microvascular abnormalities (narrowing 
vessels) with advancing age. 
These findings are summarised diagrammatically in Table 4.4. 
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Table 4.4 Summary of microvascular abnormalities in the hippocampus of OSA 
patients. 
Parameter Region OSA severity CPAP use Age 
String vessel CA1  ─ ─ 
Narrowing vessel CA1 
 
─ ─ 
CA4 ─ ─  
Stricture CA1  ─ ─ 
String + narrowing + strictures CA1  ─ ─ 
Dilated/constricted vessel CA1  ─ ─ 
 Subiculum  ─ ─ 
Tortuous vessel ─ ─ ─ ─ 
    = Increased;  ─ , No change. 
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4.4 Discussion 
This is the first study to examine the brain tissue of OSA patients for the presence of 
microvasculature abnormalities, and as far as we are aware, the first comprehensive 
quantitative study of microvascular abnormalities in the human brain. The results of the 
present study indicate that abnormal microvessels are surprisingly common, and that the CA1 
region stands out as having more microvascular abnormalities in patients with moderate-
severe OSA. By contrast, neither patient age nor CPAP use had much influence on the 
incidence of abnormal microvessels. Our results provide a new line of evidence relating to 
the selective vulnerability of the CA1 region  (Kirino 1982, Pulsinelli, Brierley et al. 1982, 
Bartsch, Döhring et al. 2015, Bartsch and Wulff 2015, Schmidt-Kastner 2015), and they 
support the idea that abnormal microvessels are permanent degenerative changes (Sforza 
2012). The implications of these interesting findings will be discussed below. 
Among the five hippocampal regions examined, the fimbria region had the highest burden of 
abnormality, with approximately half of the microvessels examined exhibiting some 
abnormality. This is of particular concern, since the data in the previous chapter revealed that 
the fimbria has far fewer microvessels than the other hippocampal regions examined. Taken 
together, these data indicate that the fimbria region is likely to be vulnerable to perturbed 
regional blood flow. However, no significant differences were found between the low and 
high OSA groups, or between the two age groups, suggesting that factors other than hypoxia 
and age are responsible for the high incidence of abnormal microvessels in the fimbria. 
String vessels result from the collapse of the capillary walls, caused by loss of endothelial 
cells (Brown 2010). Since string vessels do not carry blood, their presence indicates a 
reduced capacity to support blood flow to that region. It is notable that the numbers of string 
vessels found in AD patients are double the number found in non-demented plaque-free 
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controls, suggesting that AD neuropathology is associated with a reduction in cerebral blood 
flow (Hunter, Kwan et al. 2012). It is therefore significant that the present study found that in 
the CA1 region the number of string vessels in the high OSA group was 2.56-fold higher than 
in the low OSA group.  
Narrowing vessels were defined for the first time in the present study. We speculate that 
narrowing vessels are a precursor of string vessels, with the narrow part of the vessel 
becoming increasingly narrow and extending along the length of the vessel segment to form a 
string vessel. Although it was not possible to confirm this speculation in the present study, 
the diameter of narrowing vessels is too small to permit blood flow, so they are certainly 
abnormal and will impede the provision of nutrients to neurons in their vicinity. The present 
study reported significantly more narrowing vessels (3.71-fold more) in the CA1 region of 
patients with high OSA, which is consistent with our observations for string vessels.  
Strictures are also a novel form of abnormal microvessel, and like string vessels and 
narrowing vessels, they have a point of constriction where the vessel calibre is too small to 
permit the flow of blood. We speculate that strictures are the precursor to narrowing vessels. 
While it is not possible to confirm this speculation from the present data, it is supported by 
the fact that strictures, like string vessels and narrowing vessels, were 2.44-fold more 
common in the CA1 of patients in the high OSA group compared to the low OSA group.  
Dilated/constricted vessels, that is, vessels with a series of focal constrictions and dilations 
along their course, have been reported in the cerebral cortex of AD patients (Miyakawa, 
Uehara et al. 1988), although they have not been quantitatively analysed before. The present 
study quantified the degree of variability in vessel width in various hippocampal regions of 
OSA patients, and found that in the CA1 region the high OSA group had 1.18-fold more 
vessel width variation than the low OSA group. Although this type of abnormality will not 
Chapter 4 Microvascular Abnormalities 
134 
 
prevent blood flow, the variation in vascular diameter will contribute to turbulence in blood 
flow, which in turn will slow the blood flow by increasing vascular resistance (Farkas and 
Luiten 2001). 
Interestingly, the last type of microvascular abnormality, tortuous vessels, were equally 
represented in all regions examined, apart from the fimbria which had fewer. Overall, 
tortuous microvessels were uncommon and their frequency did not differ between the low 
and high OSA groups or between the two age groups. It should be noted that the present 
findings differ from an earlier report that the tortuosity of cerebral arterioles increases after 
age 50 (Thore, Anstrom et al. 2007). Since the present study focussed on capillaries, it 
remains possible that arterioles in the hippocampus do become more tortuous with age. 
Nonetheless, the fact that tortuous capillaries are not particularly common means that they are 
not major contributors to impaired blood supply in the hippocampus.  
Combining the above findings together, the CA1 region showed significantly more 
microvascular abnormalities in response to increased OSA severity than any of the other 
subregions; the subiculum was mildly affected, whereas the fimbria, CA4 and the collateral 
sulcus region were unaffected. The fact that the CA1 showed a substantial increase in 4 
different types of abnormal microvessel in response to increased OSA severity is particularly 
interesting. As mentioned in the introduction, evidence indicates that abnormalities of the 
cerebral microvasculature arise through injury caused to capillary endothelial cells by ROS 
and hypoxia (Lavie 2003). The CA1 is the hippocampal subregion most sensitive to hypoxic 
injury, and the present results provide a new line of evidence in support of this vulnerability. 
Interestingly, all of the types of microvascular pathology observed in the recent study will 
reduce blood flow to the CA1, leading to a vicious cycle where hypoxia causes microvascular 
abnormalities which in turn will worsen tissue hypoxia. The preceding chapter demonstrated 
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that the CA1 appears to be unable to respond adaptively to hypoxia through angiogenesis or 
vascular remodelling, and it is likely that this inability increases the vulnerability of the CA1 
to hypoxic injury. 
CPAP treatment was hypothesised to reverse the microvascular alterations and reduce 
abnormal microvascular morphologies that might result from the oxidative stress that 
accompanies OSA. However, no significant differences were found between regular CPAP 
users and non-CPAP users, which suggests that abnormal microvessels are permanent 
degenerative changes. Since the continuing presence of abnormal microvessels may limit the 
effectiveness of CPAP to reverse memory impairments, it may be necessary to apply CPAP 
treatment to diagnosed OSA patients at an early stage, in order to maximise functional 
recovery and minimise residual injury (Dewan, Nieto et al. 2015). 
The present study compared the microvascular morphology between patients younger than 
67.5 years and older than 67.5 years. Significantly more narrowing vessels were observed in 
the CA4 region of patients aged older than 67.5 years, whereas string vessel frequency did 
not increase, which is in line with a report that string vessels in healthy normal subjects do 
not appear to increase in prevalence with age (Challa, Thore et al. 2002). If, as suggested 
earlier, the narrowing vessels are a precursor of string vessels, the age-related increase in 
narrowing vessels in the CA4 may indicate the beginning of a trend towards the generation of 
string vessels in old age. This possibility will need to be explored in a future study that has a 
larger sample size and a broader spread of patient ages. 
In conclusion, this is the first study to address the effect of OSA severity on the prevalence of 
abnormal microvessels in the human hippocampus and it adds to the current literature by 
defining two new types of abnormal vessels, as well as introducing quantitative measures for 
defining five types of abnormal microvessel. There were significantly more microvascular 
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abnormalities in the CA1 of moderate-severe OSA patients. Our finding that regular CPAP 
use does not reduce the incidence of microvascular abnormalities suggests that these 
degenerative changes are permanent, which may limit the effectiveness of CPAP to reverse 
memory impairments. 
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Chapter 5 Contribution of ageing to the distribution of corpora amylacea in the 
hippocampus of obstructive sleep apnoea patients 
5.0 Abstract 
Corpora amylacea (CoA) are spherical aggregates of glucose polymers and proteins that 
appear in the brain during ageing. They are primarily found within periventricular, 
perivascular and subpial regions of the cerebral cortex and in the hippocampal cornu 
ammonis (CA) subfields. The present study aimed to quantify the distribution of CoA in the 
hippocampus of obstructive sleep apnoea (OSA) patients, and to assess the role of ageing, 
while the companion study (Chapter 6) examines the contributions of OSA severity and 
neurodegeneration.  
Using autofluorescence, CoA were observed in 29 out of 30 OSA patients (96.67%), and 
were most abundant in the periventricular regions (wall of lateral ventricle, alveus, fimbria, 
and CA4). In a few cases, sparse CoA were found in the CA3 and CA1 regions, but no CoA 
were detected in the CA2 or subiculum. The packing density of CoA in subpial regions was 
4.36 − 18.28-fold higher than in the corresponding deeper neuropil, and they had larger mean 
and maximum diameters (1.16 − 1.26-fold larger). On the basis of maps of CoA distribution 
prepared for each hippocampus, a spatio-temporal sequence was postulated, beginning in the 
vicinity of the fimbria and progressively spreading around the subpial layer until they 
extended medially around the wall of the lateral ventricle and laterally to the collateral sulcus. 
When brain sections were arranged in an order that reflected this sequence, it was found that 
the sequence was not significantly correlated with patient age. Furthermore, the packing 
density of CoA did not change with age. However the mean diameters of CoA were strongly 
correlated with age. These findings support the view that CoA gradually become larger with 
age, possibly due to the accretion of new material. 
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5.1 Introduction 
Corpora amylacea (CoA) are polyglucosan bodies with a round or oval profile, that have 
been reported in various organs and species (Cavanagh 1999, Rohn 2015). CoA can be 
stained with various histochemical methods including luxol fast blue, Haematoxylin and 
Eosin, Periodic Acid Schiff and cresyl violet; they can also be revealed by their 
autofluorescence (Cissé and Schipper 1995, Buervenich, Olson et al. 2001, Cherian, 
Radhakrishnan et al. 2003, Nam, Kim et al. 2012, Estupiñán-Díaz, Morales-Chacón et al. 
2015, Augé, Cabezón et al. 2017). Immunohistochemistry directed against tubulin, tau, 
GFAP, neurofilament, amyloid β has also been used to label CoA, with varying degrees of 
success, (Cissé and Schipper 1995, Pisa, Alonso et al. 2016, Augé, Cabezón et al. 2017). 
CoA in the brain have been associated with various conditions, such as normal ageing, 
hippocampal sclerosis, temporal lobe epilepsy, multiple sclerosis, AD and Parkinson’s 
disease (Cavanagh 1999, Abel, Hebb et al. 2010, Estupiñán-Díaz, Morales-Chacón et al. 
2015, Augé, Duran et al. 2018, Pisa, Alonso et al. 2018). Since 1837 when CoA were first 
described by J.E. Purkinje, various hypotheses have been proposed regarding the origins of 
CoA (Wilhelmus, Verhaar et al. 2011, Augé, Cabezón et al. 2017, Augé, Bechmann et al. 
2019). Despite sophisticated analyses of the molecular and biochemical composition of 
CoA, no consensus has been reached.  
CoA have been associated with ageing process. For instance, in patients with myopathies and 
polyneuropathies who underwent muscle biopsies, CoA were only detected in 1% of biopsies 
from patients under 20 years of age, while the proportion was 31% in patients aged 20 – 39, 
49% in patients aged 40 – 59, and 48% in the 60 – 79 age group (Bernsen, Busard et al. 
1989). Moreover, in another study with sural nerve biopsies, no CoA were observed under 5 
years of age, while 26% of subjects aged 31 – 50 contained CoA, and the percentage reached 
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60% in the group aged 51 – 80 (Busard, Gabreëls-Festen et al. 1990). Three studies have 
related CoA count to continuous age. The first study examined CoA in the 
ventroposterolateral nucleus of the human thalamus: CoA were not observed in patients 
younger than 50, and thereafter the numbers and size of CoA appeared to increase with age, 
although this relationship was not analysed statistically (Mizutani, Satoh et al. 1987). The 
second study counted CoA in 51 non-glaucomatous human eyes (aged 2.5 − 78 years), and 
reported that CoA count showed a positive linear correlation with ageing (r = 0.424, p < 0.01) 
(Kubota, Holbach et al. 1993). The third was a study of the subpial white matter of human 
spinal cords, which detected a trend of increased CoA count with advancing age, but some 
aged subjects had small numbers of CoA and the correlation between number of CoA and age 
did not reach statistical significance (Cavanagh 1998).  
In the human lung, CoA are 30 – 40 μm in diameter and can reach 100 μm (Michaels and 
Levene 1957), however studies of the human nervous system have consistently indicated a 
much smaller diameter. For instance, the diameters of CoA in the human retina and optic 
nerve range from 3.6 – 11.0 µm (Kubota, Holbach et al. 1993), and in the anterior horn grey 
matter of spinal cord, most range between 4 – 12 µm, with few exceeding 20 µm (Cavanagh 
1998). While it is often claimed that CoA increase in diameter with age, this claim is based 
on a report that large CoA (more than 20 µm) were observed within myelinated axons after 
80 years of age (Mizutani, Satoh et al. 1987). There have been no systematic studies of CoA 
diameter as a function of age. 
Recent ultrastructure studies have distinguished immature CoA from mature CoA (Navarro, 
Genoud et al. 2018, Augé, Bechmann et al. 2019). Immature CoA are intracellular 
inclusions that are enclosed by the cytoplasmic membrane of a cell (primarily in perivascular 
glial cells), with diameters typically less than 10 µm (Navarro, Genoud et al. 2018), but they 
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do not contain a membrane of their own (Augé, Bechmann et al. 2019). By comparison, 
mature CoA are extracellular, are more abundant, can measure up to 30 µm in diameter, and 
are surrounded by myelin sheaths and cells (Navarro, Genoud et al. 2018). These recent 
reports focused on the composition and ultrastructure of CoA in 3 − 6 aged patients 
(Navarro, Genoud et al. 2018, Augé, Bechmann et al. 2019), and the sample sizes were too 
small to permit an assessment of whether the diameters of CoA increase over time.  
In aged brains, CoA tend to aggregate in periventricular, perivascular, subpial and 
subependymal regions (Erdamar, Zhu et al. 2000, Nishio, Morioka et al. 2001, Meng, Zhang 
et al. 2009, Abel, Hebb et al. 2010, Rohn 2015), suggesting an association with 
cerebrospinal fluid (CSF) (Meng, Zhang et al. 2009, Maurizi 2010, Nam, Kim et al. 2012). In 
the hippocampus, CoA have been reported to aggregate beneath the pial border (Cavanagh 
1999, Erdamar, Zhu et al. 2000). CoA were reported in the periventricular regions of the 
hippocampus in three aged subjects without any neurodegenerative diseases (Augé, 
Bechmann et al. 2019), and located within perivascular and subpial regions in four aged AD 
patients and one aged patient with vascular dementia (Augé, Duran et al. 2018).  Other 
studies have described abundant CoA in the hippocampal cornu ammonis (CA) subfields of 
patients with neurodegenerative diseases (Erdamar, Zhu et al. 2000, Cherian, Radhakrishnan 
et al. 2003, Uckermann, Galli et al. 2017, Navarro, Genoud et al. 2018).  
Cherian and colleagues (2003) classified the distribution of CoA in the hippocampus of 
patients with mesial temporal lobe epilepsy (Cherian, Radhakrishnan et al. 2003). The 
presence of CoA was graded by counting the number of CoA per field of view under × 400 
times magnification, with an absence of CoA equating to grade 0, 1 − 5 CoA as grade 1, 6 – 
10 CoA as grade 2, and more than 10 CoA as grade 3 (Cherian, Radhakrishnan et al. 2003). 
This semi-quantitative grading system was developed to investigate the CoA density in 
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specific subregions of hippocampus, and it was further applied in a study of CoA density in 
selected areas of neocortex (meningeal surface), white matter and perivascular region in 
patients with drug-resistant temporal lobe epilepsy (Estupiñán-Díaz, Morales-Chacón et al. 
2015). A limitation of this grading system is that it uses high magnification fields of view, 
which provide unrepresentative counts when the CoA are distributed non-uniformly.  
CoA have been widely reported to be located in proximity to blood vessels (Erdamar, Zhu et 
al. 2000, Meng, Zhang et al. 2009, Pirici, Margaritescu et al. 2014, Rohn 2015, Navarro, 
Genoud et al. 2018, Pisa, Alonso et al. 2018). In the only quantitative study regarding the 
association between CoA and blood vessels, CoA were reported to congregate in the 
perivascular spaces and adjacent neuropil, with 37% of CoA being located within 5 µm of a 
blood vessel and 77% within 10 µm (Navarro, Genoud et al. 2018). This pattern of 
distribution is different from that expected due to chance, and may indicate the CoA have a 
physiological relationship to blood vessels.   
A feature lacking from all studies of CoA is that none have systematically measured the 
packing density of CoA or compared CoA in different subregions of the brain in a 
quantitative way. Thus after 180 years of knowing that CoA exist, we still do not know the 
density and size of CoA that are typically found in the brain tissue of patients at different 
ages, nor do we know whether their spatial distribution is random or conforms to a pattern. 
Furthermore, there are no quantitative data concerning the putative relationships between 
CoA and the CSF or perivascular spaces. If such information were available, it might help to 
inform speculation on the origins of CoA. The present study seeks to fill these major gaps in 
our knowledge of CoA by systematically mapping the distribution and size of CoA in 
hippocampal subregions of OSA patients, and relating these parameters to patient age. 
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5.2 Methods 
5.2.1 Study sample 
The study sample consisted of 30 of the 31 patients described in section 2.3. Their ages 
ranged from 41 − 89 years. One case was excluded due to the tissue sample containing an 
incomplete hippocampus. 
5.2.2 Tissue processing 
The brain tissues used in this study consisted of a set of control slides that had undergone 
immunohistochemistry without incubation with primary antibody; thus they were unlabelled, 
yet were part of a series that had been labelled for cresyl violet, tau, amyloid β and GFAP. 
The slides had been prepared by another researcher in our laboratory (Owen 2017).  
5.2.3 Immunohistochemistry 
The immunohistochemistry carried on control slides was similar to that previously described. 
Briefly, after deparaffinisation, sections were washed with 0.1 M PBS and blocked for 3 h at 
room temperature without antigen retrieval. Sections were washed in PBS buffer, followed by 
incubation in primary antibody diluent solution with no primary antibody added. Following 
this, sections were processed as previously described (section 2.6). 
5.2.4 Image processing 
An intrinsic property of CoA is that they strongly autofluoresce as green-yellow when viewed 
under a blue light. This property was used to map the spatial distribution of CoA in tissue 
sections of the hippocampal formation. The sections were viewed with an Olympus 
fluorescence microscope (VS-BX) and camera (Hamamatsu ORCA-Flash 4.0), using a 
'Fluorescein' filter set (Emission wavelength 518 nm, filter wheel (reflected) 485, and filter 
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wheel (reflected) 525). Scanning images were acquired with an Olympus Virtual Microscopy 
Slide Scanning System (VS120) and Olympus VS-ASW-S5 software, FITC (Fluorescein 
isothiocyanate) channel at 500 ms exposure time, final magnification of 20 × (objective lens 
20 ×, camera adapter mag 1 ×), automatic Z−stacking (20 µm range, 4 µm step size, therefore 
5 planes in total) and saved as .vsi format. Images to be used for analysis were captured from 
the full view images with a ‘Crop’ tool in Olympus CellSens software at a resolution of 1600 
× 1200 pixels (equivalent to 0.2 mm2) at pre-determined locations. The coloured images were 
converted into grayscale, optimised in Adobe Photoshop CS6 Extended, and then analysed 
with Olympus CellSens software. The minimum detection size was equivalent to 3 µm. 
Objects that intersected the left hand or bottom borders of the image were excluded from 
analysis. All brain sections were processed in an identical manner. 
Seven hippocampal neuropil regions that surround the lateral ventricle were investigated in 
the present study, including the wall of lateral ventricle (LV), fimbria, cornu ammonis 4 
(CA4), cornu ammonis 3 (CA3), cornu ammonis 1 (CA2), cornu ammonis 1 (CA1), and 
subiculum. In addition, the subpial regions in the following locations were investigated: 
alveus pial surface (APS), fimbria pial surface (FPS), prosubiculum pial surface (PPS), 
subiculum pial surface (SPS), medial entorhinal cortex pial surface (MPS), lateral entorhinal 
cortex pial surface (LPS) and collateral sulcus pial surface (CPS). These regions were chosen 
because they are spaced across the hippocampal formation, and they can be reliably identified 
in sections due to their proximity to landmarks. 
5.2.5 Definition and classification of CoA stages 
In previous research, the areal density of CoA within specific brain regions has been graded 
according to the criteria of (Cherian, Radhakrishnan et al. 2003). In the present study we 
observed that CoA are not randomly distributed, and hence the use of high magnification 
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images provides variable and unrepresentative estimates of CoA density. In order to obtain 
more accurate estimates, the present study examined CoA density in lower magnification 
images (20 ×) that encompassed a much larger area (0.2 mm2) of tissue than typically 
assessed. Therefore, new criteria needed to be developed to classify the stages of CoA based 
on the density of CoA in specific regions, as well as considering the spatial distribution of 
CoA across an entire section.  
5.2.6 Full view diagrams of CoA distribution in the hippocampus 
In order to stage individual brains, it was necessary to first ascertain the distribution and 
relative frequency of CoA across the hippocampus. Full view scanned images of each brain 
section were processed with Photoshop software to generate outline diagrams of the section. 
The outline was traced with the ‘Stroke’ tool; the landmarks (dentate gyrus and grey matter 
orientation) were traced with the ‘Pencil’ and ‘Brush’ tools into grey curves. The ‘Airbrush’ 
tool was used to add red dots on the diagram to diagrammatically illustrate the location and 
density of the CoA.  
5.2.7 Quantification of CoA density in the subpial and deeper neuropil zones 
On inspection of sections it was observed that the density of CoA peaks just beneath the pial 
border; there is a fairly distinct boundary between this high-density zone and the deeper 
layers of tissue that have a low density of CoA. We have termed these two regions 'subpial' 
and 'deeper neuropil' respectively. The subpial zone of dense CoA was enclosed with a 
‘polygon’ and another line (with ‘polyline’ tool) was drawn along the centre of the enclosed 
area in Olympus CellSens software; the subpial zone depth was measured as the total area 
divided by the length of the centre line.  
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5.2.8 Statistical analysis 
Statistical analysis was performed with IBM Statistical Package for the Social Sciences 
(SPSS version 21). Two-tailed student’s t-tests with α = 0.05 were used to compare the sets 
of data between two groups. Pearson’s correlations were performed for the covariate of two 
continuous-level variables. GraphPad Prism 7 was used to generate scatterplots and graphs, 
presented as Mean ± SEM, significant differences were indicated on graphs by an asterisk (*) 
with equal variances or a hash (#) with unequal variances. 
5.3 Results 
5.3.1 CoA detection and quantification 
Hippocampal sections that had been immunolabelled in our laboratory (Owen 2017) for tau, 
amyloid β, GFAP, or stained with cresyl violet, were examined for the presence of CoA. 
Comparative images from the same hippocampal region are shown in Figure 5.1. Although 
CoA can be easily recognised with cresyl violet (Figure 5.1 A) and tau (Figure 5.1 B), these 
markers produce a strong background signal in the rest of the tissue, making it difficult to be 
able to quantify the CoA. Immunolabelling for amyloid β (Figure 5.1 C) and GFAP (Figure 
5.1 D) show the coats of a small subpopulation of CoA but do not label their contents, 
leaving a 'hole' in the background labelling to signify the location of the CoA. It was found 
that CoA were most salient when viewed under fluorescent illumination (Figure 5.1 E); the 
autofluorescent signal of the CoA was easy to distinguish from background as it was much 
brighter and less resistant to fading than the background autofluorescence of the tissue. Hence 
all of the analyses of CoA in this study are based on autofluorescence images. 
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Figure 5.1 CoA appearance revealed by five histological staining methods at the same 
location of the fimbria region. 
A, Cresyl violet (0.5%). B, Immunohistochemistry with anti-Tau (1:500); C, anti-Amyloid β 
(1:100); D, anti-GFAP (1:20,000); E, Control (without primary antibody) under fluorescent 
mode (FITC). Examples of individual CoA are indicated by arrows. 
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Of the seven hippocampal neuropil regions investigated, CoA were detected in 23 out of 24 
brain samples (95.83%) that included the wall of the lateral ventricle (Table 5.1). CoA were 
observed in 29 fimbria regions out of 30 (96.67%), the one without any CoA throughout the 
hippocampus was classified into stage 0. All of the CoA found in the CA4 region (19 out of 
30, 63.33%) were located close to the inferior horn of the lateral ventricle, rather than in the 
deeper grey matter. Sparse CoA were occasionally observed in the CA3 region (3 out of 30, 
10.00%) and CA1 region (4 out of 30, 13.33%), and no CoA were observed in the grey 
matter of the CA2 or subiculum. Since the numbers of CoA in these regions were very low, 
no further analyses were performed in the CA3, CA2, CA1 and subiculum regions.  
CoA were present in 58.33 – 96.67% of the seven pial surface regions, data analysis was 
undertaken in 10 regions in total: wall of lateral ventricle, fimbria, CA4, alveus pial surface, 
fimbria pial surface, prosubiculum pial surface, subiculum pial surface, medial entorhinal 
cortex pial surface, lateral entorhinal cortex pial surface and collateral sulcus pial surface 
(Figure 5.2). 
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Table 5.1 Hippocampal subregions examined in this study, showing the proportion of 
brain samples that contained CoA. 
Region LV Fimbria CA4 CA3 CA2 CA1 Subiculum 
Percentage (%) 95.83 96.67 63.33 10.00 0 13.33 0 
Region APS FPS PPS SPS MPS LPS CPS 
Percentage (%) 73.33 96.67 96.67 95.83 95.83 58.33 95.83 
LV: wall of lateral ventricle; APS: alveus pial surface; FPS: fimbria pial surface; PPS: 
prosubiculum pial surface; SPS: subiculum pial surface; MPS: medial entorhinal cortex pial 
surface; LPS: lateral entorhinal cortex pial surface; CPS: collateral sulcus pial surface. 
 
7 hippocampal neuropil regions 
 
7 pial surface regions 
 
Figure 5.2 Locations of the hippocampal subregions investigated in the present study. 
The coloured rectangles indicate where micrographs were taken for the analysis of CoA 
packing density. Seven hippocampal neuropil regions that surround lateral ventricle include: 
LV (wall of lateral ventricle), fimbria, CA4, CA3, CA2, CA1, subiculum. Seven pial surface 
regions included: APS (alveus pial surface), FPS (fimbria pial surface), PPS (prosubiculum 
pial surface), SPS (subiculum pial surface), MPS (medial entorhinal cortex pial surface), LPS 
(lateral entorhinal cortex pial surface) and CPS (collateral sulcus pial surface). 
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Five parameters were investigated: CoA count, the total number of CoA per field of view; 
CoA density, calculated as the total CoA count in the region of interest (count/mm2); CoA 
mean diameter (µm), the average diameter of all CoA in a field of view; CoA min. diameter 
(µm), the mean diameter of the smallest CoA in a field of view; CoA max. diameter (µm), the 
mean diameter of the largest CoA in a field of view. In some cases, no CoA were detected in 
a field of view, in such cases a ‘0’ value was recorded for the CoA count and area, and this 
value was used in the analysis. However, for CoA diameter, values of 0 µm were not 
included in the analysis.  
When diagrams of CoA burden were compared, a consistent pattern became evident: in 
sections with low burdens of CoA, they were concentrated in the vicinity of the fimbria, and 
as the burden increased, CoA extended further away from the fimbria, within the pial border, 
to the alveus and wall of lateral ventricle on one side, and towards the subiculum, entorhinal 
cortex and beyond the collateral sulcus on the other side. CoA were only observed in the deep 
white and grey matter in sections with the heaviest burdens. Based on these diagrams, three 
investigators (CX, JO and SRR) independently arranged the sections in a series, from lowest 
CoA burden to highest. There was strong concordance between investigators, and the minor 
differences in the order of the rankings were resolved by discussion. The agreed sequence 
was then divided into five stages, based on the spatial extent of spread of CoA and the 
severity of the CoA burden (Figures 5.3 and 5.4). 
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Stage 1 
 
 
Stage 2 
 
Stage 3 
 
 
Stage 4 
 
 
Figure 5.3 Representative full view hippocampus sections from four classified CoA 
stages. 
Traced diagrams of actual hippocampal sections with the location of CoA indicated by red 
dots. The purpose of these diagrams is to reflect their spatial extent, so that the sections 
could be staged. Thus one red dot may represent a few CoA in scarce locations, and 
hundreds in the highly concentrated areas.  
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Stage 1 
 
Stage 2 
 
Stage 3 
 
Stage 4 
 
Figure 5.4 The spatial distribution of CoA in the hippocampal formation according to 
Stage. 
These schematic diagrams are based on the outline of a hippocampus from an OSA patient. 
The blue colour indicates the inferior horn of the lateral ventricle, the grey lines show the 
landmarks of the hippocampus; the red solid circles indicate where CoA are found. 
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Stage 0 corresponded to no CoA being present. Stage 1 was defined as a low density of CoA 
(0 − 10 CoA per field of view) in the fimbria, without progression of CoA across the pial 
surface. Stage 2 was defined as medium density (10 − 50) CoA in the fimbria and being 
distributed along the pial surface of the prosubiculum and subiculum. Stage 3 was defined as 
medium or high density (50 − 500) CoA in the fimbria, and extending continuously across 
the pial surface of the prosubiculum and subiculum, as well as into the deep white matter of 
the wall of lateral ventricle. Stage 4 was defined as medium or high density (50 − 500 CoA); 
this stage resembled Stage 3, except that CoA now extended into the deep white matter of the 
parahippocampal gyrus and fusiform gyrus. Detailed descriptions are shown in Table 5.2 and 
representative micrographs of increasing CoA density in the fimbria from each stage are 
shown in Figure 5.5.  
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Table 5.2 Definition and classification of stages of CoA extent. 
Stage Definition 
0 No CoA observed 
1 
Low density (0 − 10 count) of CoA in the fimbria, alveus, roof and walls of 
the inferior horn of the lateral ventricle 
Few CoA anywhere else 
2 
Medium density (10 − 50 count) of CoA in the fimbria, alveus, roof and 
walls of the inferior horn of the lateral ventricle 
CoA at the pial surface of the prosubiculum and subiculum 
CoA in depths of sulci and in cortical gyri 
3 
Medium or high density (50 − 500 count) of CoA in the fimbria, alveus, roof 
and walls of the inferior horn of the lateral ventricle 
Continuous CoA at the pial surface of the prosubiculum and subiculum 
CoA in depths of sulci and near the surface of gyri 
CoA in the deep white matter of the wall of the lateral ventricle 
4 
Medium or high density (50 − 500 count) of CoA in the fimbria, alveus, roof 
and walls of the inferior horn of the lateral ventricle 
Continuous CoA at the pial surface of the prosubiculum and subiculum 
CoA in depths of sulci and near the surface of gyri 
CoA in the deep white matter of the wall of the lateral ventricle 
CoA in the deep white matter of the parahippocampal gyrus and fusiform 
gyrus 
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Figure 5.5 CoA micrographs and processed images from four classified stages. 
CoA micrographs in the fimbria region from stages 1 − 4 (A − D) and the corresponding 
processed images (E − H). All micrographs are the 3rd plane of a 5-step Z−stack (Z range 20 
µm, step size 4 µm), the upper and lower step images were referred to in order to generate the 
processed images E – H; therefore, in some cases minor mismatching occurs between the 
processed image and the single slice immunofluorescent micrograph. 
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Bivariate correlations between ranked CoA sequence and measured CoA parameters (count, 
area fraction, mean, minimum and maximum diameters) in seven pial surface regions were 
conducted to investigate the reliability of the staging criteria introduced in the present study, 
as shown in Table 5.3. Ranked CoA sequence was significantly correlated with increased 
CoA count and area fraction in five out of seven pial surface regions, demonstrating that the 
subjective criteria applied in the present study are supported by quantifiable parameters. 
Increased CoA sequence did not correlate with CoA mean diameter in any of the seven pial 
surface regions investigated, however, CoA sequence was negatively correlated with the CoA 
minimum diameter in two regions, while positively correlated with the CoA maximum 
diameter in two different regions. Significant correlations, highlighted in coloured shading, 
were displayed with scatterplots in Figure 5.6. 
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Table 5.3 Pearson’s correlation of ranked CoA sequence with tested CoA parameters. 
   APS FPS PPS SPS MPS LPS CPS 
CoA count 
r .378* .478** .617** .590** .456* .311 .150 
p .039 .008 .000 .002 .025 .139 .483 
n 30 30 30 24 24 24 24 
Area 
fraction 
r .366* .552** .662** .675** .461* .344 .208 
p .047 .002 .000 .000 .023 .100 .329 
n 30 30 30 24 24 24 24 
Mean 
diameter 
r -.161 -.136 .135 -.125 .097 -.511 .259 
p .473 .483 .485 .570 .659 .062 .232 
n 22 29 29 23 23 14 23 
Minimum 
diameter 
r -.232 -.217 -.180 -.483* -.294 -.634* -.008 
p .287 .259 .349 .020 .173 .015 .971 
n 23 29 29 23 23 14 23 
Maximum 
diameter 
r .225 .260 .414* .312 .436* .314 .270 
p .314 .174 .026 .148 .037 .274 .213 
n 22 29 29 23 23 14 23 
APS: alveus pial surface, FPS: fimbria pial surface, PPS: prosubiculum pial surface, SPS: 
subiculum pial surface, MPS: medial entorhinal cortex pial surface, LPS: lateral entorhinal 
cortex pial surface and CPS: collateral sulcus pial surface. 
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Significant positive linear regressions were found between ranked sequence and CoA density 
(count and area fraction) in the alveus pial surface (r2 = 0.143, p = 0.039; r2 = 0.134, p = 
0.047; Figure 5.6 A & B), fimbria pial surface (r2 = 0.229, p = 0.008; r2 = 0.304, p = 0.002; 
Figure 5.6 C & D), prosubiculum pial surface (r2 = 0.380, p < 0.001; r2 = 0.438, p < 0.001; 
Figure 5.6 E & F), subiculum pial surface (r2 = 0.348, p = 0.002; r2 = 0.455, p < 0.001; Figure 
5.6 G & H) and medial entorhinal cortex pial surface (r2 = 0.208, p = 0.025; r2 = 0.213, p = 
0.023; Figure 5.6 I & J). These correlations support the notion that the ranked CoA sequence 
is reflective of increasing CoA burden, and that the highest burdens are found in fimbria pial 
surface region. 
Significant negative correlations between ranked CoA sequence and CoA minimum diameter 
were found in the subiculum pial surface region (r2 = 0.233, p = 0.020; Figure 5.6 K) and 
lateral entorhinal cortex region (r2 = 0.402, p = 0.015; Figure 5.6 L). Moreover, ranked CoA 
sequence was positively correlated with larger CoA maximum diameter in the prosubiculum 
pial surface region (r2 = 0.171, p = 0.026; Figure 5.6 M) and medial entorhinal cortex pial 
surface region (r2 = 0.190, p = 0.037; Figure 5.6 N). Therefore, ranked CoA sequence was 
negatively correlated with CoA minimum diameters while positively correlated with CoA 
maximum diameters. 
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Figure 5.6 CoA density in relation to classified stage and ranked sequence. 
Scatterplots showing significant linear correlations between ranked CoA sequence (1 − 30) 
and CoA count  (A, C, E, G & I), area fraction (B, D, F, H & J), minimum diameter (K & L) 
and maximum diameter (M & N) in the alveus pial surface region (A & B), fimbria pial 
surface region (C & D), prosubiculum pial surface region (E, F & M), subiculum pial surface 
region (G, H & K) medial entorhinal cortex surface region (I,  J & N) and lateral entorhinal 
cortex surface region (L). 
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The progression of CoA along the pial border was investigated in seven pial surface regions. 
In stage 1, CoA were restricted to the fimbria region (Figure 5.7 A). By stage 2 CoA were 
concentrated in the fimbria and prosubiculum regions. In stages 3 and 4 the numbers 
increased further in the fimbria and prosubiculum regions, and CoA became evident in the 
other five pial areas, with a trend to decreasing density when moving away from the fimbria 
toward the collateral sulcus (Figure 5.7 B − D). The patterns of CoA distribution in the pial 
surface were similar in stages 3 and 4, as the main criterion distinguishing these two stages 
was the presence of CoA in deep white matter.  
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A 
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C 
 
D 
 
Figure 5.7 The progression of CoA packing density according to stage. 
CoA progression in seven pial surface regions of stage 1 (A), stage 2 (B), stage 3 (C) and 
stage 4 (D). Mean ± SEM. APS: alveus pial surface, FPS: fimbria pial surface, PPS: 
prosubiculum pial surface, SPS: subiculum pial surface, MPS: medial entorhinal cortex pial 
surface, LPS: lateral entorhinal cortex pial surface and CPS: collateral sulcus pial surface.  
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At every stage, the pial surface of the fimbria region contained the most CoA, followed by 
the pial surface of the prosubiculum in second place. The CoA progression along the pial 
border started from the fimbria region and spread to the alveus, and the corner of lateral 
ventricle on one side; and towards the prosubiculum, subiculum, entorhinal cortex and 
collateral sulcus on the other side (Figure 5.8) with gradually reduced CoA packing density 
(Figure 5.7) and size, with the smallest mean and maximum diameters of CoA being found in 
the collateral sulcus pial surface region, as shown in Table 5.4.  
Table 5.4 CoA sizes in seven pial surface regions. 
 APS FPS PPS SPS MPS LPS CPS 
Mean diameter (µm) 6.07 6.87 7.08 7.01 6.76 6.44 6.28 
Min. diameter (µm) 3.94 3.33 3.70 3.69 4.48 4.46 4.49 
Max. diameter (µm) 7.71 13.47 9.91 11.19 9.31 9.55 7.75 
APS: alveus pial surface, FPS: fimbria pial surface, PPS: prosubiculum pial surface, SPS: 
subiculum pial surface, MPS: medial entorhinal cortex pial surface, LPS: lateral entorhinal 
cortex pial surface and CPS: collateral sulcus pial surface.  Mean diameter and maximum 
diameter show a trend towards a smaller size when progressing laterally from the FPS to the 
CPS, whereas minimum diameter trends towards a larger size. 
 
 
 
 
 
 
 
 
Chapter 5 Corpora amylacea Distribution 
165 
 
A  
 
B  
 
Figure 5.8 Schematic illustration of postulated progression of CoA along the pial 
surface. 
A, Schematic diagram of the hippocampus. B, Proposed progression of CoA along the pial 
surface; red curve indicates highest CoA density in the fimbria pial surface region; blue curve 
indicates the decreased CoA density along the pial surface when spreading bilaterally from 
the fimbria, as pointed by the red arrows. APS: alveus pial surface, FPS: fimbria pial surface, 
PPS: prosubiculum pial surface, SPS: subiculum pial surface, MPS: medial entorhinal cortex 
pial surface, LPS: lateral entorhinal cortex pial surface and CPS: collateral sulcus pial 
surface.  
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5.3.2 Stratification of CoA within the pial surface region: the subpial and deeper neuropil 
zones 
Examination of micrographs of the pial region revealed that CoA were concentrated in a 
well-defined zone just beneath the pial border, which we have termed the 'subpial zone'. The 
mean thickness of the seven subpial zones was 52.4 µm at the APS (alveus), 108.4 µm at the 
FPS (fimbria), 72.2 µm at the PPS (prosubiculum), 43.0 µm at the SPS (subiculum), 39.8 µm 
at the MPS (medial entorhinal cortex), 26.6 µm at the LPS (lateral entorhinal cortex) and 32.2 
µm at the CPS (collateral sulcus) (Figure 5.9 A). To simplify, for the purpose of quantitative 
analysis, the subpial zone in the present study was defined as extending from the pia to a 
depth of 100 µm at the fimbria, 70 µm at the prosubiculum and 40 µm below the pial surface 
at the alveus, subiculum, medial and lateral entorhinal cortex and collateral sulcus. 
 
 
 
 
 
 
 
Chapter 5 Corpora amylacea Distribution 
167 
 
A 
APS FPS PPS SPS MPS LPS CPS
0
50
100
150
Subpial zone thickness at seven pial surface regions
M
ea
n 
de
pt
h 
(μ
m
)
 
B 
 
C 
 
D 
 
E 
 
F 
 
G 
 
H 
 
Figure 5.9 CoA density distribution in seven pial surface regions. 
Subpial zone thickness (µm) at seven pial surface regions (A). Pial surface regions at alveus 
(B), fimbria (C), prosubiculum (D), subiculum (E), medial entorhinal cortex (F), lateral 
entorhinal cortex (G) and collateral sulcus (H). Subpial zones (top red zones) vs. deeper 
neuropil zones (bottom purple zones), with the width of the subpial zones being 40, 100, 70, 
40, 40, 40 and 40 µm, respectively.  
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The deeper region with less CoA was referred to as the 'deeper neuropil zone' and for the 
purposes of analysis consisted of the remainder of the neuropil in each micrograph (purple 
enclosed zones in Figure 5.9). Comparisons between CoA packing density (count/mm2; 
calculated as the total CoA count in the region of interest) in the subpial zone and in the 
deeper neuropil zone are shown in Figure 5.10 A. CoA packing density in the subpial zones 
was significantly higher (4.36 − 18.28-fold) than in the deeper neuropil zones in all seven 
regions investigated; moreover, a similar pattern applied to the CoA area fraction 
comparison, with the subpial zones containing 4.44 − 20.35-fold more CoA than the 
corresponding deeper neuropil zones (Figure 5.10 B), detailed descriptive data for CoA 
packing density and area fraction comparisons are shown in Table 5.5.  
The mean diameters (µm) of CoA in the seven subpial zones were similar to those in the 
corresponding deeper neuropil zones (Figure 5.10 C), except in the subiculum where CoA 
had a larger mean diameter (1.16-fold) in the subpial zone than that in the deeper neuropil 
zone. Interestingly, there was a trend for smaller CoA minimum diameters in the subpial 
zones (Figure 5.10 D), with the difference reaching significance in the prosubiculum subpial 
zone (0.83-fold; 4.2 ± 0.2 vs. 5.1 ± 0.3, t (41.6) = - 2.702, p = 0.010 #, unequal variance). The 
CoA maximum diameters in the subpial zones were significantly greater than those in the 
deeper neuropil zones (Figure 5.10 E) in the fimbria (1.17-fold; 18.8 ± 0.6 vs. 16.1 ± 0.7, t 
(55) = 2.861, p = 0.006), prosubiculum (1.25-fold; 18.9 ± 0.6 vs. 15.1 ± 0.7, t (55) = 4.044, p 
< 0.001) and subiculum (1.26-fold; 17.1 ± 0.6 vs. 13.5 ± 0.8, t (43) = 3.645, p = 0.001).  
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Figure 5.10 CoA density and diameter in seven pial surface regions. 
CoA in the deeper neuropil zones (blank bars) and in the subpial zones (striped bars), 
comparing CoA packing density (A), area fraction (B), mean diameter (C), minimum 
diameter (D) and maximum diameter (E). Unpaired 2-tailed t-tests. Bars show mean ± SEM. 
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Table 5.5 CoA packing density comparisons between seven subpial zones and 
corresponding deeper neuropil zones.  
 
Position 
Mean ± SEM                   
(Subpial vs. Deeper neuropil) 
t (df) value p value# 
CoA 
density 
(count/ 
mm2) 
APS 393.0 ± 114.8 vs. 80.5 ± 29.1 t (32.7) = 2.640 0.013 
FPS 1832.3 ± 255.3 vs. 420.0 ± 91.4 t (36.3) = 5.208 < 0.001 
PPS 2095.2 ± 267.4 vs. 185.5 ± 30.6 t (29.8) = 7.097 < 0.001 
SPS 1464.1 ± 213.9 vs. 80.1 ± 18.1 t (23.3) = 6.447 < 0.001 
MPS 1135.7 ± 192.3 vs. 103.5 ± 41.5 t (25.1) = 5.245 < 0.001 
LPS 344.6 ± 115.9 vs. 38.1 ± 27.8 t (25.6) = 2.572 0.013 
CPS 671.4 ± 104.8 vs. 49.2 ± 12.3 t (23.6) = 5.898 < 0.001 
CoA area 
fraction 
(%) 
APS 2.11 ± 0.55 vs. 0.44 ± 0.16 t (33.9) = 2.896 0.007 
FPS 11.64 ± 1.36 vs. 2.62 ± 0.55 t (38.2) = 6.150 < 0.001 
PPS 15.34 ± 1.96 vs. 1.24 ± 0.22 t (29.7) = 7.158 < 0.001 
SPS 11.32 ± 1.57 vs. 0.56 ± 0.15 t (23.4) = 6.807 < 0.001 
MPS 8.67 ± 1.59 vs. 0.81 ± 0.33 t (25.0) = 4.842 < 0.001 
LPS 2.11 ± 0.70 vs. 0.19 ± 0.12 t (24.3) = 2.715 0.012 
CPS 4.37 ± 0.78 vs. 0.29 ± 0.08 t (23.4) = 5.181 < 0.001 
# Student’s t-tests with unequal variances. APS: alveus pial surface, FPS: fimbria pial 
surface, PPS: prosubiculum pial surface, SPS: subiculum pial surface, MPS: medial 
entorhinal cortex pial surface, LPS: lateral entorhinal cortex pial surface and CPS: collateral 
sulcus pial surface. 
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5.3.3 CoA distribution in relation to the vasculature 
CoA were observed near arterioles and venules in 17 (56.7%) of the 30 OSA hippocampal 
tissues examined in the present study. However, it needs to be noted that in these 17 
specimens, the vast majority of arterioles and venules in the deeper neuropil had no 
detectable CoA in their vicinity (Figure 5.11 A & B). In the rare instances where CoA were 
observed in association with deep blood vessels, they did not appear to be preferentially 
located around arterioles or venules (Figure 5.11 C & D). Although arterioles and venules 
located close to the pial surface were more frequently surrounded by CoA (Figure 5.11 E & 
F), the correspondence did not appear to be strong, and larger blood vessels such as these 
were infrequent. Due to the limited number of vessels that had CoA clustered around them, it 
was not possible to conduct a quantitative analysis of this relationship.  
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Figure 5.11 CoA deposition in relation to venules and arterioles in the deeper neuropil 
and subpial regions. 
The deposition of CoA in relation to arterioles (A, C & E) and venules (B, D & F) in the grey 
matter (A & B), white matter (C & D) and subpial region (E & F). Examples of individual 
CoA are indicated by white arrows. 
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The distribution of CoA was compared to the distribution of microvessels, as described in 
Chapter 4 of this thesis. Although no quantitative comparison was made, it was evident that 
in all regions of the hippocampus very few microvessels are present near the pial surface, and 
there is a well-defined avascular zone, 80 – 200 µm wide, between the pial surface and where 
the first microvessels can be seen (Figure 5.12). Interestingly, CoA tend to aggregate in this 
avascular zone, suggesting that there is an inverse relationship between the packing densities 
of CoA and microvessels.  
  
  
Figure 5.12 Microvasculature and CoA density in subpial regions. 
Adjacent brain sections showing the inverse relationship between microvasculature (A & C; 
double-immunolabeled with Collagen IV and GluT-1) and CoA (B & D) in the pial surface 
regions of the alveus (A & B) and prosubiculum (C & D). There are very few microvessels 
within 100 µm of the pial border (avascular zone, red enclosed zone), whereas CoA reach 
their peak abundance in this zone (white enclosed zone). An example of an individual 
microvessel is indicated by the red arrow in A, and an individual CoA is indicated by the 
white arrow in B. 
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5.3.4 CoA progression in relation to natural ageing 
The association of patient age with CoA stages and ranked sequence were investigated. The 
mean age of patients did not differ systematically as a function of CoA stage (Table 5.6). 
Moreover, there was no significant correlation between age and ranked CoA sequence (r2 = 
0.080, p = 0.130; Figure 5.13). 
Table 5.6 Mean age of patients for each classified CoA stage. 
 Stage 0 Stage 1 Stage 2 Stage 3 Stage 4 
n 1 2 8 14 5 
Mean age 74.1 64.8 ± 8.0 68.0 ± 4.9 64.0 ± 2.8 76.8 ± 1.9 
40 50 60 70 80 90 100
0
10
20
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Age (years)
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B r2= 0.080, p=0.130, n=30
 
Figure 5.13 Scatterplot showing that postulated CoA sequence is not significantly 
correlated with patient age. 
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The seven pial surface regions were examined to determine whether correlations exist 
between patient age and CoA number, however no significant correlations were found 
between age and CoA count or between age and CoA area fraction (Table 5.7). However, the 
sizes of CoA were found to increase with natural ageing (highlighted with coloured shading). 
Scatterplots of the positive linear regressions of age with CoA mean, minimum and 
maximum diameters are shown in Figure 5.14. Patient age was significantly correlated with 
larger CoA mean and maximum diameters in the fimbria pial surface (r2 = 0.384, p < 0.001; 
r2 = 0.261, p = 0.005; Figure 5.14 A & B), prosubiculum pial surface (r2 = 0.265, p = 0.004; 
r2 = 0.196, p = 0.016; Figure 5.14 C & D), subiculum pial surface (r2 = 0.535, p < 0.001; r2 = 
0.413, p < 0.001; Figure 5.14 E & F) and medial entorhinal cortex pial surface region (r2 = 
0.304, p = 0.006; Figure 5.14 G); moreover, a significant positive linear correlation was 
found with CoA minimum diameter in the subiculum pial surface region (r2 = 0.210, p = 
0.028; Figure 5.14 H). 
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Table 5.7 Pearson’s correlation of patient age with tested CoA parameters. 
   APS FPS PPS SPS MPS LPS CPS 
CoA    
count 
r .115 -.216 -.018 -.105 .046 -.179 -.130 
p .547 .252 .926 .627 .832 .402 .545 
n 30 30 30 24 24 24 24 
Area 
fraction 
r .115 .035 .112 .167 .202 -.163 .100 
p .546 .854 .557 .436 .344 .446 .640 
n 30 30 30 24 24 24 24 
Mean 
diameter 
r .200 .619** .515** .732** .552** .087 .334 
p .373 .000 .004 .000 .006 .768 .120 
n 22 29 29 23 23 14 23 
Minimum 
diameter 
r .102 .089 .172 .458* .217 -.288 .371 
p .651 .648 .373 .028 .319 .317 .081 
n 22 29 29 23 23 14 23 
Maximum 
diameter 
r .407 .511** .443* .643** .219 .516 .288 
p .060 .005 .016 .001 .316 .059 .183 
n 22 29 29 23 23 14 23 
APS: alveus pial surface, FPS: fimbria pial surface, PPS: prosubiculum pial surface, SPS: 
subiculum pial surface, MPS: medial entorhinal cortex pial surface, LPS: lateral entorhinal 
cortex pial surface and CPS: collateral sulcus pial surface. 
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Figure 5.14 Correlations between patient age and CoA size. 
Scatterplots showing significant positive linear correlations between age and CoA mean 
diameter (A, C, E & G), maximum diameter (B, D & F) and minimum diameter (H) in the 
fimbria pial surface (A & B), prosubiculum pial surface (C & D), subiculum pial surface (E, 
F & H) and medial entorhinal cortex pial surface region (G).  
Chapter 5 Corpora amylacea Distribution 
178 
 
5.3.5 Summary 
The major findings of the present study are as follows:  
i) CoA are primarily located in the periventricular and subpial regions of the hippocampus. 
CoA are abundant in the wall of the lateral ventricle, alveus, fimbria, and in parts of the CA4 
that abut the lateral ventricle. In rare cases CoA can be found in the CA3 and CA1, but they 
are not observed in the CA2 or subiculum. 
ii) CoA aggregate beneath the pial border in a clearly-defined subpial zone (40 – 100 µm 
thick), where the CoA density is significantly greater than in the deeper tissue. 
iii) It was inferred that there is a progressive spread of CoA from the fimbria region through 
the subpial zone towards more peripheral regions, eventually reaching the collateral sulcus. 
iv) CoA do not preferentially aggregate within the perivascular spaces around arterioles or 
venules, and they are most abundant in the avascular subpial zone. 
v) Natural ageing does not account for changes in the spatial distribution of CoA or changes 
in their numbers, however ageing strongly accounts for differences in the diameters of CoA, 
with increasing age being associated with larger CoA. 
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5.4 Discussion 
This prospective study investigated the distribution of CoA in the hippocampus of OSA 
patients, and on the basis of these observations has proposed a spatiotemporal sequence to 
describe the spread of CoA. Importantly this sequence does not correlate with patient age, nor 
do the numbers of CoA in the subregions investigated, suggesting that factors other than age 
are more influential mediators of CoA deposition. On the other hand, patient age correlated 
strongly with the mean and maximum diameters of CoA, supporting the view that CoA 
increase in size with age. The majority (97%) of CoA in the hippocampi examined were 
distributed in periventricular and subpial regions, which is consistent with previous reports. 
Fewer CoA were observed in the CA1, CA2, CA3 and subiculum than in previous studies. In 
all regions where CoA were present, they were concentrated within an avascular zone that 
extended  40 – 100 µm below the pial surface. The implications of these interesting findings 
are discussed in the following sections. 
CoA were detected in 97% (29 out of the 30) of the hippocampal specimens examined in the 
present study, which is a higher prevalence than reported by other studies: 63% (26 out of 41) 
of hippocampal sclerosis specimens (Van Paesschen, Revesz et al. 1997) and 57% (33 out of 
58) of patients with mesial temporal lobe epilepsy (Cherian, Radhakrishnan et al. 2003). 
Immature CoA were found in the CA1 field of the hippocampus in 52% (24 out of 46) of 
patients with mesial temporal lobe epilepsy or hippocampal sclerosis (Das, Balan et al. 2011). 
The higher incidence of CoA observed in the present study may be due to methodological 
considerations, such as the greater sensitivity of autofluorescence for detecting CoA, our use 
of thicker brain sections, and our investigation of more extensive areas of tissue. 
Alternatively, the higher incidence of CoA in hippocampi from OSA patients may indicate 
that OSA favours the deposition of CoA. This latter possibility will be explored in Chapter 6. 
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In the present study, the mean diameter of CoA was found to be 9.1 ± 0.1 µm, and ranged 
from 6.1 – 15.3 µm; while the CoA minimum diameter varied from 3.3 – 11.5 µm, and the 
CoA maximum diameter ranged between 7.7 – 25.3 µm. These results are consistent with 
previous reports that the mean diameters of CoA in the human central nervous system range 
from approximately 4-12 µm and that the diameters rarely exceed 20 µm (Mizutani, Satoh et 
al. 1987, Kubota, Holbach et al. 1993, Cavanagh 1998). In a recent confocal 
microscopy ultrastructural study, immature intracellular CoA were reported to be smaller 
(1.87  − 11.36 μm), while mature extracellular CoA measured from 4.49 − 18.41 μm (Augé, 
Bechmann et al. 2019). It can therefore be concluded that the majority of CoA investigated in 
the present study were mature CoA. This is pertinent, since immature CoA may be disposed 
of and cleared by the perivascular system (glymphatic system), whereas this does not appear 
to be the case for mature CoA (Navarro, Genoud et al. 2018). 
The present study found that CoA generally occur in proximity to the lateral ventricle and 
subarachnoid space. CoA were common in the walls of the lateral ventricle, fimbria and the 
angle of the CA4 that is closest to the lateral ventricle. This pattern, together with the CoA 
distribution in seven subpial regions, is consistent with reports that CoA in AD are 
concentrated in periventricular and subpial regions of the hippocampus (Augé, Duran et al. 
2018). The present study also detected CoA in the pial surface of the medial and lateral 
entorhinal cortex, which is consistent with a report of CoA in the entorhinal cortex of two 
AD patients (Pisa, Alonso et al. 2018). In contrast, a case report observed CoA in the 
mediotemporal lobe and left parahippocampal white matter of a 49-year-old woman with a 
long history of headaches (Abel, Hebb et al. 2010), but no CoA were detected in cortical gray 
matter, cornu ammonis (CA) subfields, or the dentate gyrus (Abel, Hebb et al. 2010). 
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The present study detected CoA in the CA1 and CA3 regions of just 10 − 13% of subjects, 
and none were observed in the CA2 or subiculum regions. Thus, apart from the CA4 and 
fimbria, most of the hippocampus lacked CoA. This distribution differs substantially from 
the distribution of CoA in CA-subregions of the hippocampus reported by other studies. 
For example, in three aged healthy subjects and three aged Parkinson’s disease sufferers, 
CoA were observed in the CA2, as well as in the CA4 of the hippocampus (Navarro, 
Genoud et al. 2018). In another study, CoA were found in the fimbria, alveus, CA3, CA2, 
CA1 and subiculum of a 39-year-old woman with complex partial seizures (Nishio, Morioka 
et al. 2001). CoA were also observed in the CA4, CA3, CA2, CA1, subiculum and 
parahippocampal white matter of patients with complex partial seizures and Ammon's horn 
sclerosis (Erdamar, Zhu et al. 2000). Therefore, it is likely that the pattern of CoA deposition 
is linked to specific neurodegenerative conditions. This possibility will be explored in greater 
detail in Chapter 6.  
One of the dominant hypotheses concerning the nature of CoA is that they are waste 
containers that are trafficked from the brain into the blood (Augé, Cabezón et al. 2017). Three 
lines of evidence from the present study do not support this idea. First, CoA were not 
commonly observed in proximity to the perivascular space around blood vessels. Only a 
small number of hippocampal specimens in the present study exhibited CoA clustered around 
the walls of any blood vessels. These sporadic vessels had large diameters and were located 
in the deep white matter. Second, in the rare instances where CoA were observed in the 
perivascular space, they were observed equally often around arterioles and venules. Since 
only venules, with their thinner walls and lower blood pressure convey waste from the brain, 
the lack of a preferential distribution around venules argues against the waste disposal 
hypothesis. Third, CoA are most prevalent in the subpial zone, within 100 µm or so beneath 
the pial surface. It is notable that adjacent brain sections that had been immunostained to 
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show the microvessels demonstrated a lack of microvessels in this subpial region. Taken 
together, these three sets of observations make it unlikely that CoA are cleared into the 
bloodstream, unless the clearance rate is highly efficient and results in the rapid removal of 
CoA from the perivascular space. 
Our finding that most CoA are located within 100 µm of the lateral ventricle or subarachnoid 
space (adjacent to the pia) is intriguing, as in living brains both of these spaces are filled with 
CSF. This correspondence raises the possibility that CoA may interact with the CSF, or as 
several authors have speculated, CoA may originate from exudates of the CSF (Tokutake, 
Nagase et al. 1995, Selmaj, Pawlowska et al. 2008, Meng, Zhang et al. 2009, Maurizi 2010, 
Nam, Kim et al. 2012). In the context of this hypothesis, the fimbria region is unique, because 
it consists primarily of myelinated axons and it is bathed on three sides by the CSF. Perhaps 
this stronger association with the CSF is why the fimbria is the first site of CoA deposition in 
the hippocampus. The fact that the smallest CoA are found in the subpial layer rather than in 
the deeper neuropil supports the idea that newly matured CoA originate in the subpial region 
rather than in the deeper neuropil. 
An unexpected finding to emerge from the present study was that the distribution of CoA in 
subpial regions of the hippocampus conformed to a pattern: when few CoA were present in a 
section they were invariably concentrated in and around the fimbria, and as the number of 
CoA increased, they systematically extended further away from the fimbria and were smaller 
in size. Thus the packing density and size of CoA peaked in the fimbria pial surface region, 
and adjacent regions displayed a progressive reduction in the density and mean diameter of 
CoA, specifically, alveus on one side and prosubiculum, subiculum, medial entorhinal cortex, 
lateral entorhinal cortex and collateral sulcus on the other side. Moreover, the CoA maximum 
diameter in the fimbria pial surface region was consistently greater than in the adjacent 
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regions, and the smallest mean and maximum CoA diameters were found in the collateral 
sulcus region. Since CoA size is positively correlated with age, the presence of larger CoA in 
the fimbria supports the idea that the fimbria region is the first site of CoA accumulation. The 
smaller CoA in the collateral sulcus region are consistent with the delay in CoA deposition, 
as the CoA gradually spread from the fimbria region along the pial border to the collateral 
sulcus region. If the most recently generated CoA have the smallest diameters, then the 
presence of the smallest minimum diameters in the fimbria region suggest that this region is 
the most active site of CoA generation. We speculate that the positive correlation between 
patient age and CoA diameter indicates that once formed, CoA remain for a long time, 
perhaps for several decades. During this time they gradually grow in size by fusion or by 
absorbing additional materials.  
Despite the high concentration of CoA in tissue that is close to the CSF, we consider that it is 
unlikely that CoA originate from the CSF. If CoA originated from the CSF, all subpial 
regions might be expected to show an equal burden of CoA, whereas this is clearly not the 
case. The spatiotemporal sequence of CoA spread proposed in the present study implies that 
either CoA migrate laterally away from the fimbria, or (more likely) that the process that 
leads to CoA formation propagates from an affected region into adjacent tissue. This 
postulated spatiotemporal spread of CoA resembles the transmission of an infection, and it is 
notable that some authors have claimed that CoA result from microbial infection and contain 
DNA and proteins from bacteria and fungi (Sfanos, Wilson et al. 2009, Yanamandra, 
Alexeyev et al. 2009, Pisa, Alonso et al. 2015, Pisa, Alonso et al. 2016, Pisa, Alonso et al. 
2016, Pisa, Alonso et al. 2018). Unfortunately it was not possible in the present study to assay 
our tissue for the presence of bacteria.  
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The postulated spatiotemporal sequence of CoA progression did not correlate with patient 
age, and therefore other factors must contribute to this apparent and consistent progression. 
Moreover, advancing age was not associated with increased CoA density (count or area 
fraction) in any of the regions investigated. Reports of a positive association between CoA 
count and patient age are limited to a single study of the retina and optic nerve (Kubota, 
Holbach et al. 1993), while another study was unable to find a significant correlation 
(Cavanagh 1998). Nonetheless, it is generally believed that there are more CoA with ageing, 
with a major increase after 40 years of age (Mizutani, Satoh et al. 1987, Cavanagh 1999). 
Since all of the brains in the present study were older than 40 years of age, our results 
indicate that once this age is reached, the relationship between CoA burden and patient age is 
weak.  
In conclusion, the present study has extended our understanding of CoA in the human 
hippocampus. While our data are consistent with the view that the size of CoA increases with 
age, CoA burden has been shown not to increase with age. Furthermore, the present data 
strongly argue against the prevailing notion that CoA are waste containers that are disposed 
of via the vasculature. The present data indicate that CoA originate from the fimbria and then 
systematically spread through the subpial region to adjacent regions and then subsequently 
spread to deeper parts of the neuropil. The basis of this spread is unknown, but it is not age-
related and may be related to pathological changes in the tissue. Since neurodegeneration and 
oxidative stress are widely regarded as causes of CoA formation, these possibilities will be 
explored in the following chapter. 
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Chapter 6 Factors that may contribute to the formation of corpora amylacea in the 
hippocampus of obstructive sleep apnoea patients 
6.0 Abstract  
A widely-subscribed view in the literature is that oxidative stress is the primary agent that 
causes corpora amylacea (CoA) to form. Since obstructive sleep apnoea (OSA) is widely 
considered to cause oxidative stress in the hippocampus, with the extent of oxidative stress 
increasing with OSA severity, this chapter has examined the relationship between CoA 
progression, numbers and size as a function of OSA severity. As treatment with continuous 
positive airway pressure (CPAP) is expected to reduce the severity of oxidative stress, this 
chapter has examined whether regular CPAP use is associated with a reduction in the CoA 
burden. A competing hypothesis posits that CoA are formed as a consequence of 
neurodegeneration; since a companion thesis (by Jessica Owen) has examined the distribution 
of amyloid beta (Aβ), neurofibrillary tangles (NFT), and grey and white matter loss in the 
hippocampus of this same hippocampal series, the present study examines the extent to which 
CoA burden is correlated with these markers of neurodegeneration. The results show that 
increased OSA severity is correlated with CoA progression along the pial surface, and that 
moderate-severe OSA patients have a higher CoA burden in the pial surface of the fimbria 
region. In contrast, CPAP use, the burden of Aβ plaques and NFTs, neuropil loss and 
demyelination had no appreciable effect on the distribution or numbers of CoA. Taken 
together, these findings imply that either OSA does not cause oxidative stress or (more likely) 
that oxidative stress does not influence CoA formation in the hippocampus of persons with 
OSA. Furthermore, the lack of correlation with markers of neuropathology strongly argues 
against neurodegeneration being a significant driver of CoA formation. These results provide 
a conceptual advance in the field, as they help to exclude influential hypotheses about CoA 
formation that until now have been untested. 
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6.1 Introduction 
Obstructive sleep apnoea is a sleep disorder characterised by repeated cessations in 
ventilation during sleep, caused by a collapse of the muscle tone in the upper airway 
(Dempsey, Veasey et al. 2010). These cessations of airflow are often accompanied by drops 
in the blood oxygen saturation level (SaO2), leading to chronic intermittent hypoxia (CIH) 
(Yadollahi, Giannouli et al. 2010). The repeated phases of tissue hypoxia followed by 
reoxygenation cause an overproduction of reactive oxygen species (ROS), which can result in 
oxidative stress if ROS production exceeds the capacity of the cellular antioxidant systems to 
inactivate the ROS (Eltzschig and Eckle 2011). Cellular damage caused by oxidative stress 
activates the inflammatory response; consistent with this, increased levels of markers of 
oxidative stress and inflammation have been reported in the blood of OSA patients compared 
to controls (Alberti, Sarchielli et al. 2003, Carpagnano, Kharitonov et al. 2003, Yamauchi, 
Nakano et al. 2005, De la Peña Bravo, Serpero et al. 2007, Nadeem, Molnar et al. 2013). In 
addition to being implicated in OSA, oxidative stress has been linked to the pathogenesis of 
ageing and Alzheimer’s disease (AD) (Mecocci, MacGarvey et al. 1994, Markesbery 1997).  
The hippocampus plays an essential role in learning and memory (Bartsch and Wulff 2015), 
and is vulnerable to pathologic insults including ischemia, oxidative stress, 
neurodegeneration and ageing (Kirino 2000, Bartsch, Döhring et al. 2015); moreover, in AD, 
the hippocampus is among the first and most extensively damaged regions of the brain 
(Robinson 2001, Mufson, Mahady et al. 2015). Both normal ageing and AD are associated 
with elevations in oxidative stress and cognitive decline (Liguori, Russo et al. 2018), so it is 
possible that the memory loss and cognitive impairments experienced by persons with OSA 
(Beebe and Gozal 2002, Ferini-Strambi, Baietto et al. 2003) are associated with hypoxic 
injury to the hippocampus. Indirect support for this idea comes from reports that hippocampal 
Chapter 6 Corpora amylacea Formation 
187 
 
structural deficits and cognitive impairments in OSA patients improve after CPAP treatment 
(Canessa, Castronovo et al. 2011, Ferini-Strambi, Marelli et al. 2013, Rosenzweig, Glasser et 
al. 2016). 
Memory loss and cognitive impairments correlate with reduced hippocampal volume in OSA 
patients (Macey, Henderson et al. 2002, Gale and Hopkins 2004, Canessa, Castronovo et al. 
2011, Torelli, Moscufo et al. 2011, Wang and Wang 2019). Interestingly, hippocampal 
degeneration (loss of grey matter volume and reduced white matter intensity) and memory 
impairments are also common among AD patients (Salat, Tuch et al. 2010, Arlt, Buchert et al. 
2013, Peng, Feng et al. 2015, Yi, Möller et al. 2016). These two observations may be linked, 
as OSA patients have increased risk of developing AD or dementia (Young, Peppard et al. 
2002, Gehrman, Martin et al. 2003, Rose, Beck et al. 2011, Yaffe, Laffan et al. 2011, Chang, 
Liu et al. 2013). Furthermore, a researcher (Jessica Owen) in our laboratory demonstrated 
cortical thinning and demyelination in response to increased OSA severity (ODI: oxygen 
desaturation index) in the same set of brain samples as used in the present study (Owen, 
Benediktsdottir et al. 2019). Moreover, Owen demonstrated that two neuropathological 
hallmarks of AD are present in in the hippocampus of OSA patients, with the burden of 
extracellular amyloid beta (Aβ) plaques and intraneuronal neurofibrillary tangles (NFTs) 
being significantly correlated with increased OSA severity (Owen 2017).  
 
Corpora amylacea (CoA) are spheroidal bodies consisting of glycoproteins that are found in 
the brains of humans and other mammals (Cavanagh 1999). The origin and function of CoA 
continue to be debated, with various hypotheses being proposed but not yet tested 
(Wilhelmus, Verhaar et al. 2011, Pisa, Alonso et al. 2016, Augé, Bechmann et al. 2019). 
The presence of CoA has been linked to advanced ageing and increased neurodegeneration 
(Cavanagh 1999, Selmaj, Pawlowska et al. 2008, Rohn 2015, Navarro, Genoud et al. 2018). 
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Furthermore, some CoA contain blood proteins that are normally found outside of the central 
nervous system, suggesting that leakage of the blood-brain barrier (BBB) is associated with 
the formation of CoA (Meng, Zhang et al. 2009, Navarro, Genoud et al. 2018). In this context 
it is noteworthy that chronic intermittent hypoxia and oxidative stress are known to impair the 
function of the BBB (Lim and Pack 2014, Pan and Kastin 2014). Recently, CoA have been 
suggested to act as ‘waste containers’ that assist in clearing or sequestering  damaged cellular 
materials and waste products (oxidised lipids and proteins) within a matrix of polymerized 
glucose (Augé, Cabezón et al. 2017, Augé, Duran et al. 2018, Navarro, Genoud et al. 2018, 
Augé, Bechmann et al. 2019). It has been proposed that CoA are drained into Virchow-Robin 
spaces and then eliminated from the brain via the glymphatic system (Cavanagh 1999, 
Navarro, Genoud et al. 2018). Furthermore, microbial infections have been suggested to 
contribute to the accumulation of CoA, because some CoA have been found to contain 
proteins of microbial origin (Pisa, Alonso et al. 2016, Augé, Cabezón et al. 2017, Augé, 
Pelegrí et al. 2018, Pisa, Alonso et al. 2018). 
In addition to the preceding hypotheses, the presence of CoA has been linked to cellular 
stress, particularly chronic hypoxia and oxidative stress (Keller 2006, Abel, Hebb et al. 2010, 
Pisa, Alonso et al. 2016). A recent study investigated the ultrastructure of CoA in the post-
mortem hippocampus of Parkinson’s disease sufferers and aged controls, and reported that 
they contained lipid membrane fragments similar to the plasma membranes of cells and the 
membranes of organelles (e.g. mitochondria and vesicles) (Navarro, Genoud et al. 2018). The 
brain contains a large amount of polyunsaturated fatty acids that are highly susceptible to 
oxidative stress and lipid peroxidation (Chiang 2006). Since oxidative stress and lipid 
peroxidation are elevated in OSA patients (Barcelo, Miralles et al. 2000, Lavie, Vishnevsky 
et al. 2004, Gozal and Kheirandish-Gozal 2008, Lavie 2015), it is anticipated that increased 
numbers of CoA will be found in the brains of patients with severe OSA. CPAP treatment has 
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been reported to reduce systemic oxidative stress (Christou, Kostikas et al. 2009, Del Ben, 
Fabiani et al. 2012) and to improve the antioxidant capacity in OSA patients (Barcelo, Barbe 
et al. 2006); therefore, it might be expected there would be a lower CoA burden in regular 
CPAP users. 
Perhaps the reason why there are so many competing hypotheses about the origins of CoA 
is that so little is known about them, and quantitative data concerning the distribution of 
CoA are virtually non-existent. This has made it difficult to ascertain whether the 
hypotheses are able to accurately predict the distribution of CoA. In order to address this 
issue, the present study utilises the quantitative data on CoA detailed in Chapter 5, and 
combines this with data previously obtained by Jessica Owen on indices of 
neurodegeneration (Aβ, NFT, neuropil loss and demyelination) in the same set of autopsy 
brain samples. This comparison has enabled an appraisal of the various hypotheses that seek 
to account for the formation of CoA. 
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6.2 Methods 
The present study used the data collected from Chapter 5, so the study sample, tissue 
processing, immunohistochemistry protocol and image analysis process were the same as 
previously described (sections 5.2.1 − 5.2.4).  
Five parameters of CoA were investigated: CoA count, the total number of CoA per field of 
view; CoA area fraction (%), the proportion of a field of view occupied by CoA; CoA mean 
diameter (µm), the average diameter of all CoA in a field of view; CoA min. diameter (µm), 
the minimum diameter of all CoA per field of view; and CoA max. diameter (µm), the 
maximum diameter of all CoA per field of view. The representative immunofluorescence 
micrographs and the corresponding processed images were shown in Figure 5.5. 
The data relating to Aβ phase, NFT stage, neuropil loss and demyelination were obtained 
from the PhD thesis conducted on the same set of brain samples by Dr. Jessica Owen (Owen 
2017). 
6.2.1 Statistical analysis 
Statistical analysis was performed with the IBM Statistical Package for the Social Sciences 
(SPSS version 21). Two-tailed student’s t-tests were used to compare the low OSA to high 
OSA groups, non-CPAP users to regular CPAP users; ANCOVA was performed to compare 
the group differences after controlling for age as a covariate factor. Pearson’s correlations 
were used to compare two continuous-level variables. GraphPad Prism 7 was used to 
generate graphs, presented as Mean ± SEM. Significant differences (p < 0.05) were indicated 
by an asterisk (*) with equal variances or a hash (#) with unequal variances. 
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6.3 Results 
6.3.1 The effect of OSA severity on CoA burden 
Hippocampal diagrams of CoA distribution were classified according to the definitions 
provided in section 5.3.1. There was one sample where no CoA were observable in the tissue, 
and this was classified as stage 0. Two samples were classified in stage 1 and were both from 
the low OSA group. Of the 8 samples classified as stage 2, 4 were from the low OSA group, 
while 4 were from the high OSA group. Stage 3 included 14 samples, 8 from the low OSA 
group and 6 from the high OSA group. Only 1 sample from the low OSA group was 
classified as stage 4, while 4 from the high OSA group were stage 4 (Figure 6.1 A). Overall, 
there was no significant difference between the low OSA and high OSA groups with respect 
to mean stage (Figure 6.1 B).  
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Figure 6.1 CoA distribution and development of stages of 30 brain samples. 
Frequency of CoA stages in the low (ODI < 20 events/h sleep; blank bars) and high OSA 
(ODI ≥ 20 events/h sleep; striped bars) groups (A). Mean CoA stage in the low and high OSA 
groups (B). Mean ± SEM. 
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The association of OSA severity with ranked CoA sequence (1 − 30) was investigated; these 
variables were positively correlated in a log linear manner (r2 = 0.137, p = 0.044), as shown 
in Figure 6.2 A. In contrast, CoA sequence was not significantly correlated with patient age 
(r2 = 0.080, p = 0.130; Figure 6.2 B), BMI (r2 = 0.076, p = 0.173; Figure 6.2 C), or time lived 
after OSA diagnosis (years) (r2 = 0.003, p = 0.768; Figure 6.2 D). 
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Figure 6.2 Postulated CoA sequence is significantly correlated with OSA severity. 
Scatterplots showing that postulated CoA sequence is significantly correlated with OSA 
severity (A), but not significantly correlated with age (B), BMI (C) or time lived after OSA 
diagnosis (D). 
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The relationship between OSA severity and several CoA parameters was examined in the 
seven pial surface regions described in section 5.3.1. The CoA count was higher (1.71-fold) 
in the high OSA group compared to the low OSA group in the pial surface region of the 
fimbria, but this difference was not statistically significant (199.6 ± 39.7 vs. 116.9 ± 18.5, t 
(19.8) = 1.889, p = 0.074 #, unequal variance; Figure 6.3 A). However, the CoA area fraction 
in the high OSA group was significantly larger (1.72-fold) in the fimbria pial surface region 
(6.28 ± 1.14 vs. 3.65 ± 0.49, t (19.0) = 2.110, p = 0.048 #, unequal variances; Figure 6.3 B). 
The mean diameters of CoA between the low and high OSA groups were similar in six of the 
pial surface regions, with the exception of the lateral entorhinal cortex pial surface region, 
where the mean diameter of CoA was significantly smaller (0.87-fold) in the high OSA group 
(8.4 ± 0.4 vs. 9.7 ± 0.3, t (12) = - 2.305, p = 0.040; Figure 6.3 C). Moreover, the minimum 
diameters of CoA in the high OSA group were also smaller (0.74 − 0.88-fold) in the fimbria 
pial surface region (4.3 ± 0.1 vs. 4.9 ± 0.2, t (27) = - 2.715, p = 0.011; Figure 6.3 D) and 
lateral entorhinal cortex pial surface region (5.5 ± 0.4 vs. 7.4 ± 0.5, t (12) = - 2.718, p = 
0.019; Figure 6.3 D). The maximum diameter of CoA did not differ between the two groups 
in any pial surface region (Figure 6.3 E). 
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Figure 6.3 The effect of OSA severity on CoA burden. 
CoA parameters in the low (ODI < 20 events/h sleep; blank bars) and high OSA (ODI ≥ 20 
events/h sleep; striped bars) groups in seven pial surface regions of CoA count (A), CoA area 
fraction (B), CoA mean diameter (C), CoA minimum diameter (D) and CoA maximum 
diameter (E). Unpaired 2-tailed t-tests between low vs. high OSA groups. Mean ± SEM. APS: 
alveus pial surface, FPS: fimbria pial surface, PPS: prosubiculum pial surface, SPS: 
subiculum pial surface, MPS: medial entorhinal cortex pial surface, LPS: lateral entorhinal 
cortex pial surface and CPS: collateral sulcus pial surface. 
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Based on the results presented in section 5.3.4, it is clear that patient age strongly influences 
the size of CoA. Therefore a one-way ANCOVA was performed between the low and high 
OSA groups to remove the covariate effect of age, as shown in Table 6.1. After controlling 
for the age effect, the comparison of CoA count in the fimbria pial surface region between the 
high OSA and low OSA group reached significance (p = 0.042), improving the original p 
value of 0.074 from the t-test. No further differences were observed between the t-tests and 
ANCOVA results in the fimbria pial surface or lateral entorhinal cortex pial surface regions. 
Moreover, patient age had no significant effect on CoA count, area fraction or minimum 
diameter, whereas age significantly contributed to the mean and maximum diameters, which 
is consistent with the results in Chapter 5. 
Table 6.1 Comparison between the low OSA and high OSA groups, showing the t-tests p 
values before adjustment and the ANCOVA p values after adjusting for patient age.  
Region CoA parameters Before adjustment Adjusted p value Age effect Sig. 
FPS 
CoA count 0.074 0.042* 0.135 
CoA area fraction 0.048* 0.049* 0.914 
CoA mean diameter 0.748 0.911 <0.001*** 
CoA min. diameter 0.011* 0.010* 0.391 
CoA max. diameter 0.509 0.713 0.006** 
LPS 
CoA count 0.217 0.190 0.333 
CoA area fraction 0.244 0.218 0.379 
CoA mean diameter 0.040* 0.036* 0.433 
CoA min. diameter 0.019* 0.031* 0.474 
CoA max. diameter 0.419 0.602 0.087 
FPS: fimbria pial surface region. LPS: lateral entorhinal cortex pial surface. The significance 
of the effect of patient age is shown in the last column. 
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6.3.2 The effect of regular CPAP use on CoA burden 
In order to investigate the effect of regular CPAP treatment on CoA parameters, comparisons 
were performed between non-CPAP users and regular CPAP users within the low and high 
OSA groups. With one exception, CPAP use was found to have no significant effect on CoA 
count, CoA area fraction, CoA mean diameter, CoA minimum diameter and CoA maximum 
diameter in any of the seven pial surface regions. There was no significant difference 
between regular CPAP users and non-CPAP users, except for the significantly larger CoA 
mean diameter (1.12-fold) in regular CPAP users in the low OSA group at the fimbria pial 
surface (9.4 ± 0.2 vs. 8.4 ± 0.3, t (13) = 2.591, p = 0.022; Figure 6.4 C). However, after 
controlling for the age effect with ANCOVA, the comparison failed to reach significance (p = 
0.209). 
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Figure 6.4 The effect of regular CPAP use on CoA burden. 
CoA parameters in non-CPAP users (blank bars) and CPAP users (striped bars) in the low 
(ODI < 20 events/h sleep; purple colour) and high (ODI ≥ 20 events/h sleep; pink colour) 
OSA groups of the fimbria region (A, C, E & G) and the fimbria pial surface region (B, D, F 
& H) of CoA count (A & B), CoA area fraction (C & D), CoA mean diameter (E & F), CoA 
minimum diameter (G & H) and CoA maximum diameter (I & J). Unpaired 2-tailed t-tests 
between non-CPAP users vs. CPAP users. Mean ± SEM. 
 
 
 
 
 
Chapter 6 Corpora amylacea Formation 
198 
 
6.3.3 The relationship between the burdens of Aβ, NFT and CoA 
The classified CoA stages were also analyzed by comparing them with their amyloid β phase 
(0 − 4) and neurofibrillary tangle (NFT) stage (0 − 4), as previously determined in the same 
set of human brain samples (Owen 2017).  If the classified CoA stages are linearly correlated 
with increasing AD pathology, then based on the number of cases of each CoA stage, the 
expected relationship with Aβ phase / NFT stage is illustrated in Figure 6.5 A. In this 
scenario there is 1 case of CoA stage 0, 2 cases of CoA stage 1, 8 cases of CoA stage 2, 14 
cases of CoA stage 3, and 5 cases of stage 4 which are distributed within 5 AD pathology 
stages (0 − 4). 
When CoA stage is plotted against actual Aβ phase / NFT stage, the pattern does not match 
the expected linear relationship. As shown in Figure 6.5 B, the 17 cases in Aβ phase 0 
corresponded to CoA stages 1 – 4, with most being at CoA stage 3. Moreover, the advanced 
Aβ phases 2-4 did not show a tendency to be associated with increasingly higher CoA stages. 
In contrast, the 8 cases in NFT stage 0 corresponded to CoA stages 1-3, with stage 2 being 
most common. For NFT stage 1, the majority of cases corresponded to CoA stage 3, and for 
NFT stage 2 an even higher number of cases corresponded to CoA stage 3. However, this 
weak linear trend did not continue for NFT stages 3-5  (Figure 6.5 C).  
Figure 6.6 illustrates the pattern of spatiotemporal spread of Aβ plaques and NFTs in brain 
sections from the same autopsy series that were examined in the present study (Owen 2017). 
It is notable that Aβ and NFT first appear in the vicinity of the collateral sulcus and then 
progressively spread across the entorhinal cortex, subiculum and CA1 towards the CA4 
region. This pattern is almost the exact opposite of the spatiotemporal spread of CoA, which 
begins in the fimbria and then progressively spreads towards the prosubiculum, subiculum, 
entorhinal cortex and finally reaches the collateral sulcus (see Figure 5.8). 
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Figure 6.5 The effect of AD pathology on CoA burden. 
A, the expected co-distribution between CoA stage and AD pathology stage, if the severities 
of the two markers were linearly related. B, the actual co-distribution of classified CoA stage 
with Aβ phase. C, the actual co-distribution of classified CoA stage with NFT stage in the 
hippocampus of OSA patients. 
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Figure 6.6 Illustration of amyloid phases and NFT stages. 
In the top four panels, the black circles indicate the presence of Aβ plaques, with larger 
circles indicating larger plaques. In the bottom four panels, black triangles indicate the 
presence of NFTs. Note that these diagrams are illustrative of the general trends and do not 
represent the locations of specific Aβ plaques or NFTs (reprinted from (Owen 2017)). 
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The CoA density (area fraction %) in seven periventricular and perivascular regions were 
compared as a function of each Aβ phase (0 − 4) and NFT stage (0 − 4), as shown in Figures 
6.7 and 6.8. The mean CoA density in Aβ phase 0 across all ten periventricular and subpial 
regions was similar to those in phases 1 – 3, with an exception of the increased CoA density 
in Aβ phase 4 (Figure 6.7 E), which was based on a single sample. There was no significant 
differences in mean CoA density between the five NFT stages (0 − 4) across all ten regions 
investigated (Figure 6.8 A − E).  
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Figure 6.7 Mean CoA density in five beta amyloid phases. 
Mean CoA density (area fraction %) in APS (alveus pial surface), FPS (fimbria pial surface), 
PPS (prosubiculum pial surface), SPS (subiculum pial surface), MPS (medial entorhinal 
cortex pial surface), LPS (lateral entorhinal cortex pial surface) and CPS (collateral sulcus 
pial surface) regions. Mean ± SEM. 
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Figure 6.8 Mean CoA density in five neurofibrillary tangle stages. 
Mean CoA density (area fraction %) in APS (alveus pial surface), FPS (fimbria pial surface), 
PPS (prosubiculum pial surface), SPS (subiculum pial surface), MPS (medial entorhinal 
cortex pial surface), LPS (lateral entorhinal cortex pial surface) and CPS (collateral sulcus 
pial surface) regions. Mean ± SEM. 
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6.3.4 The effect of neuropil loss and demyelination on CoA burden 
Hippocampal atrophy in the grey and white matter has been investigated in the same set of 
autopsy samples (Owen, Benediktsdottir et al. 2019). Therefore, the present study correlated 
CoA density with the extent of neuropil loss in the CA4 and lateral entorhinal cortex regions. 
Owen and colleagues (2019) reported significant negative correlations between OSA severity 
and CA4 length (r2 = 0.136, p = 0.038; Figure 6.9 A) and layer 1 thickness of the lateral 
entorhinal cortex (r2 = 0.186, p = 0.028; Figure 6.9 C), but not with the overall thickness of 
the lateral entorhinal cortex (r2 = 0.069, p = 0.196; Figure 6.9 B); moreover, an analysis of 
unpublished data from (Owen 2017), showed that OSA severity was not correlated with the 
overall myelin levels in the lateral entorhinal cortex (r2 = 0.058, p = 0.245; Figure 6.9 D). In 
the present study, the CoA density (count/mm2) in the CA4 was not correlated with CA4 
length (Figure 6.9 E), CoA density in the subpial zone of the lateral entorhinal cortex was not 
correlated with overall thickness of the lateral entorhinal cortex (Figure 6.9 F), while 
thickness of layer 1 of the lateral entorhinal cortex was weakly correlated (Figure 6.9 G). 
However, none of these associations reached significance. The only significant association 
found was between increased CoA density and increased myelin levels in the lateral 
entorhinal cortex region (r2 = 0.194, p = 0.031; Figure 6.9 H).  
In addition to CoA density, aspects of CoA size (mean diameter, minimum diameter and 
maximum diameter) also had no significant correlations with the neuropil loss/demyelination 
data (data not shown). 
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Figure 6.9 Correlations between CoA density and measures of neuropil loss or 
demyelination. 
The association of OSA severity with neuropil loss in CA4 (A), overall lateral entorhinal 
cortex (B) and layer 1 of lateral entorhinal cortex (C); as well as with amount of myelin in 
lateral entorhinal cortex (D). The association of CoA density with length of CA4 (E), 
thickness of overall lateral entorhinal cortex (F), layer 1 thickness of lateral entorhinal cortex 
(G) and amount of myelin in lateral entorhinal cortex (H). The amount of myelin was 
expressed as the inverse grey scale intensity of tissue immunostained for myelin basic protein 
(MBP). 
Chapter 6 Corpora amylacea Formation 
206 
 
6.3.5 Summary 
The major findings of the present chapter were: 
i) Increased OSA severity is associated with a more extensive spatiotemporal spread of CoA 
along the pial surface. 
ii) Increased OSA severity is associated with higher numbers and densities of CoA in the pial 
surface region of the fimbria. 
iii) Increased OSA severity is associated with smaller CoA mean diameters in the pial surface 
region of the lateral entorhinal cortex, and with smaller minimum diameters in the pial 
surface regions of the fimbria and lateral entorhinal cortex.  
iv) Regular CPAP treatment is not associated with any significant changes in CoA size or 
distribution. 
v) The patterns of spatiotemporal spread of Aβ and NFT are not associated with the 
spatiotemporal spread of CoA, and the burdens of Aβ and NFT are not associated with the 
burden of CoA. 
vi) The extent of neuropil loss and demyelination are not associated with the burden of CoA 
or their size. 
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6.4 Discussion 
Many hypotheses have been proposed to account for the formation of CoA; however 
quantitative data available to support or refute these hypotheses are scarce. The research in 
the present chapter has investigated whether the speculated causes of CoA can account for the 
CoA burdens in OSA patients. It was found that ranked CoA sequence (1 − 30) positively 
correlates with increased OSA severity, suggesting that OSA contributes to the CoA 
progression along the pial surface. Furthermore, the CoA area fraction (density) in the 
fimbria of the high OSA group (ODI ≥ 20 events/h sleep) was 1.72-fold higher than that in 
the low OSA group (ODI < 20 events/h sleep). In addition, in the lateral entorhinal cortex, the 
high OSA group had smaller CoA mean and minimum diameters (0.74 − 0.88-fold).  
In contrast to these effects, regular CPAP use had no significant influence on the distribution 
of CoA, suggesting that CPAP use cannot ameliorate the burden of CoA. Furthermore, the 
presence of CoA in hippocampi that lacked any AD pathologies, combined with the fact that 
the 5 Aβ / NFT stages did not differ with respect to CoA burden, suggest that no association 
exists between CoA and neurodegenerative changes. Moreover, there were no significant 
correlations between CoA density and neuropil loss / demyelination, suggesting that there is 
no association between CoA burden and neurodegeneration. The implications of these 
findings are discussed in the following pages. 
As discussed in Chapter 5, the individual brain samples were ranked from 1 to 30 according 
to the extent of their CoA burden at the pial surface. Since the spatial sequence was found not 
to be significantly correlated with ageing, we speculated that additional factors must 
determine the CoA progression from the fimbria to the collateral sulcus. The present study 
investigated the effect of increased OSA severity on CoA progression, and found a significant 
positive correlation between ranked CoA sequence and ODI. This finding is consistent with 
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the possibility that OSA contributes to the distribution of CoA in the periventricular and 
subpial regions of the hippocampus. Interestingly, the mean and minimum diameters of CoA 
in the lateral entorhinal cortex decreased as OSA severity increased. This observation is 
consistent with the idea that newly-generated CoA are small, and they gradually increase in 
size over time. This interpretation is also consistent with the data presented in the previous 
chapter which showed that the mean size of CoA increases with age. 
An influential hypothesis of CoA formation states that CoA are a marker of oxidative stress 
(Cissé, Lacoste-Royal et al. 1991, Schipper and Cissé 1995, Sahlas, Liberman et al. 2002). 
OSA is thought to be a potent source of oxidative stress, and this stress and the associated 
neuroinflammation are significantly attenuated after starting CPAP treatment (Carpagnano, 
Kharitonov et al. 2003, Alonso-Fernández, García-Río et al. 2009, Christou, Kostikas et al. 
2009, Del Ben, Fabiani et al. 2012, Tichanon, Wilaiwan et al. 2016). While the present study 
used archived autopsy materials for which serum levels of oxidative stress markers were not 
avaliable, we do have reliable data for regular CPAP use. It was expected that the regular 
CPAP users would experience less oxidative stress and have a correspondingly lower CoA 
burden than non-CPAP users with similar severities of OSA. However, the present results did 
not confirm this expectation, since no significant differences were found between regular 
CPAP users and non-CPAP users in terms of CoA count, area fraction or spatial extent. 
These results demonstrate that regular CPAP use is ineffective at reducing the burden of 
CoA, and withdraw support for oxidative stress as a primary driver of CoA formation in OSA 
patients. 
As most patients in the present study had pre-existing moderate-severe OSA before beginning 
treatment with CPAP, it is possible that the full complement of CoA was deposited early in 
the course of OSA, and no new CoA were added, even in untreated cases of OSA. While this 
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possibility seems unlikely, it cannot be excluded by the present data. However, it is possible 
to conclude that CPAP use does not lead to a reduction in CoA burden. Thus, if CoA are only 
generated in early OSA, this result means that they are never cleared from the brain. 
Alternatively, if they continue to be generated, then CPAP use does not affect their rates of 
production or clearance. 
If oxidative stress or neuroinflammation are not primary drivers of CoA deposition, another 
potential factor is sleep disruption. Sleep patterns typically get disrupted and fragmented in 
OSA patients (Malhotra and White 2002, Azagra-Calero, Espinar-Escalona et al. 2012, Kielb, 
Ancoli-Israel et al. 2012), which may compromise the capacity of the glymphatic system to 
clear immature CoA from the brain, resulting in an increased CoA density in the high OSA 
group. Such an argument has been advanced to explain the increased deposition of Aβ in 
OSA (Wu, Dunnett et al. 2019), and has been used to explain the proximity of CoA to blood 
vessels and within sites of glymphatic drainage (Navarro, Genoud et al. 2018). 
Since the frequency of sleep interruptions and arousals increase with as OSA severity 
increases, we considered whether a compromised glymphatic clearance system could account 
for the higher CoA burden in severe OSA. CPAP treatment is reported to restore sleep 
patterns and reduce fragmented sleep (Sullivan, Berthon-Jones et al. 1981, McArdle and 
Douglas 2001, Gelir and Ardic 2010, Tachikawa, Minami et al. 2017); although the present 
study has incomplete records for compliance and duration of CPAP use, those designated as 
CPAP users were using CPAP until their death, so their sleep patterns should have been fairly 
normal, and this should have allowed their glymphatic system to function normally. In view 
of this, the lack of difference in CoA burden between non-CPAP users and CPAP users  does 
not support the idea that CoA are cleared from the brain through the glymphatic system.  
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Since some CoA are reported to contain blood proteins (Meng, Zhang et al. 2009, Pisa, 
Alonso et al. 2016), a further possibility is that increased OSA severity compromises the 
BBB (Lim and Pack 2014), which then leads to an increased deposition of CoA. In this 
scenario CoA will form around those blood vessels that have a leaky BBB, and the burden of 
CoA would decrease with distance from these blood vessels. While such a relationship has 
been reported (Navarro, Genoud et al. 2018), this was based on an examination of a small 
number of selected vessels. The present study has examined far more brain tissue than 
Navarro and colleagues (2018), and has done so in a non-selective way; as noted in section 
5.3.3, most CoA in the present study were located within the avascular zone beneath the pia, 
and only on very rare occasions were CoA clustered in the Robin-Virchow space surrounding 
a blood vessel. Furthermore, in a study conducted in our laboratory on this brain series in 
which immunohistochemistry was used to detect proteins of blood origin, very little evidence 
was found of BBB leakage, and the few positive cases were not associated with moderate-
severe OSA (data not shown). Taken together, the present results do not support the 
hypothesis that a leaky BBB is the primary cause of CoA deposition in OSA. 
In AD, Aβ plaques and NFTs have both been reported to begin in the vicinity of the 
hippocampus before spreading to other cortical regions (Braak and Braak 1991, Thal, Rüb et 
al. 2000, Braak, Alafuzoff et al. 2006). A study in our laboratory found that OSA severity 
was significantly correlated with the distribution stages of Aβ and NFTs in the hippocampus 
(Owen 2017). Previous studies have reported that AD is associated with an increased burden 
of CoA (Cavanagh 1999, Meng, Zhang et al. 2009, Abel, Hebb et al. 2010, Lee, Kim et al. 
2017, Augé, Duran et al. 2018, Pisa, Alonso et al. 2018). For instance, Notter and Knuesel 
(2013) reported increased CoA deposition in the subiculum of AD patients compared to non-
demented individuals (Notter and Knuesel 2013), while Song and colleagues (2014) reported 
significantly increased CoA numbers in various hippocampal regions of patients with mild 
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cognitive impairment, when compared to cognitively normal controls (Song, Zukor et al. 
2014). Despite this apparent association between CoA and neuropathology in AD, the present 
study found no association between the burdens of Aβ or NFT and the burden of CoA in 
patients with OSA. Furthermore, the spatial distribution and spread of CoA across the 
subregions of the hippocampus progressed in the opposite direction to Aβ and NFT: CoA 
began in the fimbria and gradually spread laterally until they reached the collateral sulcus, 
whereas Aβ and NFT first appeared at the collateral sulcus and then gradually spread 
medially until they reached the CA4 and fimbria.  
Two potential explanations of this discrepancy come to mind. First, since the OSA patients in 
the present study were known not to suffer from dementia, it follows that if AD causes CoA 
deposition, it may be caused by an aspect of the disease that is independent of Aβ or NFTs. A 
second explanation comes from the fact that OSA increases the risk of developing AD (Pan 
and Kastin 2014, Osorio, Gumb et al. 2015, Brzecka, Leszek et al. 2018, Sharma, Varga et al. 
2018), and is commonly comorbid with AD (Cooke, Ayalon et al. 2009, Peter-Derex, 
Yammine et al. 2015, Emamian, Khazaie et al. 2016, Polsek, Gildeh et al. 2018). Therefore, 
the increased presence of CoA in AD may be due to the presence of comorbid OSA, rather 
than to AD itself. 
It has been suggested that CoA act as ‘waste containers’ that assist in clearing or sequestering  
damaged cellular materials and waste products (oxidised lipids and proteins) within a matrix 
of polymerized glucose (Augé, Cabezón et al. 2017, Augé, Duran et al. 2018, Navarro, 
Genoud et al. 2018, Augé, Bechmann et al. 2019). A corollary of this hypothesis is that those 
areas of the hippocampus that experience the greatest levels of cell damage in OSA should 
have the highest burdens of CoA. In OSA, hippocampal neuropil loss and demyelination 
involve the length of CA4, thickness of the CA1, thickness of some layers of the entorhinal 
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cortex, and the myelin of the deep cortical white matter, and all of these losses are correlated 
with increases in OSA severity (Owen, Benediktsdottir et al. 2019). Therefore the present 
study investigated whether a correlation exists between CoA burden and thinning in the CA4 
or CA1 or thinning of the lateral entorhinal cortex. 
The CA1 region of the hippocampus is particularly sensitive to intermittent hypoxia and 
oxidative stress (Gozal, Gozal et al. 2002, Row, Liu et al. 2003, Snyder, Shell et al. 2017), 
and there is increased neuropil loss in the CA1 in response to increased OSA severity, as 
demonstrated by significant negative correlations between OSA severity and the thickness of 
most of the layers of the CA1 (Owen, Benediktsdottir et al. 2019). However, the present 
study found no association between the thickness of the CA1 and CoA burden; indeed, only 4 
brains out of the 30 examined contained any CoA in the CA1 region. This absence of an 
association strengthens the earlier conclusion that oxidative stress is not a driver of CoA 
formation. Moreover, CoA density in the CA4 and subpial zone of the lateral entorhinal 
cortex were not significantly correlated with the length of the CA4, or the overall thickness of 
lateral entorhinal cortex, demonstrating that CoA burden is not associated with neuropil loss. 
Although CoA burden was significantly correlated with the amount of myelin in the lateral 
entorhinal cortex, this correlation was a positive one, so it is inconsistent with the hypothesis 
that CoA originate from fragments of oxidised myelin that result from demyelination 
(Singhrao, Neal et al. 1994, Singhrao, Morgan et al. 1995, Cavanagh 1999, Selmaj, 
Pawlowska et al. 2008). Taken together, our results are inconsistent with those hypotheses 
that posit that CoA are caused by neurodegeneration (Keller 2006, Wilhelmus, Verhaar et al. 
2011, Rohn 2015, Schipper and Song 2015, Augé, Cabezón et al. 2017). 
One hypothesis of CoA formation that the present results do not rule out is the idea that CoA 
are formed by, or in response to, a bacterial infection of the brain. This hypothesis is 
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supported by evidence of bacterial and fungal proteins and neo-epitopes within CoA (Pisa, 
Alonso et al. 2016, Augé, Cabezón et al. 2017, Augé, Pelegrí et al. 2018, Pisa, Alonso et al. 
2018). In the present study, the systematic spatiotemporal spread of CoA from the fimbria to 
adjacent pial surface regions may be consistent with the slow spread of an infection between 
adjacent regions at the pial surface. However, as the present study was unable to examine the 
tissue sections for the presence of bacterial markers, this will need to be a topic for a future 
study.  
Several studies have noted that CoA contain high concentrations of metal ions. For instance 
Singhrao and colleagues (1993) reported that CoA in AD brains and in normal controls 
contain elevated levels of iron and copper, but not aluminium (Singhrao, Neal et al. 1993). 
However, a recent study of brain tissue from patients with multiple sclerosis has reported that 
extracellular deposits of aluminium, not normally found in brain, colocalise with some CoA 
(Mold, Chmielecka et al. 2018). Those authors postulate that as aluminium is neurotoxic, its 
concentration within some CoA may represent the debris of neurons that have died from 
neurotoxicity. This finding may be relevant to OSA, because approximately 50% of OSA 
patients suffer from gastroesophageal reflux disease, and as the severity of OSA increases, 
there is a heightened risk of gastroesophageal reflux disease (Kim, Lee et al. 2018, Wu, Yang 
et al. 2019). The most common treatment for gastroesophageal reflux disease is the 
consumption of antacid solutions or tablets that contain aluminium hydroxide (e.g. Gaviscon; 
(Mandel, Daggy et al. 2000)). Given this link between OSA severity and the dietary 
consumption of aluminium, there is a need to investigate whether CoA in OSA contain 
elevated levels of aluminium, as this may provide insights into whether aluminium 
contributes to the deposition of CoA. 
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In conclusion, the present study has shown that oxidative stress, fragmented sleep, BBB 
leakage, neurodegeneration, neuropil loss and demyelination are unlikely to be significant 
contributors to CoA formation in OSA. Nonetheless, since CoA burden was correlated with 
the severity of OSA, another factor associated with OSA is likely to be a cause. Further 
investigations are required to determine the factors responsible for causing CoA to deposit in 
the hippocampus of OSA patients. 
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Chapter 7 General Discussion 
7.0 Overview 
The present thesis investigated angiogenesis and microvascular remodelling, microvascular 
abnormalities, and the distribution and burdens of CoA in the hippocampi of OSA patients. 
The research also examined whether OSA severity, regular CPAP use or advancing age 
influence the above-mentioned parameters. Investigations were made by comparing low vs. 
high OSA groups, non-CPAP users vs. CPAP users, and patients aged < 67.5 years vs. those 
aged > 67.5 years. Of note is the significant correlation (r2 = 0.175, p = 0.019) between OSA 
severity (ODI) and patient age in the present study; it is likely that age contributes to some of 
the significant changes observed in relation to OSA severity. 
Chapter 3 investigated whether OSA severity influences angiogenesis or microvascular 
remodelling. While no evidence of angiogenesis was found, microvascular remodelling was 
found to occur in response to both increased OSA severity and ageing (Figure 7.1 A). 
Chapter 4 investigated the effect of OSA severity on microvascular abnormalities, which 
were mostly observed in the selectively vulnerable CA1 region in response to increased OSA 
severity and ageing (Figure 7.1 B). 
Chapter 5 investigated the distribution of CoA in the hippocampus of OSA patients in 
relation to ageing. While the diameters of CoA were found to increase with age, no 
associations with increasing age were found between ranked CoA sequence or CoA density 
(Figure 7.1 C). 
Chapter 6 investigated other factors that have been postulated to contribute to CoA formation. 
It was found that the ranked CoA sequence, CoA density and size were associated with OSA 
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severity, whereas CPAP use or markers of neurodegeneration, neuropil loss and 
demyelination had no association with CoA distribution, density or size (Figure 7.1 D & E). 
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Figure 7.1 Schematic illustration of the main findings in relation to the research aims. 
The arrows indicate the main independent variables considered in relation to the research 
aims in the four data chapters. The ticks indicate where the variables were found to have a 
significant effect, while the crosses indicate where no significant effect was found. The grey 
colour indicates no effect of these variables or no change to the investigated parameters. 
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While each of these findings were discussed in the relevant chapters, the purpose of the 
present chapter is to review these findings together, in order to: i) gain an appreciation of how 
the present study has advanced our understanding of the field; ii) describe the limitations of 
the present findings; and iii) outline how further research can build on the current findings. 
7.1 Increased microvascular remodelling in relation to advanced OSA severity and 
ageing 
OSA is characterised by intermittent hypoxia (Kanagy 2009, Lavie 2015, Li, Ren et al. 2018), 
and both angiogenesis and vascular remodelling have been reported in animal IH models 
(Kanaan, Farahani et al. 2006, Lim, Brady et al. 2016, Suarez-Giron, Castro-Grattoni et al. 
2018). Therefore it was hypothesised that angiogenesis and/or microvascular remodelling 
would be more common in the high OSA group when compared to the low OSA group. 
Indeed, the present study found that the high OSA group had significantly more 
microvascular remodelling (increased capillary diameter and length), however no evidence of 
angiogenesis was found in the hippocampi of OSA patients.  
The present study found no significant difference in the number of capillaries labelled with 
GluT-1 between the high OSA and low OSA groups, which contrasts with a previous report 
of increased capillary density (numbers of vessels labelled with GluT-1) in the hippocampus 
of IH mice compared to normoxic control mice (Kanaan, Farahani et al. 2006). This 
difference may result from the fact that Kanaan and colleagues (2006) used young mice, 
whereas the present study examined old humans; thus there could be species differences in 
the brain's response to intermittent hypoxia or alternatively, the capacity for angiogenesis 
may decline with age.  In support of this latter possibility, there were significantly fewer 
CD34-positive vessels in patients aged > 67.5 years compared to those aged < 67.5 years in 
the fimbria region (Figure 3.9 A), which is consistent with previous reports from animal 
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models that angiogenesis is impaired and delayed with age (Rivard, Fabre et al. 1999, Sadoun 
and Reed 2003, Ingraham, Forbes et al. 2008, Benderro and Lamanna 2011, Harb, Whiteus et 
al. 2013). Another possibility is that the degree of hypoxia experienced by mice in the IH 
model was more severe than the intermittent hypoxia experienced by humans with moderate-
severe OSA. In support of this possibility, Lim and colleagues (2016) reported that the extent 
of angiogenesis in mice varies in response to the severity of IH, and was only detectable at 
extreme hypoxia severities that are not observed clinically in OSA patients  (Lim, Brady et al. 
2016).  
In contrast to the lack of angiogenesis, the present study found clear evidence of 
microvascular remodelling (enlargement of capillary diameters and elongation of capillary 
lengths) in response to increased OSA severity and advanced age, in the fimbria and CA4 
regions (Figures 3.4, 3.5 and 3.9). The amount of remodelling was extensive, and contributed 
to a 30% increase in the area of brain tissue occupied by blood vessels (Figures 3.6 and 3.9). 
Such an increase in area fraction will improve blood flow to the fimbria and CA4 regions, 
and this adaptation will almost certainly confer a degree of protection from hypoxia. 
Conversely, the absence of microvascular remodelling in the CA1, subiculum or collateral 
sulcus regions suggests that these regions are less able to adapt to hypoxia and consequently 
are more vulnerable to hypoxic injury. Alternatively, these regions may receive better blood 
supply to begin with and consequently there may be a sufficient supply of oxygen even 
during severe episodes of hypoxia. As discussed in the following section, the former scenario 
appears to be more likely. 
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7.2 Compromised microvasculature may explain the selective vulnerability of CA1 
region 
While it is widely established that the CA1 region of the human hippocampus is particularly 
vulnerable to hypoxia, and is one of the first regions of the brain to show neurodegenerative 
changes after a severe hypoxic injury (Kreisman, Soliman et al. 2000, Fung, Xi et al. 2009, 
Fung, Xi et al. 2012), the reasons for this vulnerability are unknown. The present study did 
not find significantly increased angiogenesis or microvascular remodelling in moderate-
severe OSA patients in the CA1 region. By contrast, in mice exposed to hypobaric hypoxia 
for 4 weeks, significantly increased capillary diameters and elongated vessel length were 
reported in the CA1 region (Boero, Ascher et al. 1999). The conflicting results between the 
present study and that by Boero and colleagues (1999) are probably attributable to species 
differences or the fact that the mice used in Boero’s study were immature, at only 21 days old 
(Casoli, Spagna et al. 1996, Riddle, Sonntag et al. 2003, Burke and Barnes 2006, Topiwala 
and Ebmeier 2012). Regardless of the reason for the difference, the present data indicate that 
the CA1 region of the human hippocampus does not adapt to increased OSA severity by 
generating new microvessels or by remodelling existing ones. This lack of adaptation may 
render the CA1 more vulnerable to hypoxia than the fimbria and CA4 regions of the 
hippocampus that do adapt.  
A further indication that the CA1 is more vulnerable to hypoxia comes from our 
investigations of microvessel abnormalities; such vessels are markers of physiological stress 
and disease. The CA1 region of the moderate-severe OSA group had significantly increased 
numbers of string vessels (vessel diameter < 1.5 µm), narrowing vessels (narrowest vessel 
diameter > 1.5 µm and < 2.5 µm), strictures (abrupt narrowing with diameter typically less 
than 4 µm) and total abnormal vessels (string + narrowing + strictures) (Figure 4.3). No other 
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regions of the hippocampus exhibited increased numbers of abnormal microvessels in 
moderate-severe OSA. The smaller diameters of string vessels, narrowing vessels and 
strictures will have the effect of limiting regional blood flow, leading to compromised 
metabolic support for neurons. Since vessel diameter in the CA1 appears to be unable to 
increase in response to worsening OSA, we speculate that the associated hypoxia damages 
microvessels, which subsequently develop abnormalities that further restrict blood flow, 
creating a vicious circle that causes the neurons in CA1 to become selectively vulnerable to 
hypoxia. This scenario is consistent with a hypothesis by (Riddle, Sonntag et al. 2003) 
that  altered vessel shape and structure in old brains compromises blood flow and decreases 
metabolic support for neurons, while reduced microvascular plasticity in relation to ageing 
reduces the responsiveness of capillaries to increases in neural activity, collectively leading to 
cognitive disturbances. Thus the findings of the present study may have provided new 
insights into the basis of the CA1's vulnerability to hypoxia. 
7.3 Factors that may influence CoA burden and size 
Although many hypotheses have been proposed regarding the origins and functions of CoA 
in ageing and in neurodegenerative deseases, no study has investigated the presence of CoA 
in OSA. The present study investigated the distribution and progression of CoA in the 
hippocampus of OSA patients in relation to ageing. CoA were observed in 29 out of 30 
(96.7%) OSA patients, where they were mainly located in the periventricular regions (e.g. 
wall of lateral ventricle, alveus, fimbria) and the subpial regions (40 – 100 µm below the pial 
border). The extremely high incidence of CoA observed in the present study (96.7% of brains 
examined) was much higher than reported by previous studies (63%, 57% and 52%) of CoA 
in neurodegenerative diseases (Van Paesschen, Revesz et al. 1997, Cherian, Radhakrishnan et 
al. 2003, Das, Balan et al. 2011), and this high incidence supports the idea that OSA is a 
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primary cause of CoA deposition. This idea is further supported by our findings that the 
ranked CoA sequence (a measure of CoA progression) is significantly and positively 
correlated with OSA severity (Figure 6.2 A). Furthermore, the CoA density (count and area 
fraction) is significantly higher in the high OSA group compared to the low OSA group in the 
fimbria pial surface region, after controlling for the effect of age (Figure 6.3 A & B; Table 
6.1). 
In addition to OSA severity, the other factor found to correlate significantly with CoA was 
patient age. Interestingly, age did not correlate with CoA progression or CoA density, but 
instead increasing age correlated linearly with CoA size (Figure 5.14). In other words, CoA 
tend to be larger in older brains, which is consistent with a previous report that CoA grow 
larger with age (Cavanagh 1999). Thus, it is possible that CoA deposition begins early in life 
due to OSA (or another factor) and then the material in existing CoA is gradually added to 
over time so that they become larger. In such a scenario, the largest CoA will be the oldest, 
while the smallest will be the youngest. While we were unable to determine the age of CoA 
in the present study, it was noted that the smallest mean and maximum diameters of CoA 
were observed in the vicinity of the collateral sulcus (Table 5.4), which incidentally is the last 
region of the hippocampal formation to display CoA. By contrast, the largest maximum 
diameters and highest packing density were found in the fimbria, which is the hippocampal 
site where CoA deposition appears to begin (Figure 5.7). 
Since the findings presented in Chapters 5 and 6 of this thesis revealed that OSA severity is 
correlated with CoA burden and progression, the next step was to ask what features of OSA 
might conceivably be responsible for this association? Three features were considered: sleep 
fragmentation, oxidative stress and neurodegeneration. While direct data for sleep 
fragmentation and oxidative stress are not available for the patients included in this study,  it 
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was reasoned that as CPAP use is known to reduce both sleep fragmentation and oxidative 
stress in OSA, it should be possible to detect a protective effect of CPAP in the current 
dataset. However, no protective effect was found for CPAP use for any of the CoA 
parameters measured, making it unlikely that sleep fragmentation or oxidative stress are 
significant factors in the deposition or growth of CoA in OSA patients. This lack of an effect 
was unexpected. CoA have frequently been postulated to be a marker of oxidative stress in 
the brain, and CoA have also been postulated to be cleared via the glymphatic drainage 
system (Rohn 2015, Augé, Cabezón et al. 2017, Augé, Bechmann et al. 2019) that is believed 
to be compromised by frequent sleep disruptions (Xie, Kang et al. 2013, Jessen, Munk et al. 
2015, Ju, Finn et al. 2016, Ju, Zangrilli et al. 2019). The present data, showing the lack of a 
protective effect of CPAP, represent a major challenge to these two influential hypotheses of 
CoA deposition and clearance. 
Another influential hypothesis posits that CoA represent the debris of injured and dead 
neurons, and CoA are formed as a consequence of neurodegeneration (Erdamar, Zhu et al. 
2000, Kawamura, Morioka et al. 2002, Cherian, Radhakrishnan et al. 2003, Uckermann, Galli 
et al. 2017, Navarro, Genoud et al. 2018). The present study had multiple lines of direct 
evidence relating to this hypothesis: quantitative measurements of demyelination, neuropil 
thinning, Aβ plaque density and NFTs in the same tissue series as used in the present study. 
Remarkably, none of the measures in any of the hippocampal regions examined were 
significantly correlated with CoA burden, sequence or size. Indeed, the spatiotemporal spread 
of Aβ plaques and NFT's progressed in the opposite direction to the spatial progression of 
CoA. Taken together, these data rule out neurodegeneration as a causal factor in the 
formation of CoA.  
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Another hypothesis advanced to account for CoA formation is that CoA are composed of 
blood proteins that have leaked into the brain due to a compromised BBB barrier (Meng, 
Zhang et al. 2009, Pisa, Alonso et al. 2016, Navarro, Genoud et al. 2018). Since intermittent 
hypoxia and oxidative stress are thought to increase the leakiness of the BBB (Lim and Pack 
2014, Pan and Kastin 2014), OSA should favour the formation of CoA in the vicinity of 
blood vessels. However, in the present study, few CoA were observed in the immediate 
vicinity of arterioles or venules; indeed, the vast majority of CoA were located within 100 
µm of the pial border (Figures 5.9 and 5.12), which is an avascular zone. Thus the present 
observations are inconsistent with the hypothesis that CoA originate from a leaky BBB, at 
least in OSA patients. 
By undertaking the first systematic, quantitative investigation of CoA distribution, density 
and size in the human brain, this study has provided an opportunity to test the predictions of 
the various hypotheses that have been advanced (but not previously tested) to explain the 
occurrence of CoA. While the present results do not support any of the main hypotheses of 
CoA formation and clearance, they do indicate a role for OSA and ageing, and by so doing 
they help to clarify what directions may be fruitful for future research.  
7.4 Limited protective/reverse effect of regular CPAP treatment 
The present study found no evidence that regular CPAP use is able to ameliorate IH induced 
microvascular alterations (Figure 3.8), reduce the numbers of string vessels, narrowing 
vessels, strictures or total vessel abnormalities in the hippocampus of OSA patients (Figure 
4.6). Furthermore, CPAP use did not reduce the burden of CoA (Figure 6.4). Although there 
have been reports that CPAP can normalise sleep architecture, improve daytime productivity 
and daily function (Weaver and Grunstein 2008), and quality of life (Kandasamy, 
Almaghaslah et al. 2019), some aspects of impaired executive functions do not improve after 
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CPAP treatment, suggesting that CPAP treatment only partly reverses cognitive dysfunction 
in OSA patients (Ferini-Strambi, Baietto et al. 2003). It seems likely that by improving sleep 
quality, CPAP is able to improve those cognitive symptoms that are due to chronic tiredness, 
whereas neurodegenerative changes are fairly permanent and cannot be reversed by CPAP. 
Hence, a recommendation originating from the present study is to screen for OSA in all at-
risk individuals so that interventions may be started at an earlier stage, and the chances of 
minimising or reversing structural changes are maximised. If treatment is delayed until the 
person has had OSA for many years, the vascular changes and CoA deposition are unlikely to 
reverse, as the aged human brain loses its structural and functional plasticity (Casoli, Spagna 
et al. 1996, Riddle, Sonntag et al. 2003, Burke and Barnes 2006, Topiwala and Ebmeier 
2012).  
7.5 Limitations 
Due to the retrospective nature of the autopsy series used, the present thesis has several 
limitations, specifically: i) a modest sample size (31); ii) a sample consisting entirely of 
Icelandic participants; iii) the absence of a healthy age-matched control group; iv) incomplete 
clinical records; v) the autopsy samples are limited to the hippocampus and adjacent cortex. 
These limitations are discussed below. 
Sample size: Between 1987 and 2014, a total of 8,853 OSA patients (18 years and older) 
were registered in Iceland with a diagnosis of OSA, and by March 2014, 1322 had died. Of 
these, consents had been received from 121 patients (9.2% of those who had died) for 
donation autopsies after death. Only half of these donors (61) had autopsy material that 
included brain tissues, and half of these met the exclusion criteria for the present study: a 
diagnosis of dementia (including AD), head trauma, stroke, multiple sclerosis, cerebral 
infection, pulmonary disease, as well as treatment of OSA other than CPAP. Consequently, 
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the present study only had access to the hippocampal tissues of 31 (2.3%) of those in the 
program who had died.  
The relatively small sample size in the present study limited the statistical power, particularly 
once the group had been stratified by OSA severity and CPAP use. This limited power 
prevented the use of multivariate statistics that can assess the relative contributions of 
possible co-factors, such as age, gender and BMI. In future years, as more patients enrolled in 
the program die, it will be possible to confirm the present findings in a larger sample, and to 
conduct more thorough analyses of the influence of confounding variables. 
Icelandic sample: The samples were sourced from our collaborators (Prof. Thorarinn 
Gislason and Prof. Bryndis Benediktsdottir) in Iceland, therefore the OSA patients may not be 
representative of the global population, as Iceland is less genetically diverse (98.6% 
Caucasian plus 1.4 % other with no African American, Asian, or South American ethnicity) 
than many other countries  (Keenan, Kim et al. 2018). Genetic diversity is an important 
consideration, as genotype is known to affect OSA risk. For instance, south-east Asians have 
a craniofacial structure that predisposes individuals to develop OSA at a lower BMI than in 
Caucasians (Keenan, Kim et al. 2018); moreover, South Americans are particularly 
susceptible to the effect of weight gain on OSA severity, while African Americans are least 
affected (Sutherland, Keenan et al. 2019). The research team of our collaborators has 
identified three distinct clinical phenotypes of OSA patients in Iceland, namely a disturbed 
sleep cluster (32.7%), minimally symptomatic cluster (24.7%), and daytime sleepiness cluster 
(42.6%) (Ye, Pien et al. 2014). While these three clusters can be observed in more genetically 
diverse cohorts, the prevalence differs (19.8%, 40.4% and 39.8%, respectively) based on a 
global study from six countries (Keenan, Kim et al. 2018), demonstrating ethnic differences 
in clinical symptoms. Therefore, while the results of the present study are relevant to the 
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Icelandic population, and probably to Caucasians generally, their relevance to other ethnic 
backgrounds may be limited.  
No control group: The participants in the present study came from a pool of patients who 
were diagnosed with OSA, and who had agreed for their autopsy brain material to be used for 
research. Since it was not possible for a patient to join this pool if they did not have OSA, the 
present study lacks a control group of individuals who were diagnosed not to have OSA. 
Therefore, it was necessary to stratify the sample according to OSA severity, and to divide it 
into two groups based on the median ODI value. While some of the individuals in the low 
OSA group had very mild OSA, it is recognised that a future study would benefit from 
having a comparator group that consists entirely of individuals who had been diagnosed not 
to have OSA at the time of their death. Despite this limitation, the range of OSA severities 
encompassed by the present study (ODI range: 4.1 − 92.2 events/h sleep) was heterogeneous 
enough to allow assessments of whether the variables of interest were correlated with the 
severity of OSA. 
Incomplete clinical records: The hippocampal tissues were sourced from patients in Iceland 
who had been diagnosed with OSA as early as 1987. During last century, the medical records 
in Iceland were paper-based and some of these records have been misplaced in the 
intervening period.  Consequently, some of the medical records for these 31 patients lack 
AHI data, or data about CPAP compliance or data about the likely age of onset of OSA. 
Furthermore, at the time these medical records were obtained, the present study had not yet 
been conceived, so measures that seem obvious with the wisdom of hindsight (e.g. nadir O2, 
time spent less than 90% O2, serum markers of oxidative stress) were not recorded. Medical 
records collected since the turn of the century are more complete and more readily accessible, 
however few patients diagnosed after 2000 were able to be included in the present study.  
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Limited to hippocampus: The pathologist who collected the brain samples for autopsy did 
so before the present study was conceived. Consequently, not a great amount of care was 
given to obtaining identically-sized and similarly-oriented tissue blocks from each specimen. 
We are fortunate that the hippocampal blocks are comparable in size and orientation. 
However, tissue blocks from other brain regions were often unlabelled and appeared to have 
been collected in a less systematic manner, which prevented the present study from extending 
the analyses to other brain regions. In the future it will be important to systematically collect 
tissue from other key regions (e.g. basal ganglia, frontal cortex) in order to determine whether 
the findings from the present study can be generalised to other parts of the brain.  
The findings regarding the hippocampal microvasculature (Chapter 3 & 4) are likely to be 
generalisable to other brain regions. However, the CoA distribution and progression pattern 
(Chapter 5) reported here is specific to the hippocampus since CoA deposition starts from the 
fimbria and progresses bilaterally to adjacent subpial regions. It remains to be determined 
whether other brain regions exhibit a similar process, whereby CoA deposit at a precise 
subregion and gradually spread laterally from there. When it comes to the contributing factors 
to CoA formation (Chapter 6), the effects of increased OSA severity, oxidative stress, sleep 
fragmentation, BBB leakage, ageing, neurodegeneration, neuropil loss and demyelination can 
all be demonstrated at other brain regions.  
7.6 Directions for future research  
The preceding section highlighted some of the limitations placed on the present study, due to 
the use of archived autopsy material that had been collected prior to the inception of the 
present study. It is evident that there is a need for a prospective study that is able to confirm 
and build on the present findings. Such a study would include a larger sample of perhaps 200 
brains, plus a control group comprised of patients who had been verified not to have OSA. In 
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this ideal study, there would be full polysomnographic records for all participants including 
blood oxygen levels, continuous blood pressure measurements and CPAP compliance data. 
There would be detailed medical records for all participants including medication history, 
comorbidities, and cognitive status as confirmed by a clinical neuropsychologist. There 
would also be comprehensive assays of blood and urine samples for multiple markers of 
inflammation and oxidative stress. Furthermore, entire brains would be archived, so that 
identical blocks could be obtained from selected brain areas of interest. The ideal study 
would be a multicentre study that included a wide range of countries, so that ethnic and 
cultural factors could be controlled for.  
Another area for investigation is related to the microvascular alterations observed in OSA. It 
is clear that animal models of OSA offer some advantages with respect to being able to 
standardise environmental and genetic variables, to minimise the post-mortem interval, and to 
record parameters such as oxidative stress immediately prior to death. However, current 
animal models of IH routinely use young adult rodents, and it seems likely from the present 
study that the adaptiveness of the microvasculature diminishes significantly in old age. Thus 
if animal models of IH are to be representative of OSA they ought to be conducted on old, 
overweight rodents. 
The associations between microvascular abnormalities and regional CBF are worthy of future 
investigation. The microvessels examined in the present study demonstrated increased 
ultrastructural alterations in relation to OSA severity. One of the questions arising from this 
study is whether the microvessel abnormalities cause reduced CBF and lead to neuronal loss 
or whether insufficient microvascular remodelling causes stress to the tissue and leads to 
microvessel abnormalities. It might be possible to differentiate between these possibilities in 
animal models of IH.  
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The present study advanced our understanding of CoA distribution and progression in the 
hippocampus: starting from the fimbria region and spreading bilaterally to adjacent subpial 
regions with gradually reduced density. However, the mechanism(s) responsible for this 
progression cannot be determined at present. A speculation advanced here is that CoA are 
formed in the neuropil and then move towards the pial surface where they are cleared into the 
CSF. In support of this speculation, CoA were found to be more numerous and larger near the 
pial surface. Furthermore, individual CoA were sometimes observed on the pial surface, 
within the ventricular cavity (see Figure 7.2). Perhaps the rate of clearance of CoA from the 
ventricular surface is affected by the rate of flow of CSF through the ventricular system. 
Since the rates of CSF production and clearance slow down significantly with natural ageing 
(Masseguin, LePanse et al. 2005, Redzic, Preston et al. 2005, Kress, Iliff et al. 2014, Ma, 
Ineichen et al. 2017), this would reduce the rate of clearance of CoA and lead to a 
corresponding accumulation of CoA in the adjacent neuropil. Future studies can test this 
possibility by examining whether the protein components of CoA can be detected in the CSF, 
and if so, whether the concentration of these components decreases with age. 
 
Figure 7.2 Immunofluorescent micrograph of CoA on the ventricular side of the pial 
border. 
CoA were sometimes observed on the pial surface, where they appeared to be located within 
the ventricular cavity (arrows), rather than in the neuropil.  
Pial 
border 
CSF 
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The present study introduced a new way of quantifying the distribution, density and size of 
CoA in the hippocampus. It would be important to examine whether other brain regions show 
similar patterns of spatiotemporal spread in response to increasing severity of OSA. The 
results of the present study have challenged prevailing hypotheses of CoA formation and 
have cast doubt on age, oxidative stress and neurodegeneration as the primary causes of CoA 
formation. However, as the present study was unable to investigate other potential 
contributors to CoA formation, such as bacterial infections or aluminium accumulation, these 
factors ought to be the subject of future studies. 
7.7 Summary & Conclusions 
The present study has investigated the microvascular alterations and CoA burden in the post-
mortem hippocampi from 31 OSA patients (15 males and 16 females) from Iceland who died 
between 1987 and 2014, at an age that ranged between 41.7 – 89 years, with the average age 
at death being 67. The OSA severity (ODI) of these samples varied from very mild (4.1 
events/h sleep) to very severe (92.2 events/h sleep). Note that the slightly smaller sample size 
(n = 30) in Chapters 3 – 6 resulted from different reasons: patient number 18 was excluded in 
Chapters 3 & 4 due to faint immunostaining with the blood vessel markers; while patient 
number 19 was excluded in Chapters 5 & 6 due to insufficient hippocampal tissue being 
available for analysis. 
To summarise, the main conclusions are as follows: 
i) Increased microvascular remodelling and microvascular abnormalities are related to 
elevated OSA severity and advancing age.  
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ii) The absence of microvascular remodelling, combined with increased numbers of abnormal 
microvessels may contribute to the selective vulnerability of the CA1 region to hypoxia and 
oxidative stress. 
iii) CoA distribution and progression in the hippocampus are associated with increased OSA 
severity, while age is associated with an increase in the diameters of CoA. While OSA 
severity is likely to contribute to the formation of OSA; oxidative stress, sleep fragmentation, 
BBB leakage, ageing, neurodegeneration, neuropil loss and demyelination are unlikely to 
contribute. The actual mechanism(s) responsible for the formation of CoA is(are) yet to be 
elucidated. 
iv) The microvascular alterations and CoA burdens that are related to OSA severity cannot be 
reversed by CPAP treatment. To prevent these changes from occurring it may be necessary to 
begin CPAP treatment at an early stage of OSA. 
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